Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,-0.142115588518702,0.00273333141821935,-0.147472918098412,-0.136758258938992,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39980,0.442846362565339,0.011090643472141,0.421108701359943,0.464584023770736,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,40332,0.159910934331049,0.00372926196005233,0.152601580889347,0.167220287772752,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,-0.14974295402065,0.00268131350531172,-0.154998328491061,-0.144487579550239,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,0.143099845072917,0.00375205841973101,0.135745810570245,0.15045387957559,2.07950628723095e-302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,-0.0848725284821232,0.00246891663957054,-0.0897116050956815,-0.0800334518685649,6.60674713045637e-250
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,40293,0.122252098616328,0.00364004080815724,0.11511761863234,0.129386578600317,6.03618112716999e-239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37990,0.238925850948849,0.00713931993786281,0.224932783870638,0.25291891802706,5.36687564579929e-236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37562,0.284247579671671,0.00851239890060749,0.267563277826481,0.300931881516862,1.03759122818473e-234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,40305,0.275276067485607,0.00831672951286012,0.258975277640401,0.291576857330813,2.29507477630701e-232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,0.0807248957932837,0.00266340996532905,0.0755046122612388,0.0859451793253286,3.52090278808506e-196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40489,0.182720570784561,0.00604907025169577,0.170864393091238,0.194576748477885,5.41835999724148e-195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40516,0.145014013015063,0.00485353264711423,0.135501089026719,0.154526937003407,6.10578655861536e-191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,0.146172462774186,0.00493507977141941,0.136499706422204,0.155845219126168,7.9199239475039e-187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37987,-0.0627660930008503,0.00219631602030329,-0.0670708724006447,-0.0584613136010558,1.81653522133883e-174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,0.330565413901223,0.0120608432905884,0.30692616105167,0.354204666750777,1.14875901515995e-161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,0.129314126378174,0.00478436482015665,0.119936771330667,0.138691481425681,2.40036422691646e-157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,0.162913347540712,0.00614249012633019,0.150874066893105,0.174952628188319,1.21335368812792e-151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0766575506084106,0.00292851994435009,0.0709176515174844,0.0823974496993368,7.00122820909148e-148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.276568787290271,0.0107477769241331,-0.297634430061572,-0.25550314451897,3.9688257575317e-143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,40372,-0.0629557454608309,0.00245368577915734,-0.0677649695879793,-0.0581465213336826,2.66959244925559e-142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,-0.0725718324187391,0.00285479923704015,-0.0781672389233378,-0.0669764259141404,9.16978303723343e-140
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,38013,-0.150214378916248,0.00608212838101943,-0.162135350543046,-0.13829340728945,9.04220595970767e-132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,0.11652344747165,0.00490913872780677,0.106901535565149,0.126145359378152,2.05044963527647e-122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9,Complement component C9,37987,-0.104471272030717,0.00446930646619947,-0.113231112704468,-0.0957114313569663,1.67234743415245e-118
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40489,-0.0739628110250497,0.00317016484554874,-0.0801763341223252,-0.0677492879277741,2.00531473778131e-118
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,-0.112532085152814,0.0049053227206412,-0.122146517685271,-0.102917652620358,1.39292179540716e-114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,40357,0.11111700441522,0.00485874218683036,0.101593869729032,0.120640139101407,6.38533846573554e-114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,40280,0.162316663539283,0.00716630139803211,0.14827071279914,0.176362614279426,8.29690879761098e-112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,40359,0.122013410057749,0.00547468992752394,0.111283017799802,0.132743802315696,2.24840269321649e-108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,0.105235407442591,0.00475162235167404,0.0959222276333094,0.114548587251872,9.71368506658736e-107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.136752706106673,0.00621265344583983,0.124575905352827,0.148929506860519,8.4555620181625e-106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,-0.0441633631540888,0.00200769792609487,-0.0480984510892347,-0.0402282752189428,1.12205711746202e-105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,40359,-0.0921779957717412,0.0042246861699205,-0.100458380664785,-0.083897610878697,5.12008740171481e-104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,0.0639833433381956,0.00294064669238949,0.0582196758211122,0.069747010855279,4.05469788715678e-103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,40337,0.200898316963425,0.0092823641610056,0.182704883207854,0.219091750718996,2.12211478393748e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,40352,0.151472050331431,0.00701314948358198,0.137726277343611,0.165217823319252,5.42231987685343e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,40309,0.106371718582207,0.00492867267471422,0.096711520139767,0.116031917024647,7.66918371595499e-102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0816208685808973,0.00386173314165898,0.0740518716232457,0.0891898655385489,8.06810155498047e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39961,0.0975202003541479,0.00463159429266889,0.0884422755405169,0.106598125167779,4.63298475990788e-97
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FURIN,Furin,40411,0.0648939363869748,0.00309964524387598,0.0588186317089779,0.0709692410649717,4.9100690168107e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0572710896822574,0.00273960050070599,-0.0626407066636411,-0.0519014727008736,9.31306675460616e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40489,0.0648846859205077,0.00311785255978712,0.058773694903325,0.0709956769376905,6.20332315009592e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0661650864115773,0.00317975841050635,0.0599327599269849,0.0723974128961698,6.61547509349899e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40470,0.0382463836745587,0.00184223686841093,0.0346355994124733,0.0418571679366442,1.71138824763499e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,0.0496376207705288,0.00238901549655674,0.0449551503972776,0.05432009114378,2.15016644578034e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40536,0.0822936166329594,0.00397304934593678,0.0745064399149233,0.0900807933509954,4.45932693617549e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,0.0932881386152474,0.00451157027752864,0.0844454608712913,0.102130816359204,9.95579947366695e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,40332,0.0809569357270894,0.00392438856207791,0.0732651341454167,0.0886487373087621,2.50517709620122e-93
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40536,0.100356751910289,0.00488249727285191,0.0907870572554997,0.109926446565079,1.08851330784207e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,0.0642471461928503,0.00314647869967436,0.0580800479414886,0.0704142444442121,1.68076051436013e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,0.0694905421696803,0.00341033268913485,0.062806290098976,0.0761747942403846,3.84615766141803e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,40375,-0.0378271604841371,0.0018565410657599,-0.0414659809730265,-0.0341883399952477,4.02916971841696e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,-0.0636863680013881,0.00314305073854199,-0.0698467474489304,-0.0575259885538458,3.74146650827187e-90
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,40044,0.142514788332601,0.00706856378310404,0.128660403317717,0.156369173347485,2.90547055428778e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37671,0.0776352724850719,0.00384886403804067,0.0700914989705122,0.0851790459996316,3.84557470767361e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37572,0.146052029860001,0.00726023085016745,0.131821977393673,0.160282082326329,1.13826867572849e-88
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,0.137944461736089,0.00687655305487138,0.124466417748541,0.151422505723637,2.13832578594482e-88
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0780925340194745,0.00391128611251282,0.0704264132389494,0.0857586547999996,1.34719895136356e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0690571266600564,0.00347106419781855,0.0622538408323321,0.0758604124877808,8.32038394822441e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.049044107866136,0.00248412818432403,-0.0539129991074111,-0.0441752166248609,9.77711440743188e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.0997244126496746,0.00507886176311465,0.0897698435939699,0.109678981705379,7.85612978203334e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,40392,0.0580274768938887,0.00297469695737175,0.05219707085744,0.0638578829303373,9.05480717467008e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40453,0.207519599831303,0.0107981331621371,0.186355258833514,0.228683940829092,2.15499500239113e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,40415,0.0606454884412004,0.00315870232852904,0.0544544318772834,0.0668365450051173,3.07401564867233e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40502,-0.0955995982510013,0.00501039439296386,-0.10541997126121,-0.0857792252407921,2.84773843262798e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,40305,0.0629689909897951,0.00333921254535572,0.0564241344008978,0.0695138475786923,1.84150094817352e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,0.0800582976963977,0.00426543154841871,0.071698051861497,0.0884185435312984,9.26813561143293e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,40372,0.0309017696973262,0.00166353187893878,0.0276412472146062,0.0341622921800462,3.20909132379494e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,40398,0.109884601997241,0.00592553977268656,0.0982705440427758,0.121498659951707,5.70752336143001e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,40424,-0.0482899716388176,0.00260718281418336,-0.053400049954617,-0.0431798933230182,8.54445907745637e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0649906184771149,0.00352629132601328,0.0580790874781289,0.0719021494761009,4.45617009801107e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.0591304758626301,0.00321080469709679,0.0528372986563204,0.0654236530689399,5.82963240137729e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,39243,0.0674326652788162,0.00369157270439314,0.0601971827782056,0.0746681477794267,9.84866065017412e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40536,0.074863829720338,0.00412065990429135,0.066787336307927,0.0829403231327491,4.97440525801299e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37642,0.0604326796082708,0.00334561729671051,0.0538752697067182,0.0669900895098234,4.57436410152606e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37990,0.151612330552092,0.00842579442135692,0.135097773486233,0.168126887617952,1.48145192264894e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,40419,0.0971026398702897,0.00540660603026402,0.0865056920509722,0.107699587689607,2.02018996415369e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0688056013026515,0.00383996277417578,0.061279274265267,0.076331928340036,4.2635979398225e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.090696445670146,0.00506641327903967,0.0807662756432282,0.100626615697064,5.73026187777452e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,40376,0.0492732641317594,0.00277229040293272,0.0438395749420112,0.0547069533215075,5.37619409030097e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,40330,0.047509285675694,0.00267796403405336,0.0422604761689494,0.0527580951824386,9.55370052783059e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,0.0489126943731002,0.00276611901629232,0.0434911011011673,0.0543342876450332,2.61897470319607e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40516,0.049168481189513,0.0027819119757319,0.0437159337170784,0.0546210286619475,2.98877340922975e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,40338,-0.0744858812342224,0.00421508566729853,-0.0827474491421275,-0.0662243133263173,3.20663462297275e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,40372,0.0551769125875857,0.00313181071130748,0.0490385635934231,0.0613152615817484,8.02841203907026e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40516,0.0427799037684632,0.00242900560164592,0.0380190527892372,0.0475407547476892,8.8073255625269e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,0.0496132376386032,0.00282173999221838,0.0440826272538552,0.0551438480233513,1.49908111230514e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,40305,0.0805911976430386,0.00458820359769771,0.0715983185915511,0.0895840766945261,2.03415196833453e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0550294808440648,0.00313709459659781,0.048880775434733,0.0611781862533965,3.02843060172597e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.240202371109461,0.0137031668683673,0.213344164047461,0.267060578171461,3.83934790148808e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0557499325330673,0.00320759055365498,0.0494630550479035,0.062036810018231,4.75868738675295e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37901,0.109611933154174,0.00631913291974322,0.0972264326314775,0.121997433676871,1.1216963623491e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39963,0.0951755070141529,0.00550767417994149,0.0843804656214675,0.105970548406838,2.75165921889003e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,40422,-0.0707894102062742,0.0041046293996744,-0.078834483829636,-0.0627443365829124,4.73361987708471e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0505437901594994,0.00293899839950777,-0.0563042270225347,-0.0447833532964642,1.08374729315415e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,-0.0583339731209691,0.00339898193412802,-0.0649959777118601,-0.0516719685300782,2.51253356551577e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,40345,0.0492685100831621,0.00288028624506775,0.0436231490428293,0.0549138711234949,5.16152091464523e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40536,-0.0437977015509076,0.00256107188644608,-0.048817402448342,-0.0387780006534733,5.4450030490119e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.125123538901858,0.00732203537036511,0.110772349575942,0.139474728227774,6.87194413947468e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0837801933228698,0.00491299953548861,0.0741507142333121,0.0934096724124275,1.25258741329025e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,-0.0425341542400009,0.00250135459105452,-0.0474368092384678,-0.0376314992415341,2.81967494761118e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37671,0.0451965627452572,0.00267052912307868,0.039962325664023,0.0504307998264914,1.3921564192686e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.0718072867517259,0.00425421289857897,0.0634690294705111,0.0801455440329407,2.31850192091221e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,0.128272939487389,0.00766334914655982,0.113252775160132,0.143293103814646,2.35075554330626e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.13027445354354,0.00779656616812918,0.114993183854007,0.145555723233073,3.89734677361669e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,-0.042703266597563,0.00256571014055574,-0.0477320584730522,-0.0376744747220738,1.11089312942551e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.0902165684848022,0.00542751826030371,0.0795786326946069,0.100854504274997,1.63965851466679e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37959,0.0708438694422436,0.00426266636538627,0.0624890433660865,0.0791986955184006,2.04456366915188e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,40332,-0.0413355236514797,0.00249443354899013,-0.0462246134075004,-0.0364464338954591,3.6767005198987e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,40332,0.036236276663884,0.00219170230122433,0.0319405401534843,0.0405320131742837,6.80654101666685e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,-0.0395491167725255,0.00239896105160243,-0.0442510804336663,-0.0348471531113847,1.4554016028474e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.114731605186042,0.00696320623888096,0.101083720957836,0.128379489414249,2.09270149832667e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MME,Neprilysin,40305,0.124022052588133,0.00753640488353249,0.109250699016409,0.138793406159857,2.38807152726933e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.125091323307233,0.00769096616623703,0.110017029621409,0.140165616993058,6.39551226415806e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,0.0407599881621038,0.00251307863850939,0.0358343540306254,0.0456856222935822,1.33788062479325e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40536,-0.0245466462154167,0.00151948566328211,-0.0275248381154496,-0.0215684543153837,3.02919432478159e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,0.151692968872337,0.0094057617177717,0.133257675905505,0.17012826183917,4.87607550768811e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.0918952932806555,0.0057115206244305,0.0807007128567717,0.103089873704539,8.86483956650268e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0516058841362031,0.0032096095668366,-0.0578967188872028,-0.0453150493852034,1.01616780724552e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,0.0815602288917841,0.00507624934894245,0.0716107801678569,0.0915096776157113,1.26743108474075e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0645748617705523,0.00401977182485613,0.0566961089938343,0.0724536145472704,1.29089754608482e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.048995443996926,0.00305243551514132,0.043012670387249,0.054978217606603,1.5717784969702e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40516,0.0508695649884799,0.00317234562810069,0.0446517675574026,0.0570873624195573,2.02033211127903e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,-0.0365206766194339,0.00227806131825215,-0.0409856768032081,-0.0320556764356597,2.17439040889213e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37901,0.163928055750641,0.010234062066974,0.143869294099371,0.18398681740191,3.23946101823227e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40516,0.0395289994367968,0.00252443306569579,0.034581110628033,0.0444768882455605,7.38726583141109e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,40422,0.0593477058818972,0.00379749487387107,0.0519046159291099,0.0667907958346845,1.18956564992764e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0500789238542377,0.00322097763851493,0.0437658076827485,0.056392040025727,4.09610550388654e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40536,0.0809520916898793,0.00522993562302854,0.0707014178687433,0.0912027655110152,1.17928368223334e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0629534143586257,0.00406887187861006,0.05497842547655,0.0709284032407014,1.34234230986304e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,37345,-0.0639991457291994,0.00413715038078364,-0.0721079604755354,-0.0558903309828635,1.68776050784948e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,40465,0.0377931878261711,0.00245272478260129,0.0329858472522725,0.0426005284000696,3.44746183782539e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0533263487468052,0.00346113601546201,0.0465425221564996,0.0601101753371107,3.51604647632837e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37628,0.0776051802518435,0.00504815672880577,0.0677107930633842,0.0874995674403028,7.14448006164116e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0437052014902945,0.00285370365763495,0.03811194232133,0.049298460659259,1.43837132843374e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,40353,-0.0767996791750968,0.00501692135442012,-0.0866328450297602,-0.0669665133204333,1.59825767930849e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0403458752362965,0.0026411990882129,0.0351691250233992,0.0455226254491938,2.60569548463823e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,0.108961450639326,0.00714406566553094,0.0949590819348857,0.122963819343767,3.74325189338649e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,0.106759456856394,0.00701863835683561,0.0930029256769963,0.120515988035792,7.08614906610298e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,40224,-0.0401119710981954,0.00263807456294628,-0.0452825972415701,-0.0349413449548207,7.63500436636494e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.147791083128722,0.00972179438533082,0.128736366133474,0.166845800123971,7.95113066500145e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,0.0381296263265535,0.002511733059191,0.0332066295305392,0.0430526231225679,1.09085263136834e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,-0.0420425559438273,0.00277767041774787,-0.0474867899626132,-0.0365983219250415,2.17325714056178e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,40359,0.0828462197752618,0.00552053314172561,0.0720259748174796,0.0936664647330439,1.46720542968033e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0424303390287686,0.00283075668070603,-0.0479786221229524,-0.0368820559345848,2.24424684130657e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37981,-0.0504051886482547,0.00336516622494316,-0.0570009144491433,-0.0438094628473661,2.56688017837116e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40469,0.0851383515349929,0.00572038831115624,0.0739263904451267,0.0963503126248592,9.09692549863176e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFM,Afamin,38013,0.0256902224316504,0.00173037312206233,0.0222986911124083,0.0290817537508926,1.78862533184603e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.0536230736896656,0.00362074574813718,0.0465264120233167,0.0607197353560144,2.69692441711137e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,40332,0.0776037095889191,0.00524059762370621,0.0673321382464549,0.0878752809313833,2.76501490413411e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,40305,0.0759836575695653,0.00513372679819018,0.0659215530451125,0.086045762094018,3.0815822876251e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40471,-0.0511696726319535,0.00345846317639025,-0.0579482604576784,-0.0443910848062286,3.30885381770411e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,40434,0.0652869103490569,0.00441478889846409,0.0566339241080673,0.0739398965900465,3.68699506577558e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0753414154553569,0.00509988516241552,0.0653456405370225,0.0853371903736913,4.64221535460577e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.0756580949135856,0.00516923248703902,0.0655263992389891,0.085789790588182,3.44332803346824e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0571565867242069,0.00390746643695463,0.0494979525077758,0.064815220940638,3.85056905982016e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,40461,-0.0463005533528549,0.00317664455800573,-0.0525267766865461,-0.0400743300191636,8.16429188200171e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0328109389276557,0.00225118816301349,-0.0372232677271622,-0.0283986101281493,8.18004970940141e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,40228,-0.0449279725962998,0.00311530510330896,-0.0510339705987854,-0.0388219745938142,7.5058481540609e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0309777523822655,0.00215100857136946,0.0267617755823813,0.0351937291821496,9.94773539158461e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.122761270484962,0.00852644181917856,0.106049444519372,0.139473096450552,1.06590163150149e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REN,Renin,40359,0.0951023966278927,0.00663076430068137,0.0821060985985572,0.108098694657228,2.30665806634578e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OCLN,Occludin,37959,0.058018119365634,0.00404393211293152,0.0500920124242882,0.0659442263069798,2.43770028751393e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POSTN,Periostin,37998,-0.0501997387975808,0.00350938291540641,-0.0570781293117773,-0.0433213482833842,4.44501811175599e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,40192,0.0728310249248183,0.00510812087296665,0.0628191080138036,0.0828429418358329,7.72471971647544e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0467651499789192,0.00328137514531171,0.0403336546941083,0.0531966452637302,8.37486942372764e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,40330,0.0392368889787751,0.00275891852801132,0.0338294086638729,0.0446443692936773,1.27834974486616e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.049384762530715,0.00349169826241492,-0.0562284911250483,-0.0425410339363818,3.84018675984511e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,40341,0.102472677915648,0.00726971512265435,0.088224036275245,0.11672131955605,7.50590381565504e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.105050675030086,0.00746300488736438,0.0904231854508517,0.11967816460932,1.00199023308252e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,0.0402530007963586,0.00286395392417915,0.0346396511049675,0.0458663504877498,1.47451918830056e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.08289298477028,0.00590802944460146,-0.0944727224816989,-0.0713132470588612,2.11441254936152e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPN,Asporin,37990,-0.0354289786957872,0.00253236639901991,-0.0403924168378662,-0.0304655405537082,3.6179059484147e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,0.0743385099345324,0.0053180246611165,0.0639151815987441,0.0847618382703207,4.27140034740969e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,40367,-0.0480366678508591,0.00343961484338323,-0.0547783129438902,-0.041295022757828,4.59303863100356e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.048821478872651,0.00350134292266144,0.0419588467442346,0.0556841110010675,6.24184042573454e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.0820658678219766,0.00590428460807974,-0.0936382656538129,-0.0704934699901403,1.14451518338556e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40489,0.034719134870357,0.00249925946999652,0.0298205863091638,0.0396176834315501,1.27155911213403e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0875854877806758,0.00631385373269725,0.0752103344645892,0.0999606410967624,1.68189591721313e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,40359,0.0333290072462269,0.00240325084968098,0.0286186355808521,0.0380393789116016,1.76552036001588e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0370124684059219,0.00268727116128842,0.0317454169297966,0.0422795198820472,6.51540322905898e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0479312116554435,0.0034844650999987,0.0411016600594461,0.054760763251441,8.31500803838891e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,0.118876253538491,0.00871471466996261,0.101795412785365,0.135957094291618,4.35958955611449e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0257763625862244,0.00189072530334969,0.022070540991659,0.0294821841807898,4.39727509017798e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.0917495918872338,0.00673360899911927,0.0785517182489601,0.104947465525508,5.3351466482268e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,-0.0476149057571516,0.00349960745274164,-0.0544741363645252,-0.040755675149778,6.35588530398369e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0611158417567097,0.00449445996053896,-0.0699249832793661,-0.0523067002340533,7.74940344065058e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37928,-0.0240422036438038,0.001772772144123,-0.0275168370462848,-0.0205675702413227,1.26280628235204e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,40042,0.0675292535988839,0.00498888017046722,0.0577510484647682,0.0773074587329997,1.64610360213854e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELE,E-selectin,40536,0.0625047619938468,0.00464760449854797,0.0533954571766928,0.0716140668110008,5.2114455296016e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,40411,0.0498274474816978,0.00371665793318883,0.0425427979326477,0.0571120970307479,9.20232978702587e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0369611773414062,0.00276429632323854,0.0315431565478587,0.0423791981349538,1.47971597197838e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.109039362973662,0.00815515275704767,0.0930552635698483,0.125023462377475,1.48925258189636e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,40403,0.062326529650783,0.00467006688980584,0.0531731985467635,0.0714798607548024,2.05981442593873e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,0.0781502048686355,0.00588315355585671,0.0666192238991564,0.0896811858381147,4.68632814058596e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0473857663117649,0.00358971724539273,0.0403499205107952,0.0544216121127347,1.53405066259357e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40489,-0.0200220417066523,0.00152093216134853,-0.0230030687428954,-0.0170410146704092,2.25313711904236e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0377631748250283,0.0028687459001819,0.0321404328606718,0.0433859167893848,2.27604756144866e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,40203,0.0360288421290793,0.00273883410485351,0.0306607272835665,0.0413969569745922,2.57365688155771e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,0.0343266432596533,0.00262413121778234,0.0291833460727999,0.0394699404465067,7.25992850163121e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,0.071050296866098,0.00545393503800265,0.0603605841916128,0.0817400095405832,1.34412046209454e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,0.157627297950734,0.0121017813553747,0.1339078064942,0.181346789407269,1.38198066881076e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40536,0.0688818912642539,0.00532331784894209,0.0584481882803274,0.0793155942481804,4.16555017894381e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0672012503163307,0.00521625789155909,0.0569773848488749,0.0774251157837865,9.50140244109275e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0508267127301583,0.00394883513234062,-0.0585664295895459,-0.0430869958707707,1.00566506018909e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,0.144842789741325,0.0112896211804344,0.122715132227674,0.166970447254977,1.87444594565987e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.0682082681183776,0.00531985621041341,0.0577813499459674,0.0786351862907879,2.08061828958089e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37987,-0.0642265381992201,0.00501862424631547,-0.0740630417219985,-0.0543900346764418,2.77956424196015e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,0.0253150121513773,0.00198546163885567,0.0214235073392202,0.0292065169635344,4.71546818952909e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0287317334569763,0.00226320762837831,-0.0331676204085978,-0.0242958465053548,9.47301734476869e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAST,Gastrin,37942,0.153462505889532,0.0120880761934298,0.12976987655041,0.177155135228654,1.01748721572443e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40471,0.0433171209156089,0.00341414290387728,0.0366254008240094,0.0500088410072083,1.0410446503756e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,0.0302690779702006,0.00239069046854562,0.0255833246518512,0.03495483128855,1.45369042649497e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.044486572221374,0.0035199106451479,0.0375875473568841,0.0513855970858639,1.9301647638739e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37628,0.0754737701681006,0.00599365176369886,0.0637262127112508,0.0872213276249503,3.75989396588661e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0452851364363996,0.00360079753610272,-0.0523426996071609,-0.0382275732656382,4.22928313555933e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40489,0.0527738697245444,0.00419830921115694,0.0445451836706768,0.061002555778412,4.5515300298255e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0322822802496606,0.00256883268071997,0.0272473681954494,0.0373171923038717,4.76441396136203e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37998,-0.0705515674268421,0.00561709207212762,-0.0815610678882123,-0.059542066965472,5.54700852941579e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,0.0601924427322816,0.00480164758321067,0.0507812134691887,0.0696036719953745,7.05057229336506e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,40360,-0.0444958920240042,0.00355276450668026,-0.0514593104570975,-0.0375324735909109,8.11166364078082e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0360906473744346,0.0028812557726474,0.0304433860600457,0.0417379086888235,8.54626731223462e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,40341,-0.039552525921428,0.00316674939437344,-0.0457593547343999,-0.0333456971084561,1.24529317963666e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37990,0.0290594482957906,0.00232920269115016,0.0244942110211363,0.0336246855704449,1.5797635704364e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0398005603962206,0.00319373534324179,-0.0460602816689745,-0.0335408391234667,1.7594810457804e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0241253311162123,0.00195056430168863,0.0203022250849026,0.027948437147522,5.59485980718864e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,0.0374027484793092,0.00302524543960097,0.0314732674176913,0.0433322295409271,5.93562365953524e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,0.040426393588723,0.00327164534022492,0.0340139687218821,0.0468388184555638,6.52051384792416e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37671,0.0593059934871349,0.00480144113623109,0.0498951688601219,0.0687168181141478,7.42365668485188e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,40332,-0.0333077082097421,0.00270309617662863,-0.0386057767159342,-0.02800963970355,9.9307135526248e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,40228,0.0465923982607465,0.00379469397126108,0.0391547980770748,0.0540299984444182,1.70235981433887e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0983293741465157,0.00800994809287409,0.0826298758844825,0.114028872408549,1.86318373739486e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,0.0747056646473256,0.00609024195809559,0.0627687904094582,0.0866425388851929,1.95728234566473e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,40341,0.0374008679465985,0.00304912124692672,0.0314245903026221,0.0433771455905749,1.97110708480833e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37671,-0.0614734110282956,0.00501134651707794,-0.0712956502017684,-0.0516511718548229,2.09921812924268e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,-0.0269807313281316,0.0022120199460648,-0.0313162904224186,-0.0226451722338446,4.56497237920891e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,40341,0.0540712368089797,0.00445474469918077,0.0453399371985854,0.062802536419374,9.38237954129433e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,40382,-0.0437425182546886,0.0036184320603207,-0.0508346450929172,-0.03665039141646,1.69653550942937e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,0.0388218523688192,0.00321317945219147,0.0325240206425239,0.0451196840951145,1.84307665230207e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.0584689986329344,0.00484602970736131,0.0489707804065062,0.0679672168593625,2.24665790629182e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37671,-0.0243608114100095,0.00201957961596285,-0.0283191874572967,-0.0204024353627223,2.49884629296235e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,0.0446770388153079,0.00371243526248131,0.0374006657008445,0.0519534119297712,3.26666052393369e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,-0.0689545237600661,0.00573434754940045,-0.080193844956891,-0.0577152025632412,3.6719060602808e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,40372,0.0314292940333248,0.00261485219428316,0.0263041837325298,0.0365544043341198,3.9036598860779e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0431581623989674,0.00359404495438255,0.0361138342883775,0.0502024905095572,4.78879097142596e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,40414,0.066183345068225,0.00552004481620959,0.0553640572284542,0.0770026329079958,5.57950848670863e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39806,0.0446316993231467,0.00373272306644248,0.0373155621129195,0.051947836533374,8.35857410784416e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,40228,-0.0279652001102183,0.00234229693020753,-0.032556102093425,-0.0233742981270115,1.02250937359041e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37959,0.0597702674366334,0.00500513899418196,0.0499601950080367,0.06958033986523,1.04702753167773e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,-0.0457056892108323,0.00383599487314783,-0.0532242391622021,-0.0381871392594626,1.35997274501233e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0302816642857144,0.00254311196705821,0.0252971648302803,0.0352661637411485,1.49133603795913e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,40145,0.039657061206429,0.00334224242568274,0.0331062660520909,0.0462078563607672,2.46142709246594e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37871,0.0281519561313819,0.00237801515820079,0.0234910464213084,0.0328128658414555,3.57148906205421e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37981,0.0300582046825133,0.00254739059181064,0.0250653191225644,0.0350510902424621,5.62566007259433e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40516,0.0486886783742715,0.00414507288957175,0.0405643355107109,0.0568130212378322,9.96433126240846e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0294084493871443,0.00250318758026934,0.0245022017298164,0.0343146970444722,1.0282650616054e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,-0.0803208074102579,0.0068470552598279,-0.0937410357195206,-0.0669005791009952,1.26245262768985e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,40341,0.0469715439865832,0.00400639416058208,0.0391190114318423,0.0548240765413241,1.29386930771164e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,0.0666394670397573,0.00569297978811997,0.0554812266550421,0.0777977074244724,1.60823823219373e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,40447,0.0403223223106157,0.00345053754679274,0.0335592687189019,0.0470853759023295,2.02135644494473e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,0.0353564272758462,0.00302571286733633,0.029426030055867,0.0412868244958254,2.16394139441836e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,0.0335486981688632,0.00287218130590719,0.0279192228092851,0.0391781735284413,2.16656177227965e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,0.0309120573927416,0.0026546371518866,0.0257089685750438,0.0361151462104393,3.26641318857338e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40489,-0.0495914629986532,0.00427430472931494,-0.0579691002681105,-0.041213825729196,5.33913370576499e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0473363008670932,0.00408025997976826,0.0393389913067474,0.055333610427439,5.41501530004572e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,40293,0.0336874795641483,0.00291144381393815,0.0279810496888295,0.0393939094394671,7.71623351363263e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,0.0638713715991879,0.00552241037509282,0.053047447264006,0.0746952959343698,8.16045368659006e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37917,0.0318005643471721,0.00275033052276987,0.0264099165225432,0.0371912121718011,8.9234030745089e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0325653077370783,0.00282370228854695,0.0270308512515263,0.0380997642226303,1.26415117692376e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0385569906546937,0.00334945241201583,0.0319920639271427,0.0451219173822447,1.53700339681909e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,40341,0.0567573265191895,0.00493253971659912,0.0470895486746553,0.0664251043637238,1.61223596972469e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,0.0299480393146602,0.00261855638234592,0.0248156688052622,0.0350804098240582,3.60182646109538e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0211901817793828,0.00185332895935401,-0.0248227065397167,-0.0175576570190489,3.73019290602953e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXN,Paxillin,39961,0.0550166484291032,0.00482070394279224,0.0455680687012304,0.064465228156976,4.76916626372524e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0692934231428563,0.0060791121869716,0.0573783632563919,0.0812084830293206,5.55558769392371e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,0.0656408676623875,0.00576371467995084,0.0543439868896838,0.0769377484350911,6.22348375815287e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0608397956979003,0.00535052351475217,0.0503527696089861,0.0713268217868146,7.99652584615108e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,40332,0.0378613408533783,0.00333344397356893,0.0313277906651832,0.0443948910415734,8.81523161979492e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,0.0347865249232351,0.00306766715528434,0.0287738972988777,0.0407991525475924,1.13900040185054e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.0715066647082314,0.00631833998841372,0.0591227183309405,0.0838906110855223,1.47696245904351e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.068251187766373,0.00606446205797976,0.0563648421327327,0.0801375334000134,2.9750582005107e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASN,Vasorin,40116,-0.0288146723724014,0.00256116577487667,-0.0338345572911597,-0.0237947874536431,2.97802116205757e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,0.0830698035701976,0.0073885092217503,0.068588325495567,0.0975512816448282,3.37301525082965e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,-0.0403645777779868,0.00359130325884099,-0.0474035321653152,-0.0333256233906585,3.37679195658494e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,40374,0.0487105211071531,0.00435343246047287,0.0401777934846263,0.05724324872968,5.92011760170564e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0473538683920855,0.00423798072479604,0.0390474261714853,0.0556603106126857,7.38862700941256e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,0.0621602755426651,0.00557135380628071,0.051240422082355,0.0730801290029753,8.47159889743215e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,40411,0.0421669304243796,0.00378686144124249,0.0347446819995443,0.0495891788492149,1.08030300456353e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37598,0.0481140619995279,0.00432350777264201,0.0396399867651495,0.0565881372339062,1.22405892896141e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,0.0462224982107948,0.00416773107263939,0.0380537453084216,0.054391251113168,1.77563987507761e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,40305,0.0552340536106838,0.00498323747089202,0.0454669081677354,0.0650011990536321,1.90895939665077e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,40350,0.0331031726819376,0.00299119017398054,0.0272404399409358,0.0389659054229395,2.30505430521636e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40471,-0.023960855247431,0.00216658201070432,-0.0282073559884115,-0.0197143545064505,2.50288203979585e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,0.107841627632041,0.00976070468155284,0.0887106464561973,0.126972608807884,2.9472420477798e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0497979935427509,0.00452464893518965,0.0409296816297792,0.0586663054557226,4.7356042812965e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0280511280618142,0.00255182935072086,0.0230495425344013,0.0330527135892271,5.22940322402668e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.052130973267468,0.00474566748640579,0.0428294649941127,0.0614324815408234,5.93453591534753e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,40359,0.0653221242433075,0.00595374455058337,0.0536527849241641,0.0769914635624509,6.58929793199206e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,40359,-0.0530118598621246,0.00484820346582414,-0.0625143386551399,-0.0435093810691092,9.91413416131366e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40489,0.0370665112202678,0.00339286995079573,0.0304164861167082,0.0437165363238275,1.09802685991928e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0260269602125505,0.00238322132436683,0.0213558464167915,0.0306980740083095,1.14934823277711e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0557534905292199,0.00511591713728093,0.0457262929401493,0.0657806881182905,1.48383064863214e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.0834467500639734,0.00766634532335002,0.0684207132302074,0.0984727868977395,1.71157280941607e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.0326418994595143,0.00300307435624497,-0.0385279251977544,-0.0267558737212742,2.10671063165825e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,0.0317848572128636,0.00293775252556778,0.0260268622627507,0.0375428521629764,3.46023362317451e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0580231942894464,0.005368209620008,0.0475015034342307,0.0685448851446621,4.04783682743273e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,0.0451094526172163,0.00417657008576388,0.0369233752491191,0.0532955299853135,4.44250186126397e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,40268,0.0726051538822199,0.00674731646854046,0.0593804136038806,0.0858298941605592,6.54672550125766e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.0732918334537709,0.00682391224399803,0.0599169654555347,0.086666701452007,8.14109231589291e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.0886368287648706,0.00826145280949738,0.0724443812582557,0.104829276271485,9.25305010199267e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,-0.0329541890986097,0.00307282722656919,-0.0389769304626853,-0.0269314477345341,1.00125815752883e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,0.0332638174210074,0.00310656731661619,0.0271749454804397,0.0393526893615752,1.15434942878941e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,40332,0.0443134187376739,0.0041480809815666,0.0361831800138034,0.0524436574615445,1.50674636299713e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,0.0771808289476445,0.00722877586911251,0.063012428244184,0.091349229651105,1.6025462813656e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0381666212238635,0.00357741552306279,0.0311548867986605,0.0451783556490666,1.75138054846809e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,0.0482852130878661,0.00453269878225462,0.039401123474647,0.0571693027010851,2.07989788058897e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.0479265071952421,0.00450795758454268,0.0390909103295385,0.0567621040609458,2.60714073245093e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.0670427311247234,0.00630448243435351,0.0546859455533906,0.0793995166960563,2.62961806419393e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,40333,-0.0216892143548635,0.00204267732535128,-0.0256928619125521,-0.017685566797175,3.00884037947442e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,-0.0290316632052428,0.00273600012552087,-0.0343942234512637,-0.0236691029592219,3.2428999770296e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,0.0336548173468092,0.00319899513933757,0.0273847868737076,0.0399248478199108,8.43548513953443e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.0533932822826759,0.00507523465679008,0.0434458223553673,0.0633407422099845,8.49383588179223e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37987,0.0254423394763744,0.00241893237909628,0.0207012320133457,0.0301834469394031,8.97258039806247e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,0.0455561847628086,0.00433326512210715,0.0370629851234785,0.0540493844021386,9.45178612501419e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39757,0.0910874092878745,0.00868150264984698,0.0740716640941745,0.108103154481575,1.14747015977084e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37681,-0.0206505156431023,0.00197043634134181,-0.0245125708721323,-0.0167884604140724,1.34213107524672e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0421669574018427,0.00402382854107108,0.0342802534613434,0.050053661342342,1.35627175880379e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLN,Promotilin,40341,0.0863368980610102,0.00825295431407852,0.0701611076054163,0.102512688516604,1.57377886681531e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0429426551529789,0.00413510190434799,-0.0510474548855009,-0.0348378554204568,3.49411373602962e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0267910875182261,0.0025798993828589,0.0217344847278226,0.0318476903086295,3.51126349453702e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0510718042962738,0.00492127721950457,0.0414261009460448,0.0607175076465028,3.78303189622965e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,0.0169430458203573,0.00163322979262872,0.013741915426805,0.0201441762139096,4.04446205450725e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0349768355590606,0.00338193934823368,0.0283482344365226,0.0416054366815986,5.44732545732906e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,0.0348973593426676,0.00338015155726023,0.0282722622904376,0.0415224563948977,6.56608468113861e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,40044,0.0457810584540017,0.00443679882698324,0.0370849327531145,0.0544771841548888,6.98971259619106e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,0.053457894821618,0.00518301190546318,0.0432991914869102,0.0636165981563258,7.52335216220658e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.0645923154454925,0.00627351032453393,0.052296235209406,0.076888395681579,8.82093748515958e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37967,0.0541100482644396,0.00526458039111927,0.0437914706978458,0.0644286258310334,1.09005653938999e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40516,-0.00827588309656159,0.000805584090501779,-0.00985482791394508,-0.00669693827917811,1.11019507553505e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.0277574575198572,0.00270215405379211,-0.0330536794652897,-0.0224612355744246,1.11915606039972e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,40422,0.0406467254171593,0.00395977964505141,0.0328855573128585,0.0484078935214601,1.2098751311558e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0255371413401193,0.00249343679912797,0.0206500052138285,0.0304242774664101,1.54298809365536e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40489,0.0369084190426375,0.00360559592206516,0.0298414510353898,0.0439753870498852,1.61998665083002e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0410016673964183,0.00401442156864934,-0.048869933670971,-0.0331334011218656,2.050854116106e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0251364474501529,0.00246597769724987,0.0203031311635431,0.0299697637367626,2.52418060357183e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,40332,-0.0241659825414692,0.00237419895103687,-0.0288194124855014,-0.0195125525974369,2.93362843195325e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,40228,0.0844362928119626,0.00829790673754903,0.0681723956063665,0.100700190017559,3.02732368898377e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,0.0342272479403695,0.0033644114306153,0.0276330015363635,0.0408214943443755,3.09888074759338e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40536,0.0529876696147937,0.00521436139892498,0.0427675212729008,0.0632078179566867,3.47140123091307e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0566846793178717,0.00558988548127299,0.0457285037745766,0.0676408548611667,4.3222852242592e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,40042,-0.0222836719093435,0.00220371898914427,-0.0266029611280663,-0.0179643826906208,5.80333875253083e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37575,0.0257934028119547,0.00255123130287067,0.0207929894583282,0.0307938161655812,6.09322811198681e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37628,0.053445973104305,0.00529192865098518,0.043073792948374,0.0638181532602359,6.7815282465003e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,0.0500074733351099,0.00495624111772299,0.0402932407443728,0.0597217059258469,7.2331433636573e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,0.0203571495059554,0.00201801671410185,0.0164018367463158,0.024312462265595,7.37357410480913e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,40228,0.0349784135519837,0.00347508971978151,0.0281672377012119,0.0417895894027554,9.26093554703191e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40516,0.0377998908838065,0.00375650766404572,0.0304371358622768,0.0451626459053361,9.51401575969416e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37977,-0.0314296142266797,0.00312602361221108,-0.0375566205066134,-0.0253026079467459,1.06648632218355e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,0.063601464463061,0.00632767355660947,0.0511992242921065,0.0760037046340156,1.06740921131353e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37628,0.0570943298092548,0.00568372011541644,0.0459542383830385,0.068234421235471,1.17290650113641e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,40341,0.0574847086596242,0.00572692564980437,0.0462599343860076,0.0687094829332408,1.22496875401675e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.030959782536496,0.00308527971347993,0.0249126342980753,0.0370069307749166,1.26135310476168e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0557059105876519,0.00554992200142909,0.0448280634648509,0.0665837577104529,1.26459931898178e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0295483729864641,0.00294677048566564,-0.0353240431383687,-0.0237727028345594,1.35541060109916e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37990,0.0401108902055505,0.00401202843745483,0.0322473144681391,0.047974465942962,1.8817674490519e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,0.0864607935985294,0.00866342013032103,0.0694804901431001,0.103441097053959,2.18503621745896e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,40346,-0.0256986749574673,0.00257639153181178,-0.0307484023598184,-0.0206489475551162,2.3045215441415e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0353747393776328,0.00354659296575549,0.028423417164752,0.0423260615905136,2.33319846457254e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,0.0781144231008944,0.00784251608399526,0.0627430915762637,0.0934857546255251,2.74733476047933e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.0647291959846348,0.00651851201458557,0.051952912436047,0.0775054795332225,3.61184930031439e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0452435975544597,0.00455828794966746,0.0363093531731115,0.0541778419358079,3.77778555912464e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,-0.0316334093714372,0.00318770290820243,-0.037881307071514,-0.0253855116713604,3.83350886529358e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0452857765450667,0.0045746719522931,0.0363194195185722,0.0542521335715611,4.88151455722878e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0701282236324476,0.00709969908700232,0.056212813421923,0.0840436338429721,6.22598368352337e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37628,-0.0643730428525921,0.00652125111731377,-0.0771546950425271,-0.0515913906626571,6.65894028646383e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0562210323276473,0.00570301437410581,0.0450431241543999,0.0673989405008947,7.35307717736061e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40516,0.0448150895280365,0.00455148881395913,0.0358941714526766,0.0537360076033964,8.25561018891309e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37598,0.0763395799002153,0.00775916970810529,0.0611316072723289,0.0915475525281017,9.19766194337048e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,40305,0.0628303936716677,0.0063930306494838,0.0503000535986794,0.0753607337446559,9.91030328151768e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37998,0.0226633116319601,0.00231436705540363,0.018127152203369,0.0271994710605512,1.44156639901691e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFI,Complement factor I,38013,0.0183312308005839,0.00187331898551654,0.0146595255889715,0.0220029360121963,1.54408063115932e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,40332,-0.0221533698059044,0.00226579722406766,-0.0265943323650771,-0.0177124072467318,1.63123927354648e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,0.103246510060186,0.0105707005285208,0.0825279370242856,0.123965083096087,1.80096984753971e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,0.0571769122091957,0.00586768713538956,0.0456762454238322,0.0686775789945592,2.25997909989396e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,0.0825410588317418,0.00848199658308134,0.0659163455289024,0.0991657721345812,2.5573548636444e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0442515592174145,0.00455955567346956,0.0353148300974141,0.0531882883374148,3.31007805112035e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0239651270958161,0.00246949248882241,0.0191249218177241,0.028805332373908,3.32361042714045e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,40396,0.0515080378114058,0.00531451759723557,0.041091583320824,0.0619244923019875,3.75541000234317e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37987,0.0219232805853768,0.00226236105544664,0.0174890529167014,0.0263575082540522,3.90706203169657e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,40305,0.0460467389463929,0.00475383769111181,0.0367292170718138,0.0553642608209721,3.973806324453e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0282648638130728,0.00291979404371004,0.0225420674874011,0.0339876601387445,4.19571984524259e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.052454264031744,0.00541892828007681,0.0418331646027934,0.0630753634606945,4.22507022417528e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,0.0978131884110057,0.010108752141984,0.0780000342127171,0.117626342609294,4.49489271336155e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0444170389042363,0.00459916659133308,0.0354026723852235,0.0534314054232491,5.24446338322523e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37671,0.0408093649518275,0.00422732555254302,0.0325238068688432,0.0490949230348119,5.60258747567433e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.087365370346032,0.00905410708777144,0.069619320454,0.105111420238064,5.69041707367653e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0327643494247133,0.00340748494446758,0.0260856789335568,0.0394430199158697,8.11363443435725e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37998,0.100289606639955,0.0104371683885416,0.0798327565984138,0.120746456681497,8.60596059612616e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0374887677627291,0.00391105176740052,-0.0451544292268341,-0.0298231062986241,1.05522867881645e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.0625715101957414,0.00653439655213368,0.0497640929535593,0.0753789274379234,1.18974579044765e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,40311,0.0812326174639083,0.00850519751320355,0.0645624303380294,0.0979028045897873,1.4688702794584e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40489,0.0584020286911727,0.00611597944217369,0.0464147089845122,0.0703893483978331,1.49297785880261e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,0.108691571717675,0.0113893048260236,0.0863685342586693,0.131014609176682,1.58061585269372e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,40305,0.0696820500911684,0.00730897184078659,0.0553564652832266,0.0840076348991101,1.73185823307847e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0509336375686546,0.00534247027489354,0.0404623958298632,0.0614048793074459,1.77400487787031e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,-0.021294918814347,0.00223465226074733,-0.0256748372454117,-0.0169150003832822,1.80459246098584e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,0.0393050205261917,0.00413388121319046,0.0312026133483384,0.047407427704045,2.26814551575423e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,0.0962112620703127,0.0101260502732838,0.0763642035346764,0.116058320605949,2.36772360779278e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,38013,0.0281232606597335,0.00296203311689651,0.0223176757506164,0.0339288455688507,2.57512169537081e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0359075207051748,0.00378572217741418,-0.0433275361729066,-0.028487505237443,2.76001740550161e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,-0.0256407130177608,0.0027099012425311,-0.0309521194531218,-0.0203293065823998,3.43484079948689e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0651437062566773,0.00689294333543912,0.0516335373192167,0.078653875194138,3.90712429003611e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.064958329038969,0.00689074747390152,0.051452463990122,0.078464194087816,4.79851607237313e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,0.0264440513777033,0.00280756530046298,0.0209412233887959,0.0319468793666108,5.29267050927561e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,0.0480125386969986,0.00510186721943932,0.0380128789468975,0.0580121984470997,5.58451894290695e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37901,0.0911084377228293,0.0096797423253451,0.0721361427651529,0.110080732680506,5.6322779062751e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_E,,40341,0.0252460309654906,0.00268458525071454,0.0199842438740901,0.030507818056891,5.95025322962596e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0226627862702518,0.0024107533921049,-0.0273878629187774,-0.0179377096217262,6.27641382998886e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,0.0634909492949019,0.0067565374988508,0.0502481357971544,0.0767337627926495,6.36362508538155e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39960,0.0345421348504103,0.00367760039366172,0.0273340380788334,0.0417502316219873,6.65343020706582e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,0.0474728277773343,0.00505546274868038,0.0375641207899208,0.0573815347647478,6.76145994235257e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,40359,-0.0318316686100046,0.00339536354813554,-0.0384865811643503,-0.025176756055659,7.82551947717693e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0433274156546592,0.00462166581826271,0.0342689506508643,0.0523858806584541,7.8632841335863e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,-0.0250225220612523,0.00266968511433554,-0.0302551048853499,-0.0197899392371546,7.9914239964027e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,0.0689534402540802,0.00735632256462734,0.0545350480274106,0.0833718324807498,8.15880805292038e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,40214,0.0200484790408488,0.00214573447113403,0.0158428394774261,0.0242541186042715,1.05507538589756e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40516,0.030585501954872,0.00327851800920688,0.0241596066568265,0.0370113972529174,1.20445909761077e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRN,Agrin,40422,0.0288116606012977,0.00309063421755551,0.0227540175348889,0.0348693036677065,1.28486403278002e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,0.020062207173458,0.00215227906004011,0.0158437402157794,0.0242806741311367,1.32349670547254e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0383291279696831,0.00411439190448833,0.030264919836886,0.0463933361024802,1.39780122222443e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,0.0268158758665695,0.00287932622077054,0.0211723964738592,0.0324593552592798,1.40522213313039e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.0231094492733638,0.00248680339463224,-0.0279835839268429,-0.0182353146198846,1.7291741545841e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,40228,0.0579369371163446,0.00623745383473276,0.0457115276002684,0.0701623466324208,1.76379254808096e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.0730448897361178,0.00787190004979642,0.0576159656385168,0.0884738138337187,1.97075450461975e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,0.0300501161603477,0.00323958666269657,0.0237005263014624,0.036399706019233,1.98482042292857e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,-0.0774554051002345,0.00835303609418105,-0.0938273558448294,-0.0610834543556397,2.04310058576946e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,0.0663753308732391,0.00716636646879802,0.052329252594395,0.0804214091520832,2.25617827694332e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,0.038771713044724,0.00418874174583645,0.0305617792228845,0.0469816468665634,2.38384486409422e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.0380795229731015,0.00411537151292491,0.0300133948077687,0.0461456511384344,2.4520999443261e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40489,0.0485646577135232,0.00524890458476376,0.0382768047273862,0.0588525106996602,2.46760461520928e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,0.0353744907725196,0.00382601198607815,0.0278755072798064,0.0428734742652327,2.6219095728204e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0331488540659551,0.00358984246028122,0.0261127628438039,0.0401849452881063,2.99016087050384e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,40417,0.0573227390204282,0.00621731641150359,0.0451367988538812,0.0695086791869753,3.33899817601874e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,0.0323785928645344,0.00351233810913354,0.0254944101706326,0.0392627755584361,3.38517349247466e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.0593693194784384,0.00649360192897121,0.0466418596976548,0.072096779259222,6.82616392296911e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37671,0.0225252225034825,0.0024652254171002,0.0176933806859661,0.0273570643209989,7.33193294985456e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,-0.0322095657437606,0.00352705630483444,-0.0391225961012361,-0.0252965353862851,7.51894048342297e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,0.0518036609012851,0.00567377377438619,0.0406830643034881,0.062924257499082,7.65194100482273e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0238623634474,0.00261536921269072,0.0187362397905261,0.0289884871042738,8.09884451355112e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,0.0205798229755028,0.00225721710763595,0.0161556774445364,0.0250039685064693,8.76902746354909e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,40472,0.0197491959896429,0.00217416829200494,0.0154878261373132,0.0240105658419725,1.17111561670666e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0250587741931089,0.00275967648955961,0.019649808273572,0.0304677401126457,1.20821500107865e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.031304077858952,0.00344706781989371,0.0245478249319603,0.0380603307859436,1.22386437730575e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,0.0570898443400513,0.00629702287664442,0.0447476795018283,0.0694320091782744,1.37229149111899e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,40292,0.0399903863895966,0.00441147162355206,0.0313439020074345,0.0486368707717586,1.38809728771332e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37598,-0.0256192750953557,0.0028278914132513,-0.0311619422653282,-0.0200766079253831,1.49346519222887e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37810,-0.0901505016673429,0.00997543687007771,-0.109702357932695,-0.0705986454019906,1.82487531997006e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TF,Serotransferrin,38013,0.0184017268762252,0.00203656006256205,0.0144100691536035,0.0223933845988468,1.84738731809635e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,40228,0.0441757391434357,0.00489689364420658,0.0345778276007908,0.0537736506860806,2.07127325481186e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0435126557321864,0.00482476401059073,0.0340561182714285,0.0529691931929442,2.11776037202905e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,0.0807866231153189,0.0089616752190952,0.0632217396858923,0.0983515065447455,2.19358890694868e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.0288890931277428,0.00320917370143217,0.0225991126729358,0.0351790735825499,2.46241715266548e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0192091410597587,0.00213616205059767,0.0150222634405872,0.0233960186789301,2.68795329112448e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.0744051269669837,0.0082817870547082,0.0581728243397556,0.0906374295942117,2.89682782136705e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0413890424674563,0.00461000334306292,0.032353435915053,0.0504246490198597,3.12627994017514e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,40359,-0.0299110670366345,0.00333343556131311,-0.0364446007368082,-0.0233775333364608,3.20057193871812e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,40305,0.0785029943305646,0.00877139179725824,0.0613110664079385,0.0956949222531908,3.94577924404988e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.0792727356132432,0.00886495705560345,0.0618974197842605,0.096648051442226,4.2256633236071e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.0901420859889565,0.0100846109459352,0.0703762485349236,0.109907923442989,4.4514112223378e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0583776663486136,0.00653275987333045,0.0455734569968859,0.0711818757003412,4.56102064753345e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0506668825417323,0.00569090221138386,0.0395127142074199,0.0618210508760446,6.00114621247357e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.0175255190268937,0.00197258867832557,-0.0213917928364118,-0.0136592452173755,7.21918035041799e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37901,0.068093389478726,0.00766741602023296,0.0530652540790694,0.0831215248783826,7.46489525952681e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,40359,0.0291881744178286,0.00328744800863266,0.0227447763209086,0.0356315725147486,7.47643487176265e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,0.0698806836273621,0.00789693406855295,0.0544026928529983,0.0853586744017258,9.75621116393181e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.0609923334959719,0.00689890674232073,0.0474704762810232,0.0745141907109205,1.06977908316692e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37671,0.0514582055026096,0.00582309626082635,0.0400449368313899,0.0628714741738292,1.107004535101e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,-0.0233021921550389,0.00263824818787304,-0.02847315860327,-0.0181312257068077,1.12890824494583e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0413854949320224,0.00468915191191073,0.0321947571846774,0.0505762326793674,1.20111696244162e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.0595629746114108,0.00674815041740762,0.0463365997932919,0.0727893494295297,1.21417422983558e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40471,0.0339838179939942,0.0038540397214785,0.0264299001398963,0.0415377358480921,1.28649321358181e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RETN,Resistin,40283,0.0340834635665129,0.00386656644641396,0.0265049933315415,0.0416619338014843,1.32035543488663e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0447289148195943,0.00508246219482155,0.0347672889177441,0.0546905407214446,1.49853548021132e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37878,0.0341567966184715,0.00388294625830919,0.0265462219521855,0.0417673712847575,1.58015080011233e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,0.0695558395944036,0.00792684956125584,0.0540192144543422,0.0850924647344651,1.88485366822629e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0503973675125374,0.0057484533011875,0.0391303990422099,0.0616643359828649,2.04970801305651e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,-0.0210720594970806,0.00240612380285105,-0.0257880621506687,-0.0163560568434925,2.19075584892177e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.0682618097997212,0.00780235465094766,0.0529691946838638,0.0835544249155787,2.408266527515e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0150449677441182,0.00172032854848563,0.0116731237890863,0.01841681169915,2.4482782217298e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,-0.0234263577408878,0.00268281061050284,-0.0286846665374733,-0.0181680489443022,2.79918788255342e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,40305,0.0243917420023227,0.00280733697287816,0.0188893615354815,0.0298941224691639,4.02380247770932e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,-0.0210651842033877,0.0024259425542619,-0.025820031609741,-0.0163103367970343,4.20832717705462e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,0.0610911162617975,0.00703581879085249,0.0473009114317267,0.0748813210918684,4.22454434257534e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELL,L-selectin,38013,-0.0187634219813291,0.0021648603002699,-0.0230065481698581,-0.0145202957928001,4.92306401899059e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,-0.0268925954204505,0.00310476718231112,-0.0329779390977803,-0.0208072517431207,5.08414532371872e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREH,Trehalase,37998,0.0600109178983722,0.00692779865791063,0.0464324325288673,0.073589403267877,5.14020045854922e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37990,0.0738725350949236,0.00852848380354722,0.0571567068399711,0.0905883633498761,5.16189436418927e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,40305,0.0266599964885496,0.00308046579202713,0.0206222835361764,0.0326977094409227,5.41828952334552e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,-0.0424953624617621,0.00491919280492845,-0.0521369803594218,-0.0328537445641023,6.21984146253375e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,-0.0377893011506185,0.00437550246445696,-0.0463652859809542,-0.0292133163202829,6.34989813808362e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,40305,0.109803641419163,0.0127188802180405,0.0848746361918038,0.134732646646522,6.52995894770989e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,0.0699388948968782,0.00810630607653337,0.0540505349868728,0.0858272548068836,6.84250520235146e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELN,Elastin,37990,0.0282369324559769,0.00327338755977583,0.0218210928388163,0.0346527720731375,7.04108232099396e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,0.0344738824328635,0.00399724383572415,0.0266392845148442,0.0423084803508828,7.04255436464936e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.0514686164315263,0.00598151950782379,0.0397448381961917,0.0631923946668609,8.38200200760013e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0465523299244954,0.00541027315039497,0.0359481945497213,0.0571564652992696,8.39150288094583e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,-0.030655614852318,0.0035660665390066,-0.037645105268771,-0.0236661244358651,8.97498698608782e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,0.0952778648759197,0.0110818665507698,0.0735574064364109,0.116998323315428,9.05207353825513e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37970,0.0367391661968172,0.0042735935800847,0.0283629227798512,0.0451154096137832,9.09065697312286e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,0.0319265904765578,0.00371613407840173,0.0246429676828904,0.0392102132702252,9.5513496328633e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0337194271626276,0.0039259336907657,0.0260245971287268,0.0414142571965284,9.58605076734888e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.0682963018738365,0.00795239825837215,0.0527096012874271,0.0838830024602459,9.6503545946951e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0421600132366944,0.00491526225871218,-0.0517939272637703,-0.0325260992096185,1.05918114408502e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,40261,0.0619361507032721,0.0072523531629079,0.0477215385039726,0.0761507629025716,1.46113572603343e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EZR,Ezrin,40471,0.018778468388539,0.00220324317967633,0.0144601117563734,0.0230968250207046,1.69006615802556e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,40341,0.074400337108101,0.00874897251034913,0.0572523509878167,0.0915483232283853,1.99458058984338e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.04555392742883,0.00535686709054191,0.0350544679313678,0.0560533869262921,1.99877021540265e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAYN,Layilin,40192,0.0272601253495613,0.00320593243015834,0.0209764977864509,0.0335437529126716,2.01109963049423e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,0.0304272147358515,0.00358272909137461,0.0234050657167573,0.0374493637549458,2.19828429781504e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD248,Endosialin,37998,-0.0316858378898605,0.00373094787485063,-0.0389984957245678,-0.0243731800551533,2.22738226731579e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.030971567368683,0.00364939924007299,0.0238187448581399,0.038124389879226,2.30781317358208e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0337719095037248,0.00399235969640415,0.0259468844987726,0.0415969345086769,2.92384501831937e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0210647707362206,0.0024902728305685,0.0161838359883063,0.0259457054841348,2.93454046486174e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,40403,-0.0240153630830092,0.00284111914674078,-0.0295839566106211,-0.0184467695553973,3.08745639543089e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,-0.0310678999154091,0.0036800380994934,-0.0382807745904161,-0.023855025240402,3.37796069000544e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,0.0786111133132139,0.00931256826088826,0.0603584795218729,0.0968637471045549,3.40283061543375e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.035773130319609,0.00423835365595212,0.0274659571539429,0.0440803034852751,3.43473642134589e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0294576372201856,0.00349611669629821,0.0226052484954411,0.03631002594493,3.94169537519476e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,0.032930188999138,0.00391030295206733,0.025265995213086,0.04059438278519,4.03311530656482e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39980,0.0487028380161664,0.00578307572108028,0.037368009602849,0.0600376664294837,4.03466103711733e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0227910885765439,0.00270907695023396,0.0174812977540853,0.0281008793990025,4.33907143576491e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0234214417478378,0.00278621081852084,0.0179604685435369,0.0288824149521386,4.65767405729312e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,40097,0.0327465807579344,0.00390245177529878,0.0250977752783488,0.04039538623752,5.21548015654049e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,0.0717218490365559,0.00856114128291928,0.0549420121220341,0.0885016859510777,5.84837598909945e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,38013,0.0287876732313257,0.00343961753277371,0.0220460228670893,0.0355293235955622,6.35161422655439e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.0618494889288275,0.00741300495829276,0.0473199992105737,0.0763789786470813,7.91833693530118e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39980,0.0572040354461354,0.00686345281043269,0.0437516679376873,0.0706564029545834,8.42199604093227e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,0.0230523044613088,0.002765888835769,0.0176311623432016,0.0284734465794161,8.52559606769693e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,40305,0.0596282130216452,0.00716485004076535,0.0455851069417451,0.0736713191015452,9.32136439990132e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0235473544296992,0.00282992276871837,0.0180007058030112,0.0290940030563872,9.43125094979305e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.022362795891323,0.0026870296709788,0.0170962177362045,0.0276293740464414,9.45248388395044e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,0.0237064241640569,0.00284942967808295,0.0181215419950144,0.0292913063330995,9.5240420679316e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37942,0.0286258798420726,0.00344232380200812,0.0218789251901367,0.0353728344940085,9.97543771211316e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.107773894517373,0.0129863879013991,0.0823205742306311,0.133227214804116,1.14936704232181e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,0.0268852500987534,0.00325256495219992,0.0205102227924416,0.0332602774050652,1.51503181849283e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,0.0426239241349038,0.00516271714394765,0.0325049985327664,0.0527428497370412,1.62529115054848e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0291443605723338,0.00353110529938352,0.0222233941855421,0.0360653269591255,1.65878145139103e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0203498933525968,0.00246611080062634,-0.0251834705218244,-0.0155163161833692,1.68161891710128e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,0.0633856711095201,0.00768386321125558,0.0483252992154592,0.0784460430035811,1.71792833521451e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0440829243150294,0.00536597139950402,0.0335656203720015,0.0546002282580573,2.27961431890981e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,0.0490408734603052,0.0059717432809954,0.0373362566295542,0.0607454902910561,2.36881370723452e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,-0.0259411555384903,0.00315988765780196,-0.0321345353477821,-0.0197477757291984,2.38966325296142e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,40332,0.0407086594152484,0.00496241578861699,0.0309823244695591,0.0504349943609377,2.51437422598794e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37900,0.0749388400574308,0.00914706807984782,0.0570105866209291,0.0928670934939326,2.78441303942421e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,0.0650085378045568,0.00793925839295023,0.0494475913543743,0.0805694842547392,2.8555140903122e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40516,-0.0297796500702578,0.00364116948158107,-0.0369163422541567,-0.0226429578863589,3.08458117487252e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,-0.0222948217098628,0.0027255495047656,-0.0276368987392034,-0.0169527446805222,3.09316759955156e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.0807179795885137,0.00986975393452488,0.061373261876845,0.100062697300182,3.09409205494002e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.0794315714321686,0.00971967578918581,0.0603810068853644,0.0984821359789728,3.25417720622122e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0288346981436599,0.00352842943033773,0.0219189764601979,0.0357504198271218,3.26421060968936e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,-0.0183588081783682,0.00225019932507076,-0.0227691988555069,-0.0139484175012296,3.636573109621e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0393891791433706,0.00483136131589502,0.0299197109642163,0.0488586473225248,3.82452528258284e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40489,0.0310771544054153,0.00381299219602703,0.0236036897012024,0.0385506191096283,3.89493904493332e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37671,0.0385281657176113,0.00472931396551456,0.0292587103452027,0.0477976210900198,4.07475175711757e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,40341,0.0461049270814552,0.00566629140793419,0.0349989959219042,0.0572108582410063,4.36007737473203e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37781,0.0182207864880479,0.00223987507902509,0.0138306313331587,0.022610941642937,4.49167574845743e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0196892437308087,0.00242102365872265,-0.0244344501019051,-0.0149440373597123,4.56481097190408e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.0630346089725669,0.00775527438599768,0.0478342711760114,0.0782349467691223,4.75159824188518e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,40177,0.0255555671074627,0.00314727072168552,0.0193869164929591,0.0317242177219663,5.00840235293047e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,40341,0.0294933603588358,0.00363344764577046,0.0223718029731257,0.0366149177445459,5.11812688163689e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,-0.0275136487000318,0.00339098771212534,-0.0341599846157975,-0.0208673127842662,5.26367886057096e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,40044,0.033209052769669,0.00409963391629594,0.0251737702937289,0.041244335245609,5.87607556945388e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,40359,0.0430369323573418,0.00531692773752155,0.0326157539917996,0.0534581107228841,6.17168831994409e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,0.0508949810844982,0.00629152816672279,0.0385635858777215,0.0632263762912748,6.42106405777474e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,40192,0.0604585823480859,0.00748169367382964,0.0457944627473798,0.075122701948792,6.89421609214792e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,40332,0.0262926067864725,0.00325808898083982,0.0199067523840264,0.0326784611889185,7.53237324048945e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37671,0.0232517009777181,0.00288152281257412,0.0176039162650728,0.0288994856903634,7.68091413821408e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,0.0599579478655741,0.00743147565922031,0.0453922555735023,0.0745236401576459,7.7574281785898e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,-0.0182235948673482,0.00225994973699279,-0.0226530963518541,-0.0137940933828424,7.92234997187306e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0382438229993313,0.00474315059987377,0.0289472478235787,0.0475403981750839,8.07297209928324e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37714,0.0967223204646986,0.0120081556396667,0.0731863354109519,0.120258305518445,8.64269742838195e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0233908955495918,0.00290693973211245,0.0176932936746514,0.0290884974245322,9.10627580548341e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,0.0382889731636651,0.00475982492215867,0.0289597163162341,0.0476182300110961,9.28698677635259e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0470238576095766,0.0058771765575594,-0.058543123662393,-0.0355045915567601,1.31789535428522e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.0558576095392791,0.00698544700090635,0.0421661334175027,0.0695490856610556,1.38873725388903e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,0.0364452412118252,0.00457120358256133,0.027485682190005,0.0454048002336454,1.65515544938075e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,0.0311273998310037,0.00390918911470312,0.0234653891661856,0.0387894104958218,1.82122442509804e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.029763119293598,0.00374296993865252,0.0224268982138391,0.037099340373357,1.98470321221586e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDK,Midkine,40352,0.0374841831485222,0.00472177120375376,0.0282295115891648,0.0467388547078795,2.18070137586647e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37628,0.0544277029850944,0.0068712446332011,0.0409600635040203,0.0678953424661685,2.54249156800109e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,0.0464504452771356,0.00586850860826897,0.0349481684049284,0.0579527221493428,2.65957853122373e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,0.0545536455403076,0.00690054326916359,0.041028580732747,0.0680787103478682,2.87459275012512e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0238221118331656,0.00301530582069099,0.0179121124246113,0.0297321112417199,2.96162965052757e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,40228,-0.0312974120152319,0.00396223422292678,-0.0390633910921684,-0.0235314329382954,2.99745710833606e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,0.0581215870011965,0.00736379738955969,0.0436885441176596,0.0725546298847335,3.14922640510994e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,40436,0.0293563142047906,0.00372182185484574,0.022061543369293,0.0366510850402883,3.27808242569315e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0397798767609079,0.00504355470524834,0.0298945095386212,0.0496652439831947,3.28846054944617e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,38013,-0.0224987261540052,0.00285498031987868,-0.0280944875809674,-0.016902964727043,3.50767659100675e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,0.0217463224419294,0.00276478486641683,0.0163273441037524,0.0271653007801064,3.91559083434092e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,0.0191211043263639,0.00243718161531026,0.0143442283603558,0.023897980292372,4.58032686838586e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,0.0142793883984474,0.00182078764087543,0.0107106446223316,0.0178481321745633,4.69881239777563e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,0.0164681932189276,0.00209988294927539,0.0123524226383479,0.0205839637995074,4.75657382961395e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.0526917116040385,0.00672859503349783,0.0395036653383828,0.0658797578696943,5.20065295719056e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,40341,0.0595381453184947,0.00760861722394065,0.044625255559571,0.0744510350774183,5.39050685412167e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37900,0.0149579666741637,0.001912087878723,0.0112102744318666,0.0187056589164608,5.5479554041296e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.0560815715251525,0.00717813189455032,0.0420124330118339,0.0701507100384711,6.00192835789357e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.0553708227038948,0.00709921265600756,0.04145636589812,0.0692852795096696,6.59658105508489e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40471,0.0432500072413996,0.00555441250407448,0.0323633587334136,0.0541366557493856,7.30255081260166e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39980,0.0442996136060092,0.00570070996510905,0.0331262220743955,0.055473005137623,8.27932679354514e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,0.0308585631828574,0.00397310063004824,0.0230712859479629,0.038645840417752,8.53343574557726e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.026232313620382,0.00337810486425397,0.0196112280864442,0.0328533991543197,8.73995810046475e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,38013,0.0472888849579854,0.00609246994607572,0.0353476438636769,0.0592301260522938,8.96655014947314e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,0.0397531325196112,0.00513122143372167,0.0296959385095167,0.0498103265297056,9.96448931218014e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40516,0.0677104984574679,0.0087449089854123,0.0505704768460597,0.084850520068876,1.02983135669019e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0148330431892052,0.00191604218544146,-0.0185884858726704,-0.0110776005057399,1.05394101161761e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40516,0.039336338656698,0.00508516503663759,0.0293694151848883,0.0493032621285076,1.09078429640108e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,-0.0209495455688487,0.00271044576299177,-0.0262620192643126,-0.0156370718733848,1.15921148673708e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0298551520809481,0.00386419969389989,0.0222813206809043,0.0374289834809919,1.17471635201285e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,40359,0.0488267913379747,0.00632543326369472,0.036428942141133,0.0612246405348163,1.24068187157648e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0434738161513307,0.00564001828046092,0.0324193803216273,0.0545282519810341,1.36581233601749e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.0587451852207423,0.00764376762633729,0.0437634006731212,0.0737269697683634,1.61364205998359e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPTC,Opticin,40305,-0.0323039788312323,0.00420976031606169,-0.0405551090507132,-0.0240528486117514,1.76947788391393e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37990,0.0494903084445244,0.0064507539491465,0.0368468307041973,0.0621337861848516,1.8085105198903e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBN,Nibrin,40044,0.0364551681289962,0.0047528440256237,0.0271395938387737,0.0457707424192186,1.81870921177452e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.0437283556183221,0.00571156827710012,0.0325336817952059,0.0549230294414383,2.02925622673586e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,40341,0.0602928638446571,0.00787986085243004,0.0448483365738942,0.07573739111542,2.09988373417519e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,-0.0340359836067541,0.00445359454783658,-0.0427650289205138,-0.0253069382929944,2.25412021346189e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,40288,0.0213248286501166,0.00279393659844903,0.0158487129171565,0.0268009443830767,2.4325492380915e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0293115271225793,0.00384159613517431,-0.0368410555475209,-0.0217819986976376,2.47986374865909e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.053815578989837,0.00705917342156923,0.0399795990835613,0.0676515588961127,2.60865896346458e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,0.0436718632918794,0.0057484102466084,0.0324049792085269,0.0549387473752318,3.22973953716788e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39961,0.0424912966868728,0.00559698454259511,0.0315212069833864,0.0534613863903592,3.33364782221261e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40471,0.0426847403298666,0.00562715783289875,0.0316555109773851,0.0537139696823482,3.49379909889784e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0367591825112553,0.00485158516374024,0.0272500755903245,0.0462682894321862,3.77371295308468e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0336408496468749,0.00444011091411522,0.0249382322552091,0.0423434670385408,3.77932602193818e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,0.0372544884369223,0.00492365365304924,0.0276041272769458,0.0469048495968988,4.04602352011609e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,0.0167635093975588,0.00221680634026039,0.0124185689706484,0.0211084498244692,4.18552356620417e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,40370,-0.0199617203361608,0.00264423356983002,-0.0251444181330276,-0.014779022539294,4.61791267284777e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,40341,0.0581105354979906,0.00770223617122696,0.0430141526023858,0.0732069183935955,4.78079015140536e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,40358,0.0405049322595926,0.00537261707487147,0.0299746027928445,0.0510352617263407,4.98530107121881e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,0.0388267116333987,0.0051503379175548,0.0287320493149913,0.0489213739518061,5.00964714980205e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,40422,0.0332538260816152,0.00441173949539191,0.024606816670647,0.0419008354925833,5.04427157829945e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.0507387954129812,0.00673784553599087,0.0375326181624391,0.0639449726635233,5.3274499069914e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39934,0.0483276905674183,0.00643882518708597,0.0357075932007298,0.0609477879341068,6.44373545695011e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.0670110998167154,0.00892788713649598,0.0495124410291833,0.0845097586042475,6.48628370279739e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.0482810040566444,0.00643512527384817,0.035668158519902,0.0608938495933868,6.58696556203277e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37959,0.0720700202151643,0.00961141419224316,0.0532316483983677,0.0909083920319609,6.86358166226173e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37900,0.0271604041688582,0.00362383239196519,0.0200576926806064,0.03426311565711,7.04704912285809e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,40411,-0.0191859176225347,0.002560838315945,-0.0242051607217869,-0.0141666745232825,7.13549540375056e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,40305,0.0508714491812024,0.00681509303128634,0.0375138668398811,0.0642290315225236,8.79367735015017e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,40192,-0.0353865405675868,0.00474345031031249,-0.0446837031757993,-0.0260893779593743,9.09755938457338e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0399489139360083,0.00536781303037681,0.0294280003964697,0.0504698274755468,1.03996673035919e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40471,0.0403870199320426,0.00543291920553994,0.0297384982891843,0.0510355415749009,1.10882484122879e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,0.0170962604548909,0.0023012494558622,0.012585811521401,0.0216067093883808,1.14804904181461e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,40403,0.0694946040392444,0.00935468761205284,0.0511594163196208,0.0878297917588679,1.15083224144257e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,0.0575177821059133,0.00775284511051651,0.042322205689301,0.0727133585225257,1.24044003101832e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,40203,0.0360121650466309,0.0048627993093253,0.0264810784003533,0.0455432516929085,1.37117589268303e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0405223618957673,0.00547286885620475,0.029795538937606,0.0512491848539286,1.39897349107437e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.0653150170444486,0.00882807707148198,0.048011985984344,0.0826180481045533,1.44601133810581e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,0.0334716163781985,0.00453039768503552,0.0245920369155288,0.0423511958408681,1.5624198779942e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,40309,0.0460971423901851,0.00624505429136592,0.0338568359791079,0.0583374488012623,1.64420718640994e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.0767853211588527,0.0104109880694776,0.0563797845426765,0.0971908577750289,1.71997617490968e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,-0.0233154357927635,0.00316309000447245,-0.0295150922015295,-0.0171157793839975,1.77637612501426e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.0143841139026991,0.00195381555183346,-0.0182135923842927,-0.0105546354211055,1.90130097219929e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39961,0.0243048845770992,0.00331116443512083,0.0178150022842624,0.030794766869936,2.23713974239098e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,0.0332781675330215,0.00453408657814372,0.0243913578398598,0.0421649772261832,2.26893639044781e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,40376,0.0628265900392265,0.00858210844428398,0.0460056574884299,0.0796475225900231,2.58563889049844e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.0681906640870445,0.0093176352407221,0.0499280990152292,0.0864532291588598,2.62708110075242e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,0.0603676620052056,0.00825585656294002,0.0441861831418431,0.076549140868568,2.77810596621172e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0421071597684633,0.00576313989014804,0.0308114055837732,0.0534029139531535,2.90527682520533e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37598,0.0622482741348009,0.00852637989324735,0.0455365695440361,0.0789599787255657,3.02799340719104e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40471,0.023195464164001,0.00317942414060107,0.0169637928484229,0.0294271354795791,3.11501468749251e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0306097743651472,0.00420074328860477,0.0223763175194818,0.0388432312108125,3.32544335540833e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.0758416454437159,0.010413641127022,0.0554309088347528,0.0962523820526789,3.45114133341009e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37987,0.0492575939495172,0.00676450843886588,0.03599915740934,0.0625160304896943,3.47656995138803e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.0591960593617646,0.00813873446629182,0.0432441398078326,0.0751479789156965,3.66913052854179e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.0771900133296666,0.0106321564386399,0.0563509867099325,0.0980290399494007,4.08185649893369e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37987,0.0461488843731782,0.00636273139511288,0.033677930838757,0.0586198379075995,4.29790998826988e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,40203,0.0308152078400045,0.0042533673334841,0.0224786078663757,0.0391518078136333,4.52814819326955e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0256426776915684,0.00354018012053357,0.0187039246553226,0.0325814307278142,4.57691308427699e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,0.0697131073991346,0.00962487543280064,0.0508483515508454,0.0885778632474239,4.58994085128277e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0209407484063875,0.00289459819163454,0.0152673359507838,0.0266141608619912,4.88826864372561e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0390400427929635,0.00539743356176247,0.0284610730119091,0.0496190125740179,4.94285125926746e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,0.0560701167923425,0.00775513572364063,0.0408700507740069,0.0712701828106782,5.08838301506311e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0196230914460864,0.00271882575940864,0.0142941929576455,0.0249519899345273,5.578734675441e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,40299,0.0190673791944353,0.00264598541456994,0.0138812477818782,0.0242535106069924,6.01473323920851e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39961,0.0417426955984267,0.00580535998420165,0.0303641900293914,0.0531212011674619,6.75651957704081e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,0.046301172458262,0.00643963762227792,0.0336794827185973,0.0589228621979267,6.76462027931817e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNST,Consortin,40359,0.0723359059783047,0.0100621828223229,0.0526140276465519,0.0920577843100575,6.82248149295817e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,40276,0.0224351207998606,0.00312525562712843,0.0163096197706889,0.0285606218290323,7.35307967667121e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.0539436925598507,0.00751665547055092,0.0392110478375709,0.0686763372821305,7.53215882032504e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,0.0565084665444229,0.00788293896391981,0.0410579061751401,0.0719590269137057,7.98075959247948e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,0.0313502193495708,0.00437470571283746,0.0227757961524094,0.0399246425467322,8.05496568256567e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOC,Myocilin,40332,-0.0306470126341111,0.00427953940100686,-0.0390349098600845,-0.0222591154081376,8.34272692763528e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0301959034620391,0.0042175165033184,-0.0384622358085431,-0.021929571115535,8.44009648787939e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0172602056166351,0.00241146889208953,0.0125337265881396,0.0219866846451305,8.57057661915816e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,0.0452290633165612,0.00631961539705428,0.0328426171383348,0.0576155094947875,8.60901426746164e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.0691120607250427,0.00965673483741384,0.0501848604437115,0.0880392610063738,8.61439546456642e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,0.028905532001253,0.00403947536477016,0.0209881602863034,0.0368229037162025,8.76321776690816e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0480182997905082,0.00671729588240513,0.0348523998609942,0.0611841997200223,9.24019340043084e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.0517161779109496,0.00724242547433949,0.0375210239812442,0.065911331840655,9.77083572576757e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,0.0268921078535178,0.00376821777275645,0.0195064010189152,0.0342778146881205,9.99304390438489e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.0458356870603367,0.00642447616481922,0.0332437137772911,0.0584276603433824,1.02065655797187e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0465224433592424,0.00652755068656747,0.0337284440135701,0.0593164427049146,1.06952158807776e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,38013,0.0278015856808057,0.00390299565862991,0.020151714189891,0.0354514571717203,1.10814843176226e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0212843508319476,0.00299065863636121,0.0154226599046796,0.0271460417592156,1.15018378181658e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0232945277276829,0.00327559091670675,0.0168743695309377,0.0297146859244281,1.19753180822306e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39980,0.0276813402004271,0.00389272168769558,0.0200516056925438,0.0353110747083105,1.20185876132641e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,0.0691936527233559,0.00973869468565046,0.050105811139481,0.0882814943072308,1.25383982129395e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,40341,-0.0282911741578025,0.00398230847254745,-0.0360964987639955,-0.0204858495516095,1.26144461956994e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,0.0542175318528536,0.00764492571306386,0.0392334774552485,0.0692015862504588,1.38784827851233e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0269727331306861,0.00380903007800795,0.0195070341777905,0.0344384320835817,1.48951061355189e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37990,0.0491981410529112,0.00695485153817632,0.0355666320380856,0.0628296500677367,1.58003465651206e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,37057,0.0163208853362729,0.00230846908442065,0.0117962859308084,0.0208454847417374,1.63098487907643e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,0.024433835663276,0.00345678798709583,0.0176585312085682,0.0312091401179838,1.63371127241858e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0216469136117259,0.00307511517107922,-0.0276741393470411,-0.0156196878764106,2.02388383862444e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,0.081681592640228,0.0116506878088383,0.0588462445349048,0.104516940745551,2.46305109090487e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,0.0369615803135126,0.00527265679435162,0.0266271729965834,0.0472959876304418,2.49864127579175e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0290594894507088,0.00415262141268886,0.0209203514818387,0.037198627419579,2.70520131791452e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COCH,Cochlin,37990,0.0304126699870066,0.00434724650460416,0.0218920668379825,0.0389332731360308,2.76050066917216e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0204757990363311,0.00293071513525984,-0.0262200007014404,-0.0147315973712218,2.94271474149774e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,0.041375310517309,0.00592206465152078,0.0297680638003283,0.0529825572342897,2.95153438219659e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NADK,NAD kinase,40359,0.034907305261933,0.00499989693354286,0.025107507272189,0.044707103251677,3.03366102104147e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,0.0269330937219751,0.00385945227918339,0.0193685672547756,0.0344976201891745,3.10061000599441e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBIN,Erbin,40305,0.0666125147872866,0.00955610909327506,0.0478825409644674,0.0853424886101057,3.2786534090375e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0256755475024207,0.00368441206752944,0.018454099850063,0.0328969951547784,3.34743808612549e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37934,0.0546229059610782,0.00783955230418846,0.0392573834448689,0.0699884284772876,3.37348081889953e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,0.0440530165919118,0.00632405383476773,0.031657871075767,0.0564481621080565,3.41772856175771e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,0.0337689077634292,0.00486551850986222,0.0242324914840992,0.0433053240427591,4.05961732159044e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELP,P-selectin,40403,0.0373687200615785,0.00538462985265434,0.026814845550376,0.047922594572781,4.07522392238477e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.049486625103482,0.00717146381106202,0.0354305560338004,0.0635426941731636,5.41330147443164e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,40341,0.0584455266587949,0.00848163997747421,0.0418215123029454,0.0750695410146443,5.7552439914228e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.0432427546513935,0.00628568708084372,0.0309228079729398,0.0555627013298471,6.27408683601879e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40471,0.0227345596391369,0.00330601839228924,0.01625476359025,0.0292143556880239,6.35103464944872e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.0618462871356971,0.0090093882372145,0.0441878861907567,0.0795046880806375,6.91697153900522e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0345590009515013,0.00503483706987909,0.0246907202945383,0.0444272816084644,6.94239696625458e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,40359,0.0772916442058658,0.0112618205586026,0.0552184759110047,0.0993648125007269,6.98425887021648e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,40305,-0.0183904134722485,0.00268027511144362,-0.023643752690678,-0.013137074253819,7.07182141706931e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0270051350979022,0.00393880744055854,0.0192850725144075,0.0347251976813969,7.38610919073464e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,-0.0187415017123561,0.00273696639387096,-0.0241059558443432,-0.013377047580369,7.78466109828272e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.0435932539077609,0.00636856249647273,0.0311108714146744,0.0560756364008475,7.98371088249641e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,0.0403291692537246,0.00589277684437171,0.028779326638756,0.0518790118686931,8.04283238355827e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.0683835775349781,0.0099979061045878,0.048787681569986,0.0879794734999702,8.27263591954985e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.0660098206103431,0.00965964374807677,0.0470769188641127,0.0849427223565736,8.58236229061156e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37848,0.0591730904992846,0.00865895923989442,0.0422015303890916,0.0761446506094777,8.63050140648615e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37901,0.0660569009381527,0.00966955678682924,0.0471045696359673,0.085009232240338,8.76879787274479e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,-0.016567084448483,0.00242672488471515,-0.0213234652225246,-0.0118107036744413,8.98906638004645e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,0.0302421637725289,0.00443116262006292,0.0215570850372056,0.0389272425078522,9.11713477014483e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTD,Biotinidase,38013,0.0131684855261709,0.00192987763612999,0.00938592535935616,0.0169510456929857,9.26316692834174e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0285523600963512,0.00418517794926685,0.0203494113157882,0.0367553088769142,9.35448203485615e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.024174846004453,0.00355395830898946,0.0172090877188337,0.0311406042900723,1.06758014541691e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,40341,0.052199168293896,0.00769129742028945,0.0371242253501287,0.0672741112376633,1.1871588072215e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.0423883602477622,0.00624589349701348,0.0301464089936158,0.0546303115019086,1.18835491331765e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,-0.038755622336298,0.00571582009333258,-0.0499586297192298,-0.0275526149533661,1.24014687631449e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,40228,0.0389460656387985,0.00574784168700104,0.0276802959322764,0.0502118353453205,1.28122736229088e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,0.0501840467673838,0.00740916790301223,0.0356620776774798,0.0647060158572877,1.30314273147838e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,-0.0111757314334666,0.00165173221570451,-0.0144131265762475,-0.00793833629068581,1.36954484781554e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37942,0.047281638092627,0.00698748980206196,0.0335861580805855,0.0609771181046684,1.3727318455444e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40471,-0.0189420992571508,0.00280440458778645,-0.0244387322492122,-0.0134454662650893,1.48352169832079e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,0.0118111675929309,0.00174889946217145,0.00838332464707486,0.0152390105387869,1.5021412265179e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,40305,0.0345631173527015,0.00512577696646586,0.0245165944984284,0.0446096402069746,1.60507566487189e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,40357,0.0160805907447856,0.00238599836001577,0.0114040339591547,0.0207571475304166,1.64319651318544e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39991,0.0312548377447308,0.00464080801401326,0.0221588540372648,0.0403508214521968,1.69933210800045e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0281760170175356,0.00418378124929981,-0.0363762282661632,-0.019975805768908,1.70014515705706e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0174967695103921,0.00260236394324206,0.0123961361816377,0.0225974028391466,1.83555753616899e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,0.0458511771315633,0.00682248501341742,0.0324791065052652,0.0592232477578614,1.87139841091711e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37900,0.022281077916793,0.00331567454818997,0.0157823558023407,0.0287798000312454,1.8914322208111e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0199418609197064,0.00296862014146498,0.014123365442435,0.0257603563969778,1.92211290629412e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40497,-0.0298826272867621,0.00445085138790728,-0.0386062960070603,-0.0211589585664638,1.95828746175114e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0406332353504939,0.00605769305703795,0.0287601569586995,0.0525063137422883,2.05609491011782e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37901,0.0438764641285636,0.00654161738502881,0.0310548940539071,0.05669803420322,2.06210016996098e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37598,0.027738213158097,0.00413681750910288,0.0196300508402554,0.0358463754759386,2.09339874415935e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37778,0.0682758964974397,0.0102006269379367,0.0482826676990837,0.0882691252957957,2.26917183702229e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.0388726166597173,0.00580962527703469,0.0274857511167293,0.0502594822027053,2.30285638405469e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37735,-0.109944524866285,0.0164830404543218,-0.142251284156756,-0.0776377655758146,2.65640593292178e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,0.0151420281054237,0.00227288422227684,0.0106871750297611,0.0195968811810863,2.80512897651829e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.0484642416016677,0.00727632073721201,0.0342026529567322,0.0627258302466033,2.81837021516416e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,40263,0.052752875763161,0.00792455952245981,0.0372207390991398,0.0682850124271823,2.88897422212755e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,0.0852564251763754,0.0128487356306419,0.0600729033403174,0.110439947012433,3.34122622034546e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.0335528854828395,0.00506348191857821,0.0236284609224263,0.0434773100432528,3.55003849986382e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0291189036868429,0.00441760488913494,0.0204603981041384,0.0377774092695474,4.51391215838633e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.0632954227265697,0.00960432322428882,0.0444709492069636,0.0821198962461758,4.55623202278824e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37671,0.0182233029075197,0.00276728746481847,0.0127994194764755,0.0236471863385639,4.71263049101451e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,0.0485676605195063,0.00737691223824524,0.0341089125325456,0.063026408506467,4.76092534768441e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,-0.0114442443892016,0.00174049195314938,-0.0148556086173744,-0.0080328801610288,5.03397809720694e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0308497197697231,0.00469647372696205,0.0216446312648775,0.0400548082745687,5.23315989490425e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,0.0216984201965055,0.00330880249541183,0.0152131673054983,0.0281836730875126,5.62814108427736e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,0.0326885195277485,0.00499327042641307,0.0229017094919789,0.0424753295635181,6.06850152261455e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0262942910840466,0.00402281216424636,0.0184095792421238,0.0341790029259695,6.53884782787526e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEP,Leptin,40359,0.0388926478873017,0.00596309481679882,0.027204982046376,0.0505803137282274,7.13609325934783e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.0165967344386294,0.00254749684381716,0.0116036406247477,0.021589828252511,7.53179939725623e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0277769195113858,0.00426906399700818,0.0194095540772498,0.0361442849455218,7.91921935604263e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,0.0257229403423457,0.00395532818880727,0.0179704970922835,0.033475383592408,8.08587798249844e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0704828339557503,0.0108464335765656,0.0492238241456818,0.0917418437658188,8.37071772967314e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,0.041139943364455,0.00633168953126476,0.028729831883176,0.0535500548457339,8.40861314523722e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,0.0288218845187344,0.0044363319464114,0.0201266739037681,0.0375170951337008,8.49252716580325e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,40274,0.0296067357890521,0.0045618777889876,0.0206654553226365,0.0385480162554678,8.8369361521923e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0239315884876127,0.00369160529024397,0.0166960421187345,0.0311671348564909,9.32368610380151e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,0.0333003486854127,0.0051383737139607,0.0232291362060498,0.0433715611647757,9.44557623482445e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,0.0517607959447082,0.00799090730880807,0.0360986176194444,0.067422974269972,9.60047920929717e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0386723377198773,0.006006010774826,0.0269005566012183,0.0504441188385362,1.24466108697769e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,0.0325516810202139,0.0050650812561475,0.0226241217581648,0.042479240282263,1.34917196030469e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,0.0366761122215883,0.00570850125488907,0.0254874497620058,0.0478647746811709,1.35784972070201e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,0.0431021897180078,0.00671250438808939,0.0299456811173526,0.056258698318663,1.3901383405243e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,40411,0.031268155254236,0.00487163872270025,0.0217197433577435,0.0408165671507284,1.41592809734376e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,0.0453405492117599,0.00706871663049798,0.0314858646159838,0.0591952338075359,1.46227930383763e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.037228634898364,0.00581414343954601,0.0258329137568539,0.0486243560398742,1.57280806275724e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40536,-0.0181686094855638,0.0028389760022571,-0.0237330024499877,-0.0126042165211399,1.59983700072303e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,0.0455139667794031,0.00711495538879185,0.0315686542173711,0.0594592793414351,1.63765627025707e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.0568170200930774,0.00888349804393621,0.0394053639269624,0.0742286762591924,1.64158049902776e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0225968116678272,0.00353595355815801,0.0156663426938375,0.0295272806418169,1.69857054736156e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGN,Biglycan,39956,-0.07244669144317,0.0113492455150814,-0.0946912126527295,-0.0502021702336105,1.78129786558184e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39924,0.0405398889575655,0.00635435492147573,0.028085353311473,0.0529944246036579,1.82288299988489e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,0.0466126188564404,0.00730903755076545,0.0322869052569402,0.0609383324559407,1.85990790967122e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,40341,0.0397635412257741,0.00624211990492243,0.0275289862121262,0.0519980962394221,1.93975355387883e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0262856998536871,0.00412772132622892,0.0181953660542784,0.0343760336530958,1.96665285975965e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0395001943390317,0.00620725063228168,0.0273339830997596,0.0516664055783038,2.03617172002236e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0174991921494105,0.00275025655944993,0.0121086892928886,0.0228896950059323,2.03638101918289e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,0.0434081469593652,0.00682752112965013,0.0300262055452509,0.0567900883734794,2.11205074300503e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0573681429731746,0.00906167282522288,0.0396072642357377,0.0751290217106114,2.50350636042604e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,-0.0166836188359489,0.00263770222724558,-0.0218535152013502,-0.0115137224705475,2.59871083423581e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,0.0329087537295712,0.0052050798691022,0.0227067971861308,0.0431107102730115,2.64323675232824e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,40359,0.025051472090642,0.00396483910410928,0.0172803874465878,0.0328225567346962,2.71299259603999e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,37177,0.0728250258658024,0.0115434141322646,0.0501999341665639,0.095450117565041,2.90536934252907e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFH,Complement factor H,37301,0.0136743364511995,0.00216854246031079,0.00942399322899036,0.0179246796734087,2.96151332918866e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37900,0.0283471661333862,0.00450132850063048,0.0195245622721505,0.037169769994622,3.1187308441669e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARC,SPARC,40411,0.0415401811936962,0.00659984110926287,0.028604492619541,0.0544758697678515,3.17222618107356e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37628,0.029803198396882,0.00474822215529489,0.020496682972504,0.03910971382126,3.56660623444781e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0210807984955036,0.00336045452619041,0.0144943076241704,0.0276672893668368,3.6287958152885e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37900,0.0479649324065395,0.00764723730469189,0.0329763472893434,0.0629535175237356,3.66903411883683e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,40332,0.0229669620088089,0.00366323701348885,0.0157870174623707,0.030146906555247,3.71373412111089e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,0.0349492750801735,0.00558233793063039,0.024007892736138,0.0458906574242091,3.94917555739849e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.0538524831751532,0.00860584482528442,0.0369850273175957,0.0707199390327106,4.00996351400295e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,40360,-0.0366478497821907,0.00586210956921923,-0.0481375845378604,-0.025158115026521,4.16498461270609e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0129504767603519,0.0020770855021152,0.00887938917620613,0.0170215643444977,4.65417566763575e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40516,0.0218545365368508,0.00351045023357261,0.0149740540790485,0.0287350189946532,4.91739970811922e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0207304299868636,0.00333033306525528,0.0142029771789633,0.027257882794764,4.97073141369444e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,40147,0.0269340912502912,0.00433107889224051,0.0184451766214998,0.0354230058790826,5.13671123580865e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,0.0161311922829595,0.00259454053066659,0.0110458928428529,0.021216491723066,5.18130269754269e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.038598009601722,0.0062154170278575,0.0264157922271213,0.0507802269763227,5.43197279969109e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0193504125587574,0.00312040822998345,0.0132344124279899,0.025466412689525,5.74004413489157e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.0379493902069557,0.00612455073845338,0.025945270759587,0.0499535096543243,5.94952491880211e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,40309,0.0225788754816457,0.0036462382986784,0.0154322484162361,0.0297255025470554,6.07244241673976e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.018977770535065,0.00306600729817168,-0.0249871448394815,-0.0129683962306486,6.17484054951662e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,0.0335379366078193,0.00542314514373323,0.0229085721261022,0.0441673010895364,6.39445886343038e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,40228,0.0200517758070142,0.0032424791604188,0.0136965166525934,0.0264070349614351,6.40013682787897e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,0.0384498388050289,0.00621732071130806,0.0262638902108651,0.0506357873991927,6.42280151169358e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,0.0206869479789539,0.00335087419824009,0.0141192345504034,0.0272546614075045,6.86671408234647e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.0455849067742808,0.00739139965941469,0.031097763441828,0.0600720501067336,7.14512276970538e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,-0.0155850107360805,0.00252791103204632,-0.0205397163588913,-0.0106303051132697,7.20862473023452e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,0.057670948960425,0.00936169077459037,0.0393220350422279,0.0760198628786222,7.46574291553752e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40514,-0.0241431412035985,0.0039203814284514,-0.0318270888033632,-0.0164591936038337,7.52487208717027e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37990,0.0368473894765387,0.00598885690884986,0.0251092299351929,0.0485855490178844,7.83424208559939e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0268072558084043,0.0043671338853195,0.0182476733931781,0.0353668382236305,8.56952002884152e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,37541,0.022441661474852,0.00365712755143581,0.0152736914740378,0.0296096314756662,8.68390610331304e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37671,0.0402242721015593,0.00656286204439185,0.0273610624945513,0.0530874817085673,9.09052700510756e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40516,0.0194289033033289,0.0031732877617927,0.0132092592902152,0.0256485473164426,9.41768979725631e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0165725261409123,0.00270707533641796,0.0112666584815331,0.0218783938002915,9.50031170520116e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.0582234296015017,0.0095622237153637,0.0394814711193888,0.0769653880836145,1.16784346179145e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,-0.013596595841167,0.00223342471262204,-0.0179741082779062,-0.00921908340442781,1.17108232466838e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37628,0.0235057539422351,0.0038671063955461,0.0159262254069648,0.0310852824775055,1.24752472511732e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,0.0340927416826793,0.00562145879564406,0.0230746824432169,0.0451108009221416,1.35226501091354e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0315730146650757,0.00521598492207097,0.0213496842178166,0.0417963451123348,1.45219767966923e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37698,-0.0174714291663829,0.00288600058891332,-0.023127990320653,-0.0118148680121128,1.45242262139293e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,40228,0.0743688915998299,0.0122868489816378,0.0502866675958198,0.0984511156038401,1.45641436021995e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,0.0387414116444839,0.00641094725109133,0.0261759550323449,0.0513068682566229,1.54629225458771e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSG,Basigin,40502,0.0113867664197479,0.00188441407823564,0.00769331482640603,0.0150802180130897,1.54998607654891e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39980,0.0214474754431946,0.00355051257697707,0.0144884707923195,0.0284064800940696,1.56977788206155e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,0.0472933869723309,0.00783296196459949,0.0319407815217159,0.0626459924229459,1.59773778950408e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,40411,0.032482213648284,0.00538174720707774,0.0219339891224117,0.0430304381741564,1.61851060918316e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37598,0.024535679106172,0.0040746434877324,0.0165493778702165,0.0325219803421276,1.77358978881411e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,0.0152193134192468,0.00253036743784784,0.0102597932410651,0.0201788335974286,1.84905000980545e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,40203,0.0296929794326069,0.00493997686587029,0.0200106247755011,0.0393753340897127,1.88737332516347e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0168885383490391,0.00281252565517237,0.0113759880649013,0.022401088633177,1.96540120409157e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0167673215372277,0.00279347669813458,0.0112921072088839,0.0222425358655715,1.98758569084081e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0244766898642391,0.00408130259936659,0.0164773367694806,0.0324760429589976,2.05089829126112e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.0402967360482534,0.00672003110421855,0.027125475083985,0.0534679970125217,2.05969915701945e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0346030158761716,0.00578057627335531,0.0232730863803952,0.045932945371948,2.20569000600324e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37959,-0.0248681074228112,0.0041574823543203,-0.033016772837279,-0.0167194420083434,2.26637406095436e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,40288,0.0490283486348837,0.00820427974565248,0.0329479603334049,0.0651087369363626,2.33661377855315e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39961,0.0400571722310039,0.0067071234175637,0.0269112103325791,0.0532031341294288,2.3899486347959e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,0.0299511731443883,0.00501518574914089,0.0201214090760722,0.0397809372127045,2.40256297476467e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0203957739195861,0.00342038212966557,0.0136918249454415,0.0270997228937306,2.53972316891828e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,40266,0.0214599363179891,0.00360284593192772,0.0143983582914108,0.0285215143445674,2.63345538261912e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.014967828419878,0.00251364230418762,0.0100410895036703,0.0198945673360857,2.66130642911536e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0429863343291323,0.00722420271260838,-0.0571457716458447,-0.0288268970124199,2.7323201392917e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39980,0.0541824310839237,0.0091164452078244,0.0363141984765879,0.0720506636912596,2.85194009135642e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,0.0325056997456975,0.00548419327229773,0.0217566809319939,0.043254718559401,3.14548602079612e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,0.0423995270703562,0.00716448707358888,0.028357132406122,0.0564419217345904,3.3396981160004e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0361976555099027,0.00612559083085387,0.0241914974814291,0.0482038135383762,3.50858430878313e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37959,0.0302092191085935,0.00511753361369562,0.0201788532257501,0.0402395849914369,3.65333435335031e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0280132465115651,0.00474704593873514,0.0187090364716443,0.037317456551486,3.68142494879093e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37810,-0.0167062888900647,0.00283544384123321,-0.0222637588188818,-0.0111488189612476,3.90860219294851e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37942,0.0120858400434108,0.00205502915329606,0.00805798290295053,0.0161136971838711,4.1718690646216e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,0.0400591935649097,0.00681376486854658,0.0267042144225584,0.053414172707261,4.20785654115129e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37901,0.0155917006314008,0.00265180655083763,0.010394159791759,0.0207892414710425,4.20882275024684e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,-0.00810239792244758,0.00137941092225111,-0.0108060433300598,-0.0053987525148354,4.35912102468921e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,37441,0.0393145033976223,0.00669633904127813,0.0261896788767172,0.0524393279185275,4.4363833163102e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0282376989471909,0.00481031611845613,0.0188094793550169,0.0376659185393649,4.44044114480196e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,-0.0224469756090676,0.00382553707730844,-0.0299450282805922,-0.0149489229375431,4.50851155221125e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37966,0.024387551910551,0.00415827508223961,0.0162373327493613,0.0325377710717406,4.60118435152605e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,40044,0.0622453702755336,0.010623265700733,0.041423769502097,0.0830669710489703,4.74066183131838e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,40228,0.0527900266412497,0.00901774161937799,0.0351152530672688,0.0704648002152305,4.89359929578686e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37990,0.0159342143830029,0.00272221394714674,0.0105986750465953,0.0212697537194105,4.9276766870631e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39961,0.0367104117316238,0.00627915889552234,0.0244032602964,0.0490175631668476,5.1244870306503e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37567,0.0234308059039263,0.00400855991135323,0.0155740284776739,0.0312875833301786,5.18012357765434e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,0.0248709382040919,0.00425578684653703,0.0165295959848793,0.0332122804233044,5.19399216736096e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,40290,0.0238845380623678,0.00408784465287124,0.0158723625427402,0.0318967135819954,5.23318318836108e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0287362597669211,0.00492328816946706,0.0190866149547656,0.0383859045790765,5.44561847608758e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0180804173542119,0.00310145062075525,0.0120015741375316,0.0241592605708922,5.66108610721354e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0190777344682526,0.00327385890341799,0.0126609710175533,0.0254944979189519,5.76240203404961e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,40359,-0.0379877540023075,0.00652468820141538,-0.0507761428770817,-0.0251993651275334,5.92125516204991e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.0321694368707165,0.00552776810476847,0.0213350113853703,0.0430038623560627,6.01303191576186e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,40359,0.013171700445552,0.00226457420405546,0.00873313500560326,0.0176102658855007,6.1277542558206e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,40228,0.0391773285344803,0.00673595082214977,0.0259748649230668,0.0523797921458939,6.13821784916679e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0241925283699712,0.0041699294231226,0.0160194667006509,0.0323655900392915,6.7169023805586e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37628,0.0369354537592264,0.00636644388838477,0.0244572237379922,0.0494136837804605,6.72012314709175e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37936,0.0408710563973194,0.00704730130535643,0.0270583458388208,0.054683766955818,6.79906541807983e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0206834275801774,0.00357495093920943,0.0136765237393269,0.0276903314210278,7.35833695256698e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,40332,0.0409583874874158,0.00708146463870909,0.027078716795546,0.0548380581792856,7.43670907035255e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI3,Elafin,40074,0.0289080690137717,0.00500260321448045,0.0191029667133901,0.0387131713141534,7.67575318560028e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,40042,0.0319938962028268,0.00553675315493045,0.0211418600191631,0.0428459323864904,7.68274852362706e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,40376,0.0364518194242752,0.00630917879529727,0.0240858289854926,0.0488178098630579,7.71954919199431e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40471,0.0705640910725223,0.0122192988738187,0.0466142652798376,0.094513916865207,7.84688984804998e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37900,0.0341608247269654,0.00591597259717469,0.022565518436503,0.0457561310174278,7.89634273009549e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39980,0.0522669436604486,0.009055859962308,0.0345174581343249,0.0700164291865723,8.00129362778334e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37882,0.0248050788469929,0.00430601909720344,0.0163652814164742,0.0332448762775117,8.5673337666753e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0191227043205869,0.00331962817431429,0.0126162330989309,0.0256291755422429,8.57456195627531e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,40422,0.023285720152381,0.00404422101187897,0.0153590469690982,0.0312123933356638,8.679501256964e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,0.0414406520027502,0.00719776695532294,0.0273330287703172,0.0555482752351831,8.69787199761188e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.0359699454315906,0.00625066380502808,0.0237186443737356,0.0482212464894456,8.84954019881643e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37934,0.0522382267135106,0.00908936284468453,0.034423075537929,0.0700533778890923,9.27061779645924e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37562,0.0319225405243087,0.00555536452689821,0.0210340260515882,0.0428110549970292,9.32711749381483e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,-0.031805602030085,0.00553724270721876,-0.0426585977362338,-0.0209526063239363,9.44864053640469e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37572,0.0238557904489542,0.00415779273858036,0.0157065166813367,0.0320050642165717,9.81438286220921e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.0381048874719818,0.00665011451110261,0.0250706630302206,0.0511391119137429,1.02267937830969e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,40044,0.0375941054795423,0.00656318580421006,0.0247302613032905,0.050457949655794,1.03479278036692e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39934,0.0478208935287138,0.0083556798871606,0.031443760949879,0.0641980261075486,1.06496388825859e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,40359,-0.0163568809200388,0.00286544458280489,-0.0219731523023364,-0.0107406095377413,1.16129857577183e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,-0.032328675756364,0.00566654942883841,-0.0434351126368873,-0.0212222388758408,1.18663073568969e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37901,0.0361690276765384,0.00634556873811615,0.0237317129498308,0.0486063424032461,1.22403937257936e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40489,0.058464043650504,0.010271441452757,0.0383320184031003,0.0785960688979078,1.27828627143927e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,40442,0.0388839386297698,0.00683193465515956,0.025493346705657,0.0522745305538825,1.28138229190375e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,0.022531614026836,0.00396263756108645,0.0147648444071065,0.0302983836465654,1.32790531850883e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39925,0.0237049548586576,0.00417234875376406,0.01552715130128,0.0318827584160351,1.35968484578217e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.0453397987426759,0.00799195304284968,0.0296755707786906,0.0610040267066613,1.43116537097393e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,0.024895446802808,0.00439156362609594,0.01628798209566,0.0335029115099561,1.4619255285271e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,40295,-0.0337519603539097,0.00595459569839113,-0.0454229679227563,-0.0220809527850631,1.46801438040785e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,0.0240654654858734,0.00424576611984848,0.0157437638909704,0.0323871670807764,1.46947957383596e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0255522954507923,0.00450984597133843,0.016712997346969,0.0343915935546156,1.48777759295522e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40516,0.0241696132576816,0.0042659271337196,0.0158083960755912,0.032530830439772,1.48905653074512e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,0.0284270960019065,0.00501871646571671,0.0185904117291018,0.0382637802747113,1.5083735371282e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.033825521198507,0.00598119571113054,0.0221023776046911,0.0455486647923228,1.58238950828561e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,40192,0.0340684511512302,0.00603440324642552,0.0222410207882362,0.0458958815142242,1.67346733807952e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.0578917385329938,0.0102645486015615,0.0377732232739333,0.0780102537920543,1.72966734755052e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37628,-0.0223417713698859,0.00396715317767929,-0.0301173915981373,-0.0145661511416345,1.8210278064164e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37562,0.0246616095455366,0.00438096864329305,0.0160749110046822,0.0332483080863909,1.84698263230421e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40489,-0.0235415012051983,0.0041844748907373,-0.0317430719910434,-0.0153399304193532,1.87609917182297e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37942,-0.0192571952134573,0.00342931628748486,-0.0259786551369277,-0.012535735289987,1.99908340898275e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,0.04155318677823,0.00740350101078821,0.0270423247970852,0.0560640487593749,2.02588467043639e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0345115573611576,0.00614924992510404,0.0224590275079537,0.0465640872143615,2.02939702000942e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39980,0.0242130116370137,0.0043145693328657,0.0157564557445969,0.0326695675294305,2.0351563314314e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0186811454648598,0.00333114460504485,0.0121521020389719,0.0252101888907477,2.08121213847942e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,0.0331449127812728,0.00591489981459502,0.0215517091446666,0.0447381164178791,2.14003617334217e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,0.0468366114330885,0.00835872003039702,0.0304535201735103,0.0632197026926666,2.14496028061932e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,40303,0.0142846988767268,0.0025499523675354,0.00928679223635737,0.0192826055170961,2.15480748215432e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0195683686934616,0.00349342381876167,0.0127212580086888,0.0264154793782345,2.16044040896515e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,-0.0177857770437692,0.00317863309721272,-0.0240158979143061,-0.0115556561732323,2.23725982848971e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39934,0.0325658552340621,0.00582406801735116,0.0211506819200539,0.0439810285480704,2.28790030131705e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37959,0.0345260850507808,0.0061750344234155,0.0224230175808864,0.0466291525206752,2.29827845402586e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.0329868908743798,0.00591834016731356,0.0213869441464452,0.0445868376023143,2.53574756655932e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0352681224016475,0.00633584173240426,0.0228498726061351,0.0476863721971598,2.65091800185033e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0320216718808394,0.005754035870853,0.0207437615739676,0.0432995821877113,2.66365803109781e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37572,0.0677358694256613,0.0121887090066207,0.0438459997726847,0.0916257390786378,2.79378634278408e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,40139,0.0396830534941382,0.00715810067177537,0.0256531761774584,0.0537129308108179,3.00756490297635e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0242746327427394,0.00438461283254674,0.0156807915909478,0.032868473894531,3.146361176381e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0397430693976185,0.00718026070211923,0.0256697584214649,0.0538163803737722,3.16971429380123e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0339199323305733,0.00612833367626895,-0.0459314663360605,-0.0219083983250862,3.17151839426155e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37998,0.014381747438805,0.00260413841775913,0.00927763613999713,0.0194858587376129,3.40073531093169e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.0478026955951035,0.00866260311744377,0.0308239934849137,0.0647813977052933,3.48632228420935e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.0213808233848205,0.00387517788928923,-0.0289761720478274,-0.0137854747218136,3.49443557250245e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,-0.0221307473500874,0.00401532704586639,-0.0300007883599855,-0.0142607063401893,3.62350388011458e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0295799788818289,0.00536767655431111,0.0190593328353791,0.0401006249282787,3.64013011455682e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,40341,0.0172778368264067,0.00313750321200527,0.0111283305308764,0.0234273431219371,3.70925933269379e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,0.0589174697497442,0.0107169980671476,0.037912153538135,0.0799227859613535,3.91001395478454e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,40422,-0.0320391297122536,0.0058308930412694,-0.0434676800731416,-0.0206105793513656,3.97316091357653e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.0557309867749567,0.01014721181243,0.035842451622594,0.0756195219273194,4.04059138639607e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,0.0240423191542536,0.00437965689541957,0.0154581916392313,0.032626446669276,4.10228853369407e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39809,0.0398896877470044,0.0072688494939733,0.0256427427388167,0.054136632755192,4.13513217322794e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,40374,0.0544742229496204,0.00993734474029966,0.034997027258633,0.0739514186406077,4.2749802821384e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0233533169615492,0.0042612698981944,-0.0317054059620102,-0.0150012279610881,4.30886322349735e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0313647367639572,0.00572563213568211,0.0201424977780203,0.0425869757498941,4.36786867438036e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,40359,0.0178432682713728,0.00325827635813857,0.0114570466094212,0.0242294899333244,4.40918854578898e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,0.0473239146162705,0.00866100226104003,0.0303483501846321,0.064299479047909,4.72630435427033e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,0.0333714588947904,0.00610953756148596,0.0213967652742779,0.0453461525153029,4.77376413948779e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,0.00988320208931541,0.00181312463586149,0.00632947780302688,0.0134369263756039,5.09865050557405e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.020887429816577,0.00383227801009643,0.013376164916788,0.028398694716366,5.11430722433884e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37628,0.0252682316760203,0.00463752991493474,0.0161786730427482,0.0343577903092924,5.16683609311757e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.0456091070939994,0.00838052159862669,0.029183284760691,0.0620349294273077,5.35472743601528e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.025126709600453,0.00462117192183158,0.0160692126336631,0.0341842065672429,5.50792454178146e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,0.0363251498817334,0.00669748987416192,0.0231980697283761,0.0494522300350908,5.93839620538567e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,0.0120359483248698,0.00221949674249245,0.00768573470958458,0.016386161940155,5.95110361687711e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,0.0179095230893542,0.00330233401040177,0.0114369484289667,0.0243820977497417,5.95458456542091e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0324765281378679,0.00599285008847001,0.0207305419644667,0.0442225143112691,6.08936620205326e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0324119610778423,0.00598320097105108,0.0206848871745822,0.0441390349811024,6.14555676027217e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,0.0387442549277822,0.00715191584559415,0.0247264998704176,0.0527620099851467,6.15599856477439e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40453,0.0157534818674432,0.00290945166388775,0.0100509566062232,0.0214560071286632,6.23157665651333e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0760366938202718,0.0140450009692126,0.0485084919206151,0.103564895719929,6.25998390595062e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,-0.0158091232144592,0.00292888559402279,-0.0215497389787439,-0.0100685074501746,6.86907432846229e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,-0.0134339662519857,0.00248981134501423,-0.0183139964882136,-0.00855393601575784,6.92927574187299e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39961,0.015879094221546,0.00294566057028899,0.0101055995037796,0.0216525889393124,7.12206820311958e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,0.0145661137812481,0.00270468025030505,0.00926494049065021,0.019867287071846,7.34497627911602e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37901,0.0295424706942221,0.0054965315012028,0.0187692689518646,0.0403156724365796,7.79696144306844e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40536,0.026596240818884,0.00495277947596082,0.0168887930460008,0.0363036885917672,7.98467211487159e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.0523444971057554,0.00975078030176874,0.0332329677142887,0.0714560264972221,8.06266602180414e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0272952014471534,0.00508759935716886,0.0173235067071025,0.0372668961872044,8.22951528075283e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.0488872575557341,0.00912456366705959,0.0310031127682973,0.0667714023431709,8.56759362865499e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,0.0374085740974492,0.00698383315912325,0.0237202611055677,0.0510968870893308,8.60760013640743e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,40411,0.0146199743303699,0.00273350759193319,0.00926229945018087,0.019977649210559,8.99430385504438e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,40305,0.0452365321787105,0.00846070551342503,0.0286535493723975,0.0618195149850236,9.08324427114596e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,0.017173376071834,0.0032126582265677,0.0108765659477613,0.0234701861959067,9.14197385362296e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,-0.0235322395150566,0.00440288875229729,-0.0321619014695593,-0.0149025775605539,9.18033291571043e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37598,0.0208876707912038,0.00390992108819018,0.013224225458351,0.0285511161240565,9.33444499236116e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0177352262652021,0.00332430237411974,0.0112195936119274,0.0242508589184768,9.68454335554445e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,40435,0.0220373378085282,0.00413320998971883,0.0139362462286793,0.0301384293883771,9.8580508319568e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.0499283097699266,0.00937184117695576,0.0315595010630933,0.0682971184767599,1.00941450417499e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,0.0112806661871018,0.00212044228449465,0.00712459930949224,0.0154367330647113,1.0518872423142e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0172260695159088,0.00323895838281244,0.0108777110855964,0.0235744279462212,1.06105734928322e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0312931597057266,0.00588492459546702,0.0197587074986112,0.0428276119128419,1.06621857840278e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0174425350987114,0.00328045398014221,0.0110128452976327,0.0238722248997901,1.07181957389011e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.0417457833509158,0.00785660188228676,0.0263468436616337,0.0571447230401978,1.09306110990335e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0198305308651784,0.00373878716338368,0.0125025080249464,0.0271585537054104,1.15075017027426e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,-0.00769278148767522,0.00145136812038616,-0.0105374630036321,-0.00484809997171834,1.17096686464874e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,-0.0292083221015419,0.00551484655551319,-0.0400174213503477,-0.018399222852736,1.19727723152014e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,0.0411249403902866,0.00778642028144139,0.0258635566386615,0.0563863241419117,1.29731788690613e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,0.0399619657697689,0.00757522641636273,0.025114521993698,0.0548094095458399,1.34611085044776e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.0421532875271733,0.00799645018885945,0.0264802451570088,0.0578263298973378,1.37124846650445e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,0.0136556066494866,0.00259169336879147,0.00857588764665534,0.0187353256523179,1.39279411863968e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0111490259461528,0.00211763503046783,0.00699846128643588,0.0152995906058698,1.421452899841e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,0.0166013233480464,0.00315355477752165,0.0104203559841039,0.0227822907119888,1.42924313539288e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,0.032688126776881,0.006216521685312,0.0205037442736695,0.0448725092800925,1.47288339945685e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,40185,0.0284868538873048,0.00541913503828111,0.0178653492122739,0.0391083585623358,1.48567101263861e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.026031075331132,0.00495671064472779,0.0163159224674655,0.0357462281947985,1.5306633993119e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39961,-0.0361314891340946,0.00688203959741784,-0.0496202867450335,-0.0226426915231556,1.54011100096685e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0294747751533822,0.00561788589707632,0.0184637187951127,0.0404858315116518,1.56963527565083e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,0.0176017892996056,0.00335685654987439,0.0110223504618518,0.0241812281373594,1.5958788082423e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39961,0.0404722972456219,0.00773016517579486,0.025321173501064,0.0556234209901799,1.66567827521374e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,-0.029675151431402,0.00566961674412096,-0.0407876002498791,-0.0185627026129249,1.67930691164026e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,40267,0.0168895896155571,0.00322789340636358,0.0105629185390845,0.0232162606920298,1.69470962495328e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0252221823142203,0.00482130789788877,0.0157724188343584,0.0346719457940823,1.70418891677431e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37998,0.0199539722880962,0.00381439371671572,0.0124777606033334,0.027430183972859,1.70895695489349e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,-0.0130277032814558,0.00250160986654747,-0.0179308586198889,-0.00812454794302277,1.94037059209545e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37562,0.0325340126240787,0.00625988157801717,0.020264644731165,0.0448033805169923,2.05323895982148e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,40396,-0.0148131856196884,0.00285068700600284,-0.020400532151454,-0.00922583908792286,2.05738112277763e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0103222199854588,0.00198670788262723,0.00642827253550946,0.0142161674354082,2.0705148164093e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,40228,-0.0165899037906308,0.00319427501468764,-0.0228506828194185,-0.010329124761843,2.08789971066747e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.0345318159850733,0.00666101536962547,0.0214762258606074,0.0475874061095392,2.20183049916335e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,0.0189889936029511,0.00366495166040706,0.0118056883485533,0.026172298857349,2.23604370339712e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,0.0300540135761458,0.00580074487729626,0.0186845536166452,0.0414234735356465,2.23804351253515e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0243473719512081,0.00471176627955573,0.0151123100432789,0.0335824338591373,2.4089881952333e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,0.0134839514156118,0.00261446520040139,0.00835959962282509,0.0186083032083985,2.53330540657771e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.0501550181944953,0.00974084657073034,0.0310629589158639,0.0692470774731268,2.65076636479911e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,0.0469379630659375,0.00911874590140355,0.0290652210991866,0.0648107050326885,2.67912060179506e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,40341,0.0317847425479406,0.00617749433403824,0.0196768536532256,0.0438926314426555,2.70347937829538e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40471,0.0125297114904587,0.0024364529036775,0.00775426379925076,0.0173051591816666,2.74150175527262e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,0.0424713260826664,0.0082735975568959,0.0262550748711505,0.0586875772941824,2.88683081312256e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH1,Somatotropin,40330,-0.0839539090352681,0.0163596471581686,-0.116018817465279,-0.0518890006052576,2.90418661598117e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0155254403571589,0.00302593553336267,0.00959460671176804,0.0214562740025497,2.91933927405361e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,40332,0.0352239129493053,0.00688794279429673,0.0217235450724837,0.0487242808261269,3.19328374180181e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.0201050611078874,0.00393468537016362,0.0123930777823667,0.0278170444334081,3.2639607502275e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37901,0.032083970745706,0.00627998483799513,0.0197752004632356,0.0443927410281765,3.28434522855774e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37705,0.0107350123744149,0.00210126311468242,0.00661653666963739,0.0148534880791925,3.28651665460085e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.0403075063422264,0.00790162980520297,0.0248203119240286,0.0557947007604242,3.42288999591705e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0205760748870861,0.00403584300696124,0.0126658225934421,0.0284863271807302,3.46605697286359e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.0403610258528244,0.00791848205513778,-0.0558812506808945,-0.0248408010247544,3.48903993912761e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0264022193559302,0.00518858600615754,0.0162325907838614,0.0365718479279989,3.65065049385214e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.036328428766293,0.00715196199340208,0.0223105832592249,0.0503462742733611,3.82690126263165e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,0.031851603110158,0.00628229706863875,0.0195383008556261,0.04416490536469,4.02961711170884e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.0448833591394922,0.00886105334009599,0.0275156945929041,0.0622510236860804,4.12489283252416e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,40341,-0.0196543769675451,0.00388227640303731,-0.0272636387174982,-0.012045115217592,4.18221073732925e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.0177009223215366,0.00349783051359317,-0.0245566701281792,-0.010845174514894,4.22925138167712e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.0369963965713853,0.00731670880373431,0.022655647316066,0.0513371458267045,4.32051180681964e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0272717188464605,0.00540355396411988,0.0166807530767856,0.0378626846161355,4.53883190222307e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,0.0326501910402782,0.0064706068319605,0.0199678016496356,0.0453325804309208,4.56327589539514e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37942,0.012883604932438,0.00255320030784408,0.00787933232906358,0.0178878775358124,4.56880103780235e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0232892916950925,0.00462051045548539,0.0142330912023412,0.0323454921878439,4.70533680692148e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,0.0249628350867632,0.00495621407452,0.015248655500704,0.0346770146728224,4.78829668576592e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGN,Mimecan,40332,0.0191588436980107,0.00380418744648245,0.0117026363029051,0.0266150510931163,4.79941864364872e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,0.0230158698807043,0.00457387262987537,0.0140510795261486,0.03198066023526,4.91734843574349e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,-0.0125554909902242,0.00250157651565501,-0.017458580960908,-0.00765240101954036,5.26119493255796e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0157375716437953,0.00313597167939375,0.0095910671521836,0.0218840761354071,5.26656859612131e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40536,-0.0138173093995438,0.00275386966356914,-0.0192148939401393,-0.00841972485894828,5.29297682801548e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,0.0380737475951876,0.00760762800948188,0.0231627966966031,0.052984698493772,5.66600107686044e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,40374,0.0138152419014957,0.00276144690997077,0.00840280595795294,0.0192276778450384,5.70761112974161e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANG,Angiogenin,40309,0.0160898693633774,0.00322288371632223,0.00977301727938586,0.022406721447369,6.02718294291711e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,38013,-0.0105619740684088,0.0021154761943061,-0.0147083074092488,-0.00641564072756888,6.02752914729745e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0133092528383815,0.00266569858901766,0.0080844836039069,0.0185340220728561,6.02803974446212e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.0484368758208032,0.0097122196023695,0.029400925400159,0.0674728262414475,6.20349515025649e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0165298406212043,0.00333402525147021,0.00999515112832269,0.0230645301140859,7.2141957417191e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,0.0108719101878466,0.00219899911107944,0.00656187193013093,0.0151819484455623,7.74672762576212e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0144518981197107,0.00292543098055826,0.00871805339781647,0.0201857428416049,7.90440151507775e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0191116892330969,0.00387220300893123,0.0115221713355917,0.0267012071306021,8.08739853325844e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,40250,0.0132135796736292,0.00268058711168661,0.00795962893472346,0.018467530412535,8.33359644765035e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.0310802360014802,0.00631578255344838,0.0187013021967213,0.043459169806239,8.69678772464452e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,40396,0.0263905754970485,0.00536444840177281,0.0158762566295738,0.0369048943645232,8.76163793805587e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,40422,0.0351683210024698,0.00715170909557947,0.0211509711751341,0.0491856708298056,8.85408064233566e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,40260,0.0136381330661666,0.00277378391944272,0.00820151658405888,0.0190747495482743,8.88544219106993e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37671,0.0338187285505599,0.00690108096762053,0.0202926098540236,0.0473448472470961,9.67278284034094e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.050957574863816,0.0104201113167316,0.0305341566830221,0.07138099304461,1.01661667193276e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0110395375736146,0.00226205207148244,0.00660591551350906,0.0154731596337202,1.06950406084133e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLU,Clusterin,38013,-0.0150974734368013,0.00309771172209199,-0.0211689884121016,-0.00902595846150101,1.10738289940172e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.0413399743416494,0.00848849803738205,0.0247025181883806,0.0579774304949182,1.12797403525009e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,0.0360795349118471,0.00741797922745784,0.0215402956260297,0.0506187741976644,1.16266283295969e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.029210046503486,0.00602258507912508,0.0174057797484008,0.0410143132585712,1.24781483106818e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,0.0145187215242458,0.00299690497122454,0.00864478778064572,0.0203926552678459,1.2832881923525e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,0.0405217532762963,0.00837039165026868,0.0241157856417697,0.0569277209108229,1.30350972091211e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,40305,0.0145786845945023,0.00302013723302213,0.00865921561777893,0.0204981535712257,1.39784841586977e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,0.0230803247374681,0.00478223405695987,0.0137071459858268,0.0324535034891095,1.40410660236499e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37572,0.0360115808281388,0.00746676730133067,0.0213767169175307,0.0506464447387469,1.43064578905754e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,40341,0.0219556599060462,0.00455734726624467,0.0130232592642067,0.0308880605478858,1.46606458146153e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,40324,0.0461994485678548,0.00959381614643402,0.0273955689208441,0.0650033282148655,1.4815289587729e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,40422,0.0414512336226278,0.00861240171076012,0.024570926269538,0.0583315409757176,1.50063555118348e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37987,-0.0100551560619475,0.00209163532710008,-0.0141547613030636,-0.00595555082083131,1.54613079268962e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0193737119595107,0.00403401803005444,0.011467036620604,0.0272803872984174,1.58361523419582e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,0.0224093065905845,0.00467096179717664,0.0132542214681183,0.0315643917130507,1.62089320939565e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.024491273241066,0.00510635948134087,0.0144828086576379,0.0344997378244941,1.63174429984583e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,-0.0278047131330089,0.00580195052093869,-0.0391765361540487,-0.016432890111969,1.66696542030032e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0118060380681474,0.00246684915399612,0.00697101372631499,0.0166410624099798,1.71765405676993e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.0481227775598798,0.010054537028115,0.0284158849847745,0.0678296701349851,1.71789879358518e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0323867698243573,0.00676856880988374,0.0191203749569852,0.0456531646917295,1.7262805633907e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37987,0.0305622453027881,0.00639048196217962,0.018036900656916,0.0430875899486602,1.74984672674248e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,40044,0.0353904533027418,0.00740299868148872,0.0208805758870239,0.0499003307184597,1.76406331016667e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,40379,-0.0149057502239572,0.00311839664140255,-0.0210178076411062,-0.00879369280680821,1.76913156305005e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37901,0.0342110949143835,0.00715890636298075,0.0201796384429412,0.0482425513858257,1.78195114669157e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37942,0.0253503681523011,0.00530692952103463,0.0149487862910732,0.035751950013529,1.79942982005205e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,40044,0.0384349312715777,0.00804850291414661,0.0226598655598504,0.0542099969833051,1.8096840207959e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,0.0177269191469954,0.0037198004443668,0.0104361102760365,0.0250177280179543,1.89995891178587e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37905,0.0428169506240665,0.00898450608266681,0.0252073187020395,0.0604265825460934,1.90220956723678e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,0.0361314827229157,0.00758561578513098,0.021263675784059,0.0509992896617724,1.92282287463523e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0140367560185781,0.00294793379245563,0.00825880578536511,0.0198147062517912,1.93800229012524e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.021105195871591,0.00443239366783092,0.0124177042826424,0.0297926874605396,1.94077653310454e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.025984242819864,0.00545847898803775,0.01528562400331,0.036682861636418,1.95266880767155e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0274473681921972,0.00576609220542945,0.0161458274695555,0.0387489089148389,1.95466683994456e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.0179119161656926,0.0037659782071921,0.010530598879596,0.0252932334517891,1.98973599556462e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0123598352365754,0.00260088892889211,0.00726209293594684,0.0174575775372039,2.03007474330826e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0161491247853451,0.00339991070083434,-0.0228129497589804,-0.00948529981170977,2.05696279904696e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37900,0.028931522722998,0.00609291486058817,0.0169894095962452,0.0408736358497509,2.07160016790989e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37921,0.0140721346501057,0.00297451770386575,0.00824207995052885,0.0199021893496826,2.25800758517807e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFP,Properdin,38013,-0.00966443167048974,0.00204400270389572,-0.0136706769701253,-0.00565818637085413,2.28810733042352e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,40305,-0.0336244324232556,0.00711611608433709,-0.0475720199485563,-0.0196768448979549,2.31964504769627e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,0.0262735756070948,0.00556169878313989,0.0153726459921406,0.037174505222049,2.33252155092246e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,0.0212738673144904,0.00450595123075369,0.0124422029022132,0.0301055317267676,2.36717248476116e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,40305,0.0262954133641169,0.00557971779896884,0.015359166478138,0.0372316602500958,2.46559386974733e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,0.0205162265480281,0.0043607837440845,0.0119690904096225,0.0290633626864338,2.56756844958607e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37671,0.0298352022269621,0.00634334009471181,0.017402255641327,0.0422681488125973,2.58465960569029e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0148298778840853,0.00315532464325671,0.00864544158330219,0.0210143141848685,2.62383881035829e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,40332,0.0397684920973228,0.00846702321893979,0.0231731265882008,0.0563638576064448,2.66392534064948e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORT1,Sortilin,40330,0.0159104107780602,0.0033932265859903,0.0092596866695192,0.0225611348866012,2.76998072270676e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,40270,0.0345311040393444,0.0073667197703834,0.0200923332893929,0.0489698747892959,2.78942323110556e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.0125426213185281,0.00267596641483311,-0.017787515491601,-0.00729772714545516,2.79847083874493e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0232151542494599,0.00495491832378806,0.0135035143348353,0.0329267941640845,2.82323685480888e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37998,0.036183344318462,0.00772351809177957,0.0210452488585741,0.05132143977835,2.829212796869e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,0.0516964397416931,0.0110474851873554,0.0300433687744766,0.0733495107089097,2.90401606402378e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,0.031298860694134,0.00669061740596347,0.0181852505784456,0.0444124708098224,2.92030243713911e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0247641059710607,0.00529409880322848,0.0143876723167329,0.0351405396253885,2.93025322051928e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37572,0.0179119520873957,0.00383194108770301,0.0104013475554978,0.0254225566192936,2.97776688422546e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNC,Tenascin,40403,-0.0206763670418323,0.00442373137116242,-0.0293468805293107,-0.012005853554354,2.97855695371669e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37598,0.0251081356017721,0.00537743254424229,0.0145683678150572,0.035647903388487,3.0541364485491e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.0449088852553603,0.00962066013475791,0.0260523913912348,0.0637653791194858,3.07138878345129e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,-0.00761659888934113,0.00163416425852252,-0.0108195608360453,-0.00441363694263698,3.17457057349289e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37642,0.0445260228292855,0.00958525943142904,0.0257389143436845,0.0633131313148864,3.42931288195933e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39903,0.0497117930329362,0.0107092732828785,0.0287216173984944,0.0707019686673779,3.47993424776104e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0188401240360445,0.00405910326302022,0.0108842816405249,0.0267959664315641,3.49242440077243e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,40305,-0.0122809248401494,0.00264898176765763,-0.0174729291047584,-0.00708892057554045,3.57888915438333e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.0118806737828421,0.0025650066783377,0.00685326069330018,0.016908086872384,3.653321298844e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,0.0272241392035567,0.00587842487625917,0.0157024264460887,0.0387458519610247,3.67053643788704e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37942,0.0588627654765105,0.0127147098662334,0.0339419341386931,0.0837835968143279,3.69966342408507e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,0.0267213490765146,0.00577511240530525,0.0154021287621164,0.0380405693909129,3.74032740671393e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0148430851802995,0.00321084278784915,-0.0211363370444838,-0.00854983331611518,3.81573836544109e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.0294690752888873,0.00637645233401104,0.0169712287142256,0.0419669218635489,3.84413420163435e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40489,-0.0196150073352849,0.00424947148269179,-0.0279439714413608,-0.011286043229209,3.94487103560746e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39877,0.0366948296250608,0.00795155522298409,0.021109781388012,0.0522798778621097,3.96644973841372e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.0463827801425061,0.0100638068281934,0.026657718759247,0.0661078415257651,4.08586345388535e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.0344271820517998,0.00747333409646574,0.0197794472227269,0.0490749168808726,4.12346493659233e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,0.0191731669488552,0.00417156450713515,0.0109969005148703,0.0273494333828401,4.33639455828239e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0260383460151375,0.00566553638668031,0.0149338946972441,0.0371427973330309,4.34864328445072e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37901,0.0439258957294324,0.00957529795506158,0.0251583117375118,0.0626934797213531,4.52814779856236e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.0630557233097426,0.0137481021410315,0.0361094431133209,0.0900020035061643,4.54798296605777e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,40444,-0.0181522358137642,0.00396056553972079,-0.0259149442716169,-0.0103895273559114,4.61282317742872e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0127807129361144,0.00278957835939442,0.00731313935170129,0.0182482865205274,4.65567540160249e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0152927648828332,0.00333786545393241,0.00875054859312571,0.0218349811725408,4.65686825014268e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,-0.0145398788180615,0.00317529936838963,-0.0207634655801052,-0.0083162920560178,4.70615692705844e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.0422504852912461,0.00923053829678323,0.0241586302295509,0.0603423403529412,4.74780139794659e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0149823511957918,0.003276298465031,0.00856080620433108,0.0214038961872526,4.84603752339017e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40489,-0.013433258747769,0.00293910732127715,-0.0191939090974722,-0.00767260839806583,4.9013900227298e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,-0.0146468223859401,0.00320788230530902,-0.0209342717043458,-0.0083593730675344,5.01903103885901e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0140310177125338,0.00307612961058454,0.00800180367578812,0.0200602317492795,5.1224257094101e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,40433,0.0253630064002929,0.00556854028548189,0.0144486674407484,0.0362773453598373,5.28492245934861e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,0.0273581582196876,0.00600726144263554,0.0155839257921219,0.0391323906472532,5.29775781470299e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,40014,0.0169360923358313,0.00372132164336863,0.00964230191482874,0.0242298827568338,5.37710421498402e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2,Brorin,40167,0.0165294095551267,0.0036320674717256,0.00941055731054451,0.0236482617997089,5.38007330955973e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37572,0.029094241288662,0.00640058764819538,0.0165490894981991,0.041639393079125,5.52797350716848e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0214319138557473,0.00472732737851771,0.0121663521938525,0.030697475517642,5.84813829283916e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,0.0164126113682765,0.00362355699308866,0.00931043966182267,0.0235147830747302,5.96512242891801e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37987,0.0383855591427127,0.00847543092873542,0.0217737145223913,0.0549974037630341,5.97587489435624e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37901,0.0130076472256369,0.00287380013036367,0.00737499897012408,0.0186402954811497,6.05437109816907e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.0329143210676046,0.00727917095649462,0.0186471459928752,0.0471814961423341,6.17951523129212e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.0451580964461302,0.00998706905099599,0.0255834411061781,0.0647327517860824,6.18783937357517e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.0133281722580367,0.00294784582554948,-0.0191059500761137,-0.00755039443995977,6.18970643810497e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.0493628965760421,0.010918092037323,-0.0707623569691952,-0.0279634361828891,6.19370955595087e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.0347296411593768,0.00768539516027709,0.0196662666452337,0.0497930156735199,6.26875241361547e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,0.0480752165132251,0.0106409869026201,0.0272188821840898,0.0689315508423605,6.29772414579744e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0209856614980599,0.00464636512210749,0.0118787858587292,0.0300925371373906,6.33784277582763e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.0326154145281229,0.0072278458151647,0.0184488367304001,0.0467819923258457,6.45378465003318e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0236323021364437,0.00524238536721648,0.0133572268166994,0.0339073774561881,6.60209174801259e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0240683395386879,0.00534414375167644,0.0135938177854021,0.0345428612919737,6.72568171769794e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0128199957180464,0.00285197159909564,0.00723013138381892,0.0184098600522738,7.01030120089146e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,0.0298222368891456,0.00664116436081485,0.0168055547419485,0.0428389190363427,7.15519400805487e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,0.053145815375651,0.0118498521294431,0.0299201052019425,0.0763715255493596,7.34466455016449e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,40333,0.0378724694529808,0.00844869475740797,0.0213130277284611,0.0544319111775004,7.42405360326705e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0280527362805243,0.00625767460342025,0.0157876940578206,0.040317778503228,7.42485083675262e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,40209,0.0283477557633538,0.00632757493797099,0.0159457088849307,0.0407498026417769,7.51559644303279e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0221787975897443,0.00495779207827597,0.0124615251163234,0.0318960700631652,7.75703034310308e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,-0.0170087359904414,0.00380213968111328,-0.0244609297654234,-0.00955654221545933,7.75916433187653e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0238382788162207,0.00533208981211793,0.0133873827844696,0.0342891748479719,7.8607875092972e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37942,0.0445305778357318,0.00996881280595129,0.0249917047360673,0.0640694509353963,7.99731465447913e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,0.0137261398827695,0.00307407854904316,0.00770094592664491,0.0197513338388941,8.06741934132305e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40516,0.0263140153556624,0.00590140769652605,0.0147472562704713,0.0378807744408534,8.29246703414139e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPART,Spartin,37671,0.0321817938371404,0.0072190970247645,0.018032363668602,0.0463312240056788,8.34596860207077e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.019619920589692,0.00440156999150161,0.0109928434063488,0.0282469977730351,8.34907531850865e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37628,0.0216851734860952,0.00486654135823407,0.0121467524239564,0.031223594548234,8.42024891052666e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C3,Complement C3,37360,0.0196577749661463,0.00441772905075214,0.0109990260266721,0.0283165239056204,8.66914882659251e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37942,0.0258613603947456,0.00581537404679893,0.0144632272630197,0.0372594935264715,8.77462470123859e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0104305210036412,0.00234806753883601,0.00582830862752258,0.0150327333797597,8.97613473943899e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0235006386400149,0.00529124493593209,0.013129798565588,0.0338714787144418,8.99705767776344e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37572,0.0187297357851749,0.00421763938361518,0.0104631625932891,0.0269963089770606,9.03533934982225e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,0.0226797804755164,0.00510722007848298,0.0126696291216897,0.032689931829343,9.03923745308692e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0279986169413834,0.00630575706187664,0.0156393331001052,0.0403579007826617,9.06238322407996e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,0.027464261969903,0.00619479217006447,0.0153224693165766,0.0396060546232293,9.33732693466291e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39897,0.0194784609259893,0.00439728756412073,0.0108597773003126,0.0280971445516659,9.50333163008806e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0245360246698534,0.00554661540915229,0.0136646584679149,0.0354073908717919,9.77284885301797e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,0.0241851763627999,0.0054724779877438,0.013459119506822,0.0349112332187777,9.96145573854114e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,0.0339870397836736,0.00769983858487,0.0188953561573284,0.0490787234100187,1.0228787332449e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0153429610656153,0.00347791170702701,0.00852625411984238,0.0221596680113883,1.03312602206728e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,40332,-0.0130434974654412,0.00295969561412856,-0.0188445008691332,-0.00724249406174926,1.05479690958099e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00832321605239963,0.0018891321180503,-0.0120259150037782,-0.00462051710102105,1.06210412820957e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37562,0.0162170739174025,0.00368333332879448,0.00899774059296527,0.0234364072418397,1.07695850478717e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,40044,0.0201869216837689,0.00458979915362441,0.011190915342665,0.0291829280248727,1.09868165092294e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,-0.011165072648725,0.00254878325739409,-0.0161606878332174,-0.00616945746423256,1.19134621825711e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.0451167110610691,0.0103346545489806,0.0248607881450671,0.065372633977071,1.27605231305531e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39665,0.00921162520755679,0.00211094925332325,0.00507416467104323,0.0133490857440704,1.28702401201084e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,-0.0086638918060787,0.00198588612258972,-0.0125562286063546,-0.00477155500580284,1.29258838284886e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37671,0.0230354073590706,0.00528503683359365,0.012676735165227,0.0333940795529141,1.3188044197608e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.0379829601223241,0.00872184426469358,0.0208881453635247,0.0550777748811235,1.34119031985879e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,0.016341268522981,0.00375339629698388,0.00898461178089255,0.0236979252650694,1.34682145009791e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,-0.0131859588296235,0.0030288845307671,-0.019122572509927,-0.00724934514932003,1.3486983950728e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40516,0.0207294463061749,0.00476324586636148,0.0113934844081064,0.0300654082042434,1.35760291127062e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.00837133596548758,0.00192458340099509,-0.012143519431438,-0.0045991524995372,1.37176976962581e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39961,0.0214283420225824,0.00492952078176787,0.0117664812903173,0.0310902027548474,1.38927758198202e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,40028,0.0173507242255436,0.00399349648841156,0.00952347110825694,0.0251779773428303,1.40319993304851e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,0.0243704629187635,0.00561526992263991,0.0133645338703893,0.0353763919671377,1.43335650441268e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.011173301487748,0.00257580214762726,-0.0162218736970974,-0.00612472927839854,1.4480331884882e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37671,0.0219753402711967,0.00507067580391431,0.0120368156955246,0.0319138648468687,1.47634233893879e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.022562080636299,0.0052065234761468,0.0123572946230513,0.0327668666495467,1.47710909261576e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37987,-0.00999915501507191,0.00230794700756457,-0.0145227311498985,-0.00547557888024535,1.48495684000835e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37901,0.014094088963611,0.00325516486766165,0.00771396582299416,0.0204742121042278,1.50350807623077e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37959,0.0308447215361222,0.0071245081456568,0.0168806855706349,0.0448087575016096,1.50604994715006e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,0.0222791213762081,0.00514875947233127,0.0121875528104388,0.0323706899419774,1.52018384386559e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37628,0.0117882652746777,0.00272457997857521,0.00644808851667031,0.0171284420326852,1.5251929530698e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.0372867914983142,0.00862365718546261,0.0203844234148075,0.0541891595818209,1.54508234173944e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,0.0137306387420986,0.00317919666580967,0.00749941327711166,0.0199618642070856,1.57923883810623e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,0.00901066470296047,0.00208651037935195,0.00492110435943065,0.0131002250464903,1.58023944831676e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,40396,0.0118130878188501,0.00274158548425029,0.00643958026971955,0.0171865953679807,1.65086585913e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,0.0161912982155136,0.00376236952568515,0.00881705394517073,0.0235655424858565,1.69348923753543e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37900,0.012844151172206,0.00298469414729925,0.0069941506434995,0.0186941517009126,1.69432411701603e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37990,0.0121493112185393,0.0028234026679301,0.00661544198939626,0.0176831804476822,1.69627008565254e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,-0.0118994685625104,0.00277498491118282,-0.0173384389884287,-0.00646049813659208,1.81246269927464e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,40396,0.034487912137237,0.00805523881882817,0.0186996440523338,0.0502761802221402,1.86784608916611e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,0.0244630759965808,0.00571750442241096,0.0132567673286554,0.0356693846645063,1.89343411554048e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0318114465509288,0.00743909373694562,0.0172308228265154,0.0463920702753423,1.91407115314609e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,0.0367591366650637,0.00859984263249759,0.0199034451053684,0.0536148282247589,1.92794230994594e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0158497299203477,0.00370878473345468,0.00858051184277648,0.0231189479979188,1.93691387076537e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,0.0268712964125684,0.00630684818482506,0.0145098739703113,0.0392327188548256,2.05003381952121e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,0.035781336614713,0.00839972894751142,0.0193178678775906,0.0522448053518353,2.05973253760076e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39980,0.0212950458703564,0.00500607780304014,0.0114831333763978,0.0311069583643151,2.11367545820684e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37900,0.0158263563790579,0.00372050023732884,0.00853417591389337,0.0231185368442224,2.11571113939174e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.0127629759410581,0.00300290703006389,-0.0186486737199833,-0.00687727816213283,2.14814847305708e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37900,0.0163206548327498,0.00384257246017536,0.00878921281080612,0.0238520968546936,2.17792591252503e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.0381642694252567,0.00898885614945816,0.0205461113723187,0.0557824274781947,2.19119251478997e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,0.0400618387789224,0.00944305596530492,0.0215534490869247,0.05857022847092,2.22338840512409e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,0.0295750969509405,0.00699062143349651,0.0158734789412874,0.0432767149605937,2.3452037741858e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.027301759501614,0.0064564143940288,-0.0399563317139105,-0.0146471872893176,2.36677751631584e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37942,0.0180797570698632,0.00427771712365247,0.00969543150750431,0.026464082632222,2.38919358055827e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37998,0.0356176420353213,0.00842818871192434,0.0190983921599496,0.052136891910693,2.3942511830333e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0225872499263861,0.00534809566741381,0.012104982418255,0.0330695174345171,2.4199467648941e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,0.0162978012076675,0.0038595230087371,0.00873313611054278,0.0238624663047922,2.4269196562198e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,-0.0186389081035258,0.00442037831846835,-0.0273028496077238,-0.00997496659932788,2.49643192375028e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40536,-0.0104381203637207,0.00247655719079564,-0.0152921724576801,-0.00558406826976122,2.5139680461285e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,0.0348926907945254,0.00830357929020512,0.0186176753857234,0.0511677062033275,2.65868397521296e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.012024636726229,0.00286182254932124,-0.0176338089228987,-0.0064154645295594,2.66312482572601e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,40032,0.0170467369857217,0.00405820732056265,0.00909265063741888,0.0250008233340245,2.67738465926699e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,40042,0.0504615993397729,0.0120149373238301,0.0269123221850659,0.07401087649448,2.68510076231934e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40471,0.00878170390754852,0.00209305058708285,0.00467932475686615,0.0128840830582309,2.73557695034289e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,37482,0.0221658297133424,0.0052888635574917,0.0117996571406586,0.0325320022860261,2.79512449037574e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37628,0.0268113122353262,0.00640271057965157,0.0142619994992091,0.0393606249714432,2.83885365187484e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37714,0.0150553953718653,0.00359579807317304,0.0080076311484461,0.0221031595952844,2.84564452426089e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0151194947186584,0.00361227852815293,0.00803942880347867,0.0221995606338382,2.860019348262e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39980,-0.0330748591558444,0.00790818644909417,-0.048574904596069,-0.0175748137156199,2.90086170398668e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.0471450267817219,0.0112778383155853,0.0250404636831748,0.069249589880269,2.92703011740624e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,-0.0225774684169939,0.00540890519818128,-0.0331789226054292,-0.0119760142285586,3.00706101334733e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.0380590566288254,0.00913980322160003,0.0201450423144893,0.0559730709431615,3.14518972677753e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0191970371262375,0.00461024008044912,0.0101609665685573,0.0282331076839178,3.14698130287849e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,0.0267560059197971,0.00643322077627475,0.0141468931982986,0.0393651186412956,3.21273480759598e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,40359,0.015116829045491,0.00363761150750388,0.00798711049078341,0.0222465476001986,3.25986309106624e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,0.0200677266507874,0.00483649733755702,0.0105881918691756,0.0295472614323992,3.35651383876528e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,0.0273055691596669,0.00658347746373958,0.0144019533307373,0.0402091849885965,3.38092050338378e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0158378525116003,0.00382253657697028,0.00834568082073858,0.0233300242024621,3.44153228254869e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37990,0.0216586245941261,0.00524529285696148,0.0113778505944815,0.0319393985937706,3.66283742150705e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.0345086793565337,0.00835789048143576,0.0181272140129196,0.0508901447001478,3.66409908459216e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,0.0121183702304665,0.00293760772427077,0.00636065909089582,0.0178760813700372,3.72597067482598e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0248899794195055,0.00603445954635332,0.013062438708653,0.036717520130358,3.73249073917543e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.00986063107536811,0.002390685956241,0.00517488660113575,0.0145463755496005,3.73277438340671e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,0.0313078378479528,0.00759273082614209,0.0164260854287143,0.0461895902671913,3.75212569023721e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.0371841793864955,0.00901771991289211,0.019509448357227,0.0548589104157641,3.75463342973074e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,0.0108613739132262,0.00264024701211811,0.00568648976947468,0.0160362580569777,3.91210187757373e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,0.026854993361215,0.00653312787590924,0.0140500627244329,0.0396599239979971,3.96996487318525e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37643,0.0542360674420722,0.0132128839618321,0.0283388148768814,0.0801333200072631,4.0712452462104e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0215224844707319,0.0052439098395991,0.0112444211851177,0.0318005477563462,4.07602324523956e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0400786490439287,0.00976923900629613,0.0209309405915883,0.0592263574962691,4.10699058452153e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40483,0.0266293561259459,0.00650484903999894,0.013879852007548,0.0393788602443438,4.26495269047436e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.0442087868654664,0.0108284907351203,0.0229849450246307,0.0654326287063022,4.4746132517035e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.017745988573577,0.00434724229333465,0.00922539367864105,0.0262665834685129,4.4849334312787e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0123165064076112,0.00302271809223911,0.00639197894682257,0.0182410338683999,4.63471919234981e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37598,-0.013211865200826,0.00324255227404519,-0.0195672676579546,-0.00685646274369747,4.63788355024025e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,0.0212753035379347,0.00522977451506839,0.0110249454884006,0.0315256615874688,4.76247501811261e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0222780331756267,0.00547863074848157,0.0115399169086028,0.0330161494426505,4.80284603737965e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,-0.00983353006468711,0.00241832851907922,-0.0145734539620824,-0.00509360616729184,4.80459277915179e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0215089886176335,0.00529123559046206,0.0111381668603279,0.0318798103749391,4.83075063676869e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,-0.0107119215557656,0.00264109276647444,-0.0158884633780555,-0.00553537973347567,5.01929547806964e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,-0.00828629851903082,0.00204313810665744,-0.0122908492080794,-0.00428174782998223,5.02771649888312e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39980,0.0163166719602255,0.00402527883633069,0.00842712544101738,0.0242062184794337,5.06919106622461e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,0.0212074359719739,0.0052423720094054,0.0109323868335393,0.0314824851104085,5.24878644539165e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37628,0.0352074477581655,0.00870771958817024,0.0181403173653519,0.0522745781509792,5.30163423060191e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-0.0117117721855515,0.00289891943924228,-0.0173936542864664,-0.00602989008463665,5.37364802232269e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0358931137591294,0.00889882235676643,0.0184514219398672,0.0533348055783916,5.52190106310369e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0125007639286375,0.00310117144999925,0.006422467886639,0.0185790599706361,5.58505765336218e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,-0.0107562187855444,0.00266903603575352,-0.0159875294156213,-0.00552490815546746,5.60388038114446e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37942,0.0262098198520264,0.00654063182270783,0.013390181479519,0.0390294582245337,6.17648975940099e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,0.0222981417646088,0.00556807550622437,0.011384713772409,0.0332115697568085,6.23997080993839e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LXN,Latexin,40183,-0.0248268513749616,0.00620549728052072,-0.0369896260447822,-0.012664076705141,6.34220680879243e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,0.032676097454805,0.00817954189053667,0.0166441953493531,0.0487079995602568,6.50781347091991e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.0313155769689412,0.00784405574655135,0.0159412277057005,0.0466899262321818,6.5738054695187e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.0339191646659504,0.00851201045169281,0.0172356241806325,0.0506027051512683,6.78844952463184e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37942,0.0264433531968272,0.00664802586238076,0.0134132225065609,0.0394734838870935,6.99706111674251e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,40332,0.00985221583350748,0.00247815852879004,0.004995025117079,0.014709406549936,7.05069955437539e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,0.0489308842256221,0.0123134654378625,0.0247964919674116,0.0730652764838326,7.1054641323144e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,-0.0139466095344462,0.00351424795802458,-0.0208345355321744,-0.00705868353671802,7.26242873467833e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.0336084872235765,0.00848008091682098,0.0169875286266074,0.0502294458205456,7.43254417199315e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0216015196212248,0.00547689693128582,0.0108668016359046,0.0323362376065449,8.0441045911874e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0148535438056519,0.00376748748509347,0.00746926833486867,0.0222378192764351,8.10250524942917e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40470,0.0221897943214378,0.00562933266954907,0.0111563022891217,0.033223286353754,8.12105824721331e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,37541,0.0201847643335282,0.00513144464291406,0.0101271328334166,0.0302423958336397,8.41343936983467e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,40305,-0.00558760445329649,0.0014215895084991,-0.00837391988995473,-0.00280128901663824,8.51177463522193e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40516,0.0325417940335383,0.00828218626076242,0.0163087089624439,0.0487748791046326,8.56102633460646e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.0389850582175821,0.0099284041526938,0.0195253860783023,0.0584447303568619,8.65842094084995e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,40332,0.00912186758235001,0.00232414796852079,0.00456653756404926,0.0136771976006508,8.71597959432417e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,0.0205910161366622,0.00524797430041963,0.0103049865078397,0.0308770457654847,8.76052948662846e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,0.0189809561353059,0.00484330446627756,0.00948807938140185,0.0284738328892099,8.93681326381786e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0205287648221287,0.00524477650837889,0.0102490028657061,0.0308085267785514,9.11852488454567e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,-0.0131666735025868,0.0033649176425088,-0.019761912081904,-0.00657143492326952,9.15646151880593e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,-0.0100425762786109,0.00256776477145548,-0.0150753952306637,-0.00500975732655819,9.22851763991435e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.00994520890000656,0.00254361154325095,0.0049597302752347,0.0149306875247784,9.27224110493452e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39961,0.0180207007383316,0.00461641768113626,0.00897252208330454,0.0270688793933587,9.51687723394403e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.0311438126902051,0.00797920634958139,0.0155045682450256,0.0467830571353847,9.54210708664929e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37714,-0.0107770500811135,0.00276338423802248,-0.0161932831876375,-0.0053608169745894,9.66884156185678e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,0.0176915496567735,0.00454463617566556,0.00878406275246903,0.026599036561078,9.94910061363189e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,40250,-0.0185159690436807,0.00476072832918393,-0.0278469965688812,-0.00918494151848019,0.000100939532997376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.00687541720291006,0.00176933304416091,0.00340752443635469,0.0103433099694654,0.000102374122674492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCT,Secretin,37572,0.0167079341101068,0.00430304872712663,0.00827395860493861,0.025141909615275,0.000103761037476913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0118409137681364,0.00305460167197109,-0.0178279330451998,-0.00585389449107311,0.000106505791891364
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0244573358759504,0.00631152236715227,0.012086752036332,0.0368279197155689,0.000107130767076296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0176407507905541,0.00455374286515065,-0.0265660868062494,-0.00871541477485883,0.000107624734778217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0221073521129095,0.00570821379019352,0.0109192530841302,0.0332954511416888,0.000107978095240724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,0.0355080494483411,0.0091721174791424,0.017530699189222,0.0534853997074602,0.000108687602435571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,0.0208116143362341,0.00538009671313161,0.0102666247784962,0.0313566038939721,0.00011012914945164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.016435397251244,0.0042500127195536,0.00810537232091891,0.024765422181569,0.000110637439506544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,0.0121410586875451,0.00314480521640048,0.00597724046340019,0.0183048769116901,0.00011361260451079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37942,0.0301532336969632,0.00781263411104027,0.0148404708393243,0.0454659965546021,0.000114126454910376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.0302958041034278,0.0078497040887454,0.0149103840894868,0.0456812241173688,0.000114155678706295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0162557805350288,0.00421660443531985,0.00799123584180192,0.0245203252282557,0.000116098687871551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,40070,0.0197796122914217,0.00515182444178756,0.00968203638551812,0.0298771881973253,0.000123851536173562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40536,0.0315922164159531,0.00822862502532502,0.0154641113663161,0.0477203214655901,0.000123854771690775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39725,-0.0113355930908352,0.0029544692267382,-0.0171263527752421,-0.00554483340642837,0.000125169236660431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,40346,0.0185274710498022,0.0048300983994482,0.00906047818688375,0.0279944639127207,0.000125620720470329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,40042,0.0109470918488206,0.00285747187529154,0.00534644697324923,0.0165477367243921,0.000128102459008834
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0131963621738203,0.00345760615310722,0.00641945411373011,0.0199732702339104,0.000135908130752072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0191761327803535,0.00503243988433473,0.00931255060705747,0.0290397149536496,0.000139218581390187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,0.00935651730063183,0.00245586773734003,0.00454301653544537,0.0141700180658183,0.000139565415519096
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,0.0188888734962028,0.00496709191453591,0.00915337334371243,0.0286243736486932,0.000143702101230162
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,0.0218028724112286,0.00573393342601701,0.0105643628962353,0.033041381926222,0.000143934045253066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0144123934168296,0.00381129399246552,0.00694225719159713,0.021882529642062,0.000156561882057831
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0258902741917661,0.00685157783059861,0.0124611816437928,0.0393193667397394,0.00015821892463329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,0.0245826599536461,0.00650707445720865,0.0118287940175172,0.0373365258897751,0.000158789406419856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,-0.0122913646123514,0.00325565261471345,-0.0186724437371898,-0.00591028548751304,0.000160339842030292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37990,0.0189121038383494,0.00501064334109913,0.00909124288979508,0.0287329647869037,0.000161086677122801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0110735641299771,0.00293396452779072,0.00532299365550733,0.0168241346044469,0.000161184482568689
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39980,0.0208474319657444,0.00552396373033452,0.0100204630542888,0.0316744008772001,0.000161249103136061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,0.0342008379069276,0.00907316227754165,0.016417439842946,0.0519842359709092,0.000164199631701003
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0109167985416214,0.00289718436277917,0.00523831719057426,0.0165952798926686,0.000165109199005273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,-0.0141156389898733,0.00374969356196836,-0.0214650383713313,-0.00676623960841533,0.000167498221736542
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,0.0122073668290992,0.00325177335538681,0.00583389105254108,0.0185808426056574,0.000174732959708648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37900,-0.0411578958163927,0.0109720400063734,-0.0626630942288846,-0.0196526974039009,0.000176756129063227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0174996883678127,0.00466854363096195,-0.0266500338844981,-0.00834934285112724,0.000178577998590282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00895644752068258,0.0024006694224715,-0.0136617595887267,-0.00425113545263845,0.000191668551205121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00733320381162687,0.00196621279040865,-0.0111869808808278,-0.00347942674242593,0.000192440773441228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.0327769021795009,0.0087996798867292,0.0155295296015117,0.0500242747574901,0.000196282119746969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,0.0290748312327712,0.00780912274156893,0.013768950659296,0.0443807118062463,0.0001973994796526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,0.0313148353349055,0.00843159391831159,0.0147889112550148,0.0478407594147962,0.000204840196956543
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,0.0268540045920167,0.00723115114105726,0.0126809483555444,0.0410270608284889,0.000205129694807396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.0295540452699294,0.0079587059991213,0.0139549815116516,0.0451531090282071,0.0002051736412067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0235547699452942,0.00634646463016552,0.0111156992701698,0.0359938406204186,0.000206754294783668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,40341,0.0234049130088727,0.00630690652751207,0.0110433762149491,0.0357664498027964,0.000207148607158545
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0175251892405093,0.0047274396866595,-0.0267909710263619,-0.00825940745465666,0.000210470858899787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37959,-0.0125837587013562,0.00339462152245924,-0.0192372168853763,-0.00593030051733609,0.000210592645388106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.00968655663452971,0.00261364497591749,0.00456381248173144,0.014809300787328,0.00021130089585727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0125381492238008,0.00339231818187854,0.00588920558731888,0.0191870928602827,0.000219723507391129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.0308009937093307,0.00833853882471099,0.0144574576128972,0.0471445298057643,0.000221792443833479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.0106824532160682,0.00289605883211683,-0.0163587285270172,-0.00500617790511925,0.000226245341305946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,0.016982023090763,0.00460485628704022,0.00795650476816416,0.0260075414133618,0.000226924232232809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.00882585806264099,0.00239387265194852,-0.0135178484604601,-0.00413386766482189,0.000227929573089582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,0.0114020333337733,0.00309454613823806,0.00533672290282667,0.0174673437647199,0.000229875726232176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,0.018608172737574,0.00505831208865339,0.00869388104381335,0.0285224644313346,0.00023531121923587
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.011780751282489,0.00321235252674225,-0.0180769622349038,-0.00548454033007418,0.000246069135694687
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,0.0180106557306101,0.00493072191395254,0.0083464407792631,0.0276748706819571,0.000260308210482427
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.018615661995365,0.00510111221845701,0.00861748204718926,0.0286138419435407,0.000263933709268724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0250613361278252,0.00686861526905322,0.0115988502004808,0.0385238220551695,0.0002646154275479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37942,0.0315254021809817,0.00864039921401393,0.0145902197215144,0.048460584640449,0.000264662615248408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0167174210537409,0.00458322146811763,0.00773430697623036,0.0257005351312515,0.000265777650449051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.01889597062515,0.00518269016304148,0.00873789790558872,0.0290540433447113,0.000267396540438474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,40314,0.0137776463407337,0.00378098069945116,0.00636692416980942,0.021188368511658,0.000269358502880056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37959,0.028097990476261,0.00772205172484213,0.0129627690955705,0.0432332118569516,0.000275072357372434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,40228,-0.0190249903053182,0.00523210710239615,-0.0292799202260147,-0.00877006038462179,0.000277569746533597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,40442,0.023732181014418,0.00652834817828463,0.0109366185849801,0.0365277434438558,0.000278581915758428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,0.0338421058781969,0.0093102786846828,0.0155939596562187,0.0520902521001752,0.000279102243413009
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,0.020463264096516,0.00563788998783241,0.00941299972036443,0.0315135284726675,0.000284910253082214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0251100666545222,0.00692346418671311,0.0115400768485645,0.0386800564604799,0.000287854504198646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,-0.0137762671570293,0.00380039023138589,-0.0212250320105456,-0.00632750230351292,0.000289924869388727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.0245343708027459,0.00678885086306747,0.0112282231111336,0.0378405184943581,0.000302528345732989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,-0.00942812483274787,0.00260905427550705,-0.0145418712127417,-0.00431437845275404,0.000303086064564535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37671,0.0364877751275766,0.010097536182904,0.0166966042090848,0.0562789460460684,0.000303174533934937
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.029187702036011,0.00808251640694757,0.0133459698783938,0.0450294341936282,0.000305875397805733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,-0.00952902566582708,0.00264145446119925,-0.0147062764097776,-0.00435177492187655,0.000310118560030173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,0.0100055039529728,0.0027736131253725,0.0045692222272427,0.0154417856787029,0.000310259574030161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,-0.00758833296169687,0.00210902367892473,-0.0117220193723893,-0.00345464655100439,0.000321607009062213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,0.0141115543939419,0.00392628990309563,0.00641602618387451,0.0218070826040094,0.000326678423675093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,40411,0.0102473807227065,0.00285509642264674,0.00465139173431888,0.0158433697110941,0.000332746975531045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.00960008741309211,0.00267896168879614,0.00434932250305168,0.0148508523231326,0.000340231212688055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37990,0.0239324840801534,0.00669550581381917,0.0108092926850679,0.037055675475239,0.000352239515345425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,40221,-0.00959080528575281,0.00268519531906519,-0.0148537881111206,-0.00432782246038503,0.000355680635383282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,0.0176025995140428,0.00492861732427161,0.00794250955847043,0.0272626894696151,0.00035600395237605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0192586434033053,0.00539716712262396,-0.0298370909636482,-0.00868019584296231,0.000360612847188363
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,40310,0.0155471188914196,0.0043600976108523,0.00700132757414911,0.0240929102086901,0.000363852732972297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.0298629381589263,0.00838291943168398,0.0134324160728257,0.0462934602450269,0.000368805023567995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,0.0273900665896747,0.00771326727641435,0.0122720627279025,0.0425080704514468,0.000385024157556007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0243108296078635,0.00684759132452818,0.0108895506117883,0.0377321086039387,0.000386162033842122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,40291,0.0136225674112163,0.00383870142753512,0.00609871261324746,0.0211464222091851,0.000388193894901416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40516,0.0201824415799094,0.00568738327639077,0.00903517035818347,0.0313297128016353,0.000388339783983944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.0101023214015612,0.00284815252766164,0.00451994244734439,0.015684700355778,0.000391040387563031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.0395821964329972,0.0111673851908434,0.0176941214589442,0.0614702714070502,0.000394565534855713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40536,-0.00773793228789601,0.00218518321761956,-0.0120208913944303,-0.00345497318136169,0.000399602862501799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,0.0218427111212417,0.00617000493377183,0.00974950145104891,0.0339359207914345,0.000401049498884849
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAX,Protein max,39961,0.0345733208039467,0.00976862404291986,0.0154268176798238,0.0537198239280697,0.000402483805113497
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0161173803201875,0.00455481145149677,0.00718994987525383,0.0250448107651211,0.000403523540280033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0225606022885921,0.00638396228187257,0.0100480362161219,0.0350731683610623,0.000410766893479397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,40411,0.0210377030540738,0.00595439097938609,0.00936709673447707,0.0327083093736705,0.000411813599875649
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0126824402565223,0.00359148842311543,0.00564312294721605,0.0197217575658285,0.000415022003941991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,40311,0.0288839895428082,0.00821069078370569,0.012791035606745,0.0449769434788714,0.000436273085981248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37901,0.0110953620936912,0.00315633693699423,0.00490894169718256,0.0172817824901999,0.000440760144156841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,-0.0134705178919202,0.00383507286554236,-0.0209872607083832,-0.00595377507545714,0.000445445070465485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,40332,-0.00777244286743107,0.0022138054240783,-0.0121115014986245,-0.0034333842362376,0.000447835881956843
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,40305,0.0270021592610287,0.00769582631391916,0.0119183396857472,0.0420859788363103,0.000451591637999867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,40332,-0.0109425222330887,0.00312314625881748,-0.017063888900371,-0.00482115556580645,0.000460129761484922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,0.0269612294700494,0.00769750792635086,0.0118741139344017,0.0420483450056971,0.000462276429539974
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,40204,0.0168140295585359,0.00480407630872397,0.00739803999343691,0.0262300191236349,0.000466630378544571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,40396,-0.0270960595374968,0.00774436812213783,-0.0422750210568869,-0.0119170980181066,0.000468616757940005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,-0.0106298431339565,0.0030387523679379,-0.0165857977751148,-0.00467388849279824,0.000470135189737438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37986,0.0119159170154723,0.00340853425064048,0.00523518988421692,0.0185966441467276,0.000473967431808804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,0.0191901093892725,0.00549262818437593,0.00842455814789572,0.0299556606306494,0.000477740385902683
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37628,0.00979911515265689,0.00280654762594231,0.00429828180580996,0.0152999484995038,0.000481854517150775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37998,-0.0074876681897115,0.00214643540132562,-0.0116946815763097,-0.00328065480311329,0.00048742663211964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,40044,0.0169069542165181,0.00485152494113175,0.0073979653318999,0.0264159431011364,0.000493721026096942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,0.0146300547969517,0.00420076844003722,0.00639654865447878,0.0228635609394247,0.000497705283450535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.0108966781164524,0.00314121165377524,-0.0170534529578518,-0.00473990327505289,0.000523910886000733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00832708791161369,0.00240203896910642,0.0036190915321651,0.0130350842910623,0.00052857455970237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,0.0249956269615292,0.00721918970463211,0.0108460151404503,0.0391452387826082,0.000537095382053414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.0320150640564175,0.00924781765214472,0.0138893414582138,0.0501407866546211,0.000538026604927278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.018901019956903,0.00546036970622797,0.0081986953326962,0.0296033445811099,0.000538605340477817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,0.0383526621529204,0.0110855640366455,0.0166249566410953,0.0600803676647455,0.000542494874934216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0270160231764134,0.00783963176096406,0.0116503449249239,0.042381701427903,0.000570281912795109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0223575372745827,0.00649200744848375,0.00963320267555458,0.0350818718736109,0.000575274614356263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37900,0.012162926424649,0.00353203674183241,0.00524013441065746,0.0190857184386405,0.000575770561870635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0167739208413229,0.00487220064127571,-0.0263234340982233,-0.00722440758442253,0.000577563015228568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,-0.0112109440722196,0.00325824862433902,-0.0175971113759241,-0.00482477676851513,0.000581494958545865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,0.0222507675398698,0.0064666833505632,0.00957606817276593,0.0349254669069737,0.000581722017357171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,-0.008954112273774,0.00260713703344301,-0.0140641008593223,-0.0038441236882257,0.000595248773771452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,37352,-0.0124436863908088,0.00363299033904085,-0.0195643474553288,-0.0053230253262887,0.000616280065682726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37942,-0.012518157459311,0.00365716617428616,-0.0196862031609119,-0.00535011175771011,0.000621381807971356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,40359,-0.0268167757503414,0.00784339338872448,-0.0421898267922414,-0.0114437247084414,0.000630030437288931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,40271,0.017277135899719,0.00506825677370163,0.0073433526232638,0.0272109191761742,0.000653901787173564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39961,0.0145280779831162,0.00426646336259038,0.00616580979243905,0.0228903461737933,0.000662878619697704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,-0.0460400827649503,0.0135205967734168,-0.0725404524408473,-0.0195397130890534,0.000663121411722694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37655,-0.0118298098123993,0.00347422453625157,-0.0186392899034523,-0.00502032972134618,0.000663557088183299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37714,0.0174017721665354,0.0051111471711041,0.0073839237111714,0.0274196206218995,0.000664401278090632
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,0.0154775503880776,0.00454864652567472,0.0065622031977551,0.0243928975784,0.000668951304251037
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCN,Decorin,40042,-0.00725692446427877,0.00213468542861429,-0.0114409079043628,-0.00307294102419475,0.000676711845123026
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGMN,Legumain,40422,0.0112643393764891,0.00331539193835349,0.00476617117731625,0.0177625075756619,0.00068148350569214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40516,0.0242728354271796,0.00714612281783805,0.010266434704217,0.0382792361501422,0.000683829680548901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37901,0.0177453268514788,0.00522504143036493,0.00750424564796357,0.0279864080549941,0.000685241642733058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0163933687113126,0.00483160056338023,0.00692343160708734,0.0258633058155378,0.000693441888565858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37884,0.0279811863841249,0.00826002923194727,0.0117915290895083,0.0441708436787416,0.00070724613456975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.0366979635314057,0.010865146697842,0.0154022760036354,0.0579936510591761,0.000733324987501512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,0.00984640354091101,0.00291608402989979,0.00413087884230742,0.0155619282395146,0.000735656518960556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,-0.0238476661892234,0.00706943942975659,-0.0377037674715463,-0.00999156490690045,0.000744758655836018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,0.0193217335059521,0.00574820468995293,0.00805525231364433,0.0305882146982598,0.000777851475595027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,0.0143713123472169,0.00427617410609164,0.00599001109927727,0.0227526135951565,0.000779362540001247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,0.0117303270738841,0.00349215849608357,0.00488569642156028,0.0185749577262079,0.00078395425332266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,40332,0.0167738391300036,0.00499731407148085,0.0069791035499011,0.026568574710106,0.00079100597105588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0126283971770908,0.00376930834508438,-0.0200162415334562,-0.00524055282072546,0.000809454382200594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,37541,0.0200333179892489,0.00598510767462151,0.00830250694699074,0.0317641290315071,0.000818639512524513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0231461798227092,0.00693767736388544,0.00954833218949377,0.0367440274559247,0.000851296420411329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0196269938881595,0.00588448131998925,0.00809341050098057,0.0311605772753384,0.000853755225648087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40516,-0.012737845290957,0.0038261986407927,-0.0202371946269107,-0.00523849595500336,0.000873192077953569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,-0.0216535327050061,0.00651463109996493,-0.0344222096609374,-0.00888485574907485,0.00088992160995512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,0.0271675578560528,0.00818057764942481,0.0111336256631802,0.0432014900489255,0.000899454206803018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,-0.0121411912695266,0.00366326895382403,-0.0193211984190217,-0.00496118412003154,0.000921190241383499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0103331756875383,0.00311817611188281,-0.0164448008668287,-0.00422155050824804,0.000922698122105038
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0193980713965204,0.00586111106090276,0.00791029371715102,0.0308858490758899,0.000936734908549111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,0.00917980640095545,0.0027749661377465,0.00374087277097232,0.0146187400309386,0.000941519235418204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.0249972518292662,0.00755868096424243,0.0101822371393511,0.0398122665191814,0.000944791641380338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37998,-0.0281333687399596,0.0085137081507346,-0.0448202367153994,-0.0114465007645198,0.000954000990633814
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,-0.0326898488213978,0.00989508168898049,-0.0520842089317996,-0.0132954887109961,0.000956842232901717
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENG,Endoglin,40536,-0.00526320804170085,0.00159510385528097,-0.00838961159805155,-0.00213680448535014,0.000970324499545962
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,0.0150501294968436,0.00456853277069849,0.00609580526627454,0.0240044537274126,0.00098886129279682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0146310668488082,0.00444848353199895,0.00591203912609029,0.0233500945715262,0.00100800846902479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,-0.0124391783082617,0.00378500985095245,-0.0198577976161285,-0.00502055900039489,0.00101689355028069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,0.0175643839937139,0.005353367680881,0.00707178333918712,0.0280569846482406,0.00103703953335628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37598,0.0133505937412696,0.00407376815428237,0.00536600815887615,0.021335179323663,0.00105110265520533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,40305,0.00895737781985501,0.00273521416828088,0.00359635805002448,0.0143183975896855,0.0010595006884854
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37572,0.0149009783313868,0.0045528848576231,0.00597732401044553,0.0238246326523281,0.00106738554210066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,40359,0.0207326408474955,0.00633836410591396,0.00830944719990409,0.0331558344950868,0.00107404844883559
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00925448663335797,0.00283107504310352,-0.0148033937178409,-0.00370557954887506,0.0010824828791354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,40379,-0.0100367351322713,0.00307618992110737,-0.0160660673776418,-0.00400740288690088,0.00110582261425578
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37901,0.0138581278637997,0.0042487243463154,0.00553062814502152,0.0221856275825779,0.00111016280181772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,-0.00814548070783194,0.00249736813400962,-0.0130403222504908,-0.00325063916517308,0.00111050284312967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,0.0140166771947621,0.00430750705550049,0.00557396336598111,0.022459391023543,0.00114067824745114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,40260,0.0172183124588517,0.0052934062886262,0.00684323613314433,0.027593388784559,0.00114519660298144
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37942,-0.00928617246686731,0.0028552111706488,-0.014882386361339,-0.00368995857239565,0.00114732491923893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,0.00998879616388723,0.00307347990471677,0.00396477555064236,0.0160128167771321,0.00115646882855387
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,0.0213457872284723,0.00657544122352135,0.00845792243037043,0.0342336520265741,0.0011721315775362
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0163238389256279,0.00503001637898045,0.00646500682282622,0.0261826710284296,0.00117576289436206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0101877421670578,0.00315199387867021,0.00400983416486415,0.0163656501692514,0.00123108101923977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0144344988779414,0.00446892619493446,0.00567540353586989,0.023193594220013,0.00124099620213023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,-0.00974229374928836,0.00302543110428598,-0.0156721387136889,-0.00381244878488783,0.00128442696713019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37598,-0.0104849404111129,0.003257304916175,-0.0168692580468159,-0.00410062277540991,0.00128995448903939
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,37541,-0.010957709349339,0.00340458570028645,-0.0176306973219005,-0.00428472137677756,0.0012917029846114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0131413166694623,0.00408799631893537,0.00512884388434901,0.0211537894545757,0.00130928571923555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0153026945342389,0.00476554017055353,0.00596223579995394,0.0246431532685238,0.00132532178578061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37598,0.0154818690645319,0.00483239147155935,0.00601038178027561,0.0249533563487883,0.00135964491416799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0196453154227056,0.00613262527145822,0.00762536989064748,0.0316652609547637,0.00136126828859907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,0.0190389991262563,0.00595360812912351,0.00736992719317424,0.0307080710593384,0.00138763817216527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,0.0203909500449667,0.00637842401453478,0.00788923897647849,0.0328926611134548,0.00139207868141288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0207906416156958,0.00650799449810402,0.00803497239941188,0.0335463108319796,0.00140283672218442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0197035101629809,0.00618042135575529,-0.0318171360202613,-0.00758988430570059,0.0014357050303526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0200317607479619,0.00628600884760227,0.00771118340666149,0.0323523380892624,0.00144228750748749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,0.0209432462301346,0.00657562957117604,0.00805501227062957,0.0338314801896397,0.00145103010188506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSPN,Persephin,40341,0.0295565147150085,0.00928497660635628,0.0113579605665502,0.0477550688634668,0.0014590632143716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37931,0.019127986943607,0.00600981911296941,0.00734874148218697,0.030907232405027,0.00146194995216328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.0296556145223255,0.00932450982418452,0.0113795752669239,0.0479316537777272,0.00147417913236071
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00965331038012467,0.00303707494239849,-0.0156059772672257,-0.00370064349302362,0.0014832852836816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.012217513787964,0.00385083120388769,0.00466988462834415,0.0197651429475839,0.00151380071834715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37562,0.0118939855596643,0.003749242710884,0.00454546984633164,0.0192425012729969,0.00151548912108628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39896,0.00908663222010513,0.00286789607153868,0.00346555591988931,0.0147077085203209,0.00153580953080926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0171481559771188,0.00541305920444819,0.00653855993640033,0.0277577520178372,0.0015382946387752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00870571311484454,0.00275294102022352,-0.0141014775144826,-0.00330994871520645,0.00156866909708179
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,-0.0125010747827676,0.00395723184867302,-0.0202572492061667,-0.00474490035936847,0.00158635768063565
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,40332,0.0355746701017573,0.0112959924458403,0.0134345249079102,0.0577148152956044,0.0016395544963678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,40341,0.0169441660184042,0.00539101634722241,0.0063777739778483,0.0275105580589601,0.00167511945546062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,-0.0326704971536548,0.0104020153524005,-0.0530584472443597,-0.0122825470629498,0.00168882231566806
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39961,0.0212874380418196,0.00678210596113968,0.00799451035798582,0.0345803657256534,0.00169979389642245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,0.0255526671723548,0.00815527036694302,0.00956833725314647,0.0415369970915631,0.00173247902227459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,-0.00836800061829395,0.00267566143068238,-0.0136122970224314,-0.00312370421415649,0.00176714984308146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,-0.0126652254854532,0.00407221757960809,-0.0206467719414851,-0.00468367902942139,0.00187323812040417
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,37541,-0.0128201151751989,0.00412436958970652,-0.0209038795710237,-0.00473635077937414,0.00188518108370514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,36179,0.0303192389950455,0.00975842669802725,0.0111927226669121,0.0494457553231789,0.00189460480512401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,40228,0.00970456228643484,0.0031358814340398,0.00355823467571684,0.0158508898971529,0.00197367345539984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,0.0225059824231396,0.00731337867378866,0.00817176022251383,0.0368402046237654,0.00209190299347759
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.0230030306368159,0.00747949262403085,0.00834322509371544,0.0376628361799164,0.00210583759474303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.0271109361503648,0.00882898233274632,0.00980613077818203,0.0444157415225476,0.00213936793978723
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,0.0199713165172383,0.00650446034647846,0.00722257423814048,0.032720058796336,0.00214194319902565
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,0.0221551209879327,0.00721701543422959,0.00800977073684269,0.0363004712390227,0.00214608178052345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.0269572915395795,0.00878650475216543,0.00973574222533525,0.0441788408538237,0.00215835092002403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,0.00960192323642096,0.00313115342356408,0.00346486252623536,0.0157389839466066,0.00216888950238114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0125626514614308,0.00409903608549659,0.00452854073385748,0.0205967621890041,0.00218203786062748
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,40042,0.0242190330111299,0.0079071073009788,0.00872110270121144,0.0397169633210483,0.00219544134830409
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,0.0118348522483467,0.00386891619570719,0.00425177650476061,0.0194179279919328,0.00222559185219885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0200888907246704,0.00657394649432341,0.00720395559579648,0.0329738258535443,0.0022487581494536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,0.017510107908876,0.00573114427880349,0.00627706512242115,0.0287431506953308,0.00225242681687378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37942,0.0190923314515481,0.00624963866081655,0.00684303967634769,0.0313416232267486,0.0022553758922169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37608,0.0118439450153681,0.00388693162865593,0.00422555902320249,0.0194623310075337,0.00231503883505315
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37714,-0.0100954520314396,0.00332661183117102,-0.0166156112205348,-0.00357529284234444,0.00241197529757183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37901,0.00996182341967724,0.00328351984183377,0.00352612452968305,0.0163975223096714,0.00241886761516674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.0216804142080565,0.00715233077583935,0.00766184588741135,0.0356989825287016,0.00243954764197745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,-0.0118664766500528,0.00391508353669063,-0.0195400403819664,-0.00419291291813912,0.00244242082152909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0200505139686996,0.00661574166197993,0.00708366031121895,0.0330173676261803,0.00244425646756582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.0105953714285819,0.00350798963263444,0.00371971174861835,0.0174710311085454,0.00252951790297367
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,40044,0.023549523601418,0.00779732343546515,0.00826676966790634,0.0388322775349297,0.00253011744577631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0188185192405556,0.00623751765214454,0.00659298464235233,0.0310440538387589,0.00255774810154858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,0.0266461174004084,0.00884063912000751,0.00931846472519364,0.0439737700756231,0.00258275059694581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0172438535105827,0.00572329790620015,0.00602618961443044,0.028461517406735,0.00259238451576628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.00988478490238706,0.00328885446244313,0.00343863015599852,0.0163309396487756,0.00265609562139294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39857,-0.0186234912764548,0.00620716466011511,-0.0307895340102804,-0.00645744854262918,0.002701259643748
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,40391,-0.0111103999994027,0.00370481243664554,-0.018371832375228,-0.00384896762357744,0.00271365293430205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39980,0.0192954160969531,0.00643961890504906,0.00667376304305691,0.0319170691508492,0.00273655246714202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0181319434388596,0.00606886735350814,0.00623696342598361,0.0300269234517355,0.00281604797274665
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,-0.00742279957988947,0.00248711121185609,-0.0122975375551274,-0.00254806160465152,0.00284467840412646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,40182,-0.0193662797445591,0.00649776196841894,-0.0321018932026602,-0.00663066628645795,0.00288261702171955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37598,0.0106732068052836,0.00358116596336821,0.00365412151708194,0.0176922920934853,0.0028842526520248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40489,0.0079453015590107,0.00266849063634928,0.00271505991176611,0.0131755432062553,0.0029108991924825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,0.0103667309030759,0.00348674420400009,0.00353271226323576,0.0172007495429161,0.00295181077075963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0184669258380465,0.00621266508589545,0.00629010226969141,0.0306437494064016,0.0029586180837932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",38013,0.00454626752591503,0.00153025361540112,0.00154697043972884,0.00754556461210122,0.00297425566242303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00884263165585235,0.00298197471885953,0.00299796120688768,0.014687302104817,0.00302785722941594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37598,-0.0123876216575988,0.00418669493125733,-0.0205935437228631,-0.0041816995923344,0.00309382885169377
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0183118567934923,0.00618953283802708,0.00618037243095925,0.0304433411560254,0.00309584358508889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39947,0.0239927382442024,0.00813009562974251,0.00805775080990706,0.0399277256784977,0.00317116850749135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40489,0.0123934088615515,0.00420328740213251,0.00415496555337174,0.0206318521697312,0.00319776688621823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0162038259042437,0.00550093143821243,0.00542200028534735,0.0269856515231401,0.00322823778608194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,40116,0.0186269566547765,0.00632973137044574,0.00622068316870284,0.0310332301408501,0.00325764688204374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37942,0.0199336890338536,0.00677602272932438,0.00665268448437779,0.0332146935833294,0.00326867701460174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37770,0.00905017617042425,0.00307778212384252,0.00301772320769291,0.0150826291331556,0.00328260956222167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37990,0.0177885497287996,0.00605193847903584,0.00592675030988934,0.0296503491477098,0.00329494844421841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.023225652471605,0.00790242329651455,0.00773690281043646,0.0387144021327735,0.00329699833703346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,-0.00694030888580558,0.0023635009233718,-0.0115727706956143,-0.00230784707599686,0.00332461008557868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39961,0.0124689347418044,0.00424747809452948,0.00414387767652666,0.0207939918070822,0.0033338222189277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0240297518575667,0.0081914035006264,0.00797460099633896,0.0400849027187945,0.00335607836936584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,40359,0.00761143889507677,0.00259546008444942,0.00252433712955591,0.0126985406605976,0.00336618884813811
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39980,0.020655773562409,0.00704499473530894,0.0068475838812035,0.0344639632436145,0.00337301459480691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,37402,0.0216465722911082,0.00738658953124224,0.00716885680987341,0.036124287772343,0.00338982729489562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0140217285488145,0.00478527416808515,0.00464259117936759,0.0234008659182614,0.00339255761045042
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,-0.0089206915454714,0.00304993975680402,-0.0148985734688073,-0.00294280962213551,0.00345166342036424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,0.0121881683954082,0.00416862495060739,0.00401766349221775,0.0203586732985987,0.00346378860007663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,40332,0.0127726569475395,0.00436912999811536,0.00420916215123336,0.0213361517438456,0.00346734891440911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37998,-0.0136559764489113,0.00467863815775488,-0.0228261072381109,-0.00448584565971171,0.00351967681158469
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37598,-0.00776019219832181,0.00266108986915658,-0.0129759283418687,-0.00254445605477491,0.00354955528171582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,40341,0.0144417388300591,0.00496198472507924,0.00471624876890379,0.0241672288912144,0.00361379392124015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00892491698505052,0.00307363831088526,0.00290058589571541,0.0149492480743856,0.003693811217322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0146606217179325,0.00505747856158518,0.00474796373722557,0.0245732796986395,0.00375194656092115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,0.0234608485983856,0.00811306235228299,0.0075592463879109,0.0393624508088602,0.00383744210414682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,40042,0.0121206190482613,0.00419353302710917,0.0039012943151273,0.0203399437813953,0.00385390587815213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0131731213884852,0.00456308189176015,0.00422948088063533,0.0221167618963351,0.00389702545326042
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,-0.0126296135900029,0.00438070964518763,-0.0212158044945706,-0.00404342268543512,0.00394540982223206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,-0.00991099501698931,0.00343940442538643,-0.0166522276907467,-0.0031697623432319,0.00396293802268822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,0.0131941651454829,0.00457900013115381,0.00421932488842138,0.0221690054025443,0.00396487710365095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00797896564790182,0.00277185722882519,0.00254612547940444,0.0134118058163992,0.00400023828841395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,40209,-0.0342206657484778,0.0119064421301076,-0.0575572923234887,-0.010884039173467,0.0040568372528561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.0145194908042019,0.00506099877208362,-0.0244390483974858,-0.00459993321091801,0.00412562089956923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0141630134141964,0.00493905596726843,0.00448246371835026,0.0238435631100425,0.00414313475631949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.0300494422782818,0.0105046150338769,0.00946039681188317,0.0506384877446805,0.00423412620078871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0164615552057262,0.00576348026180503,-0.0277579765188641,-0.00516513389258838,0.00429442684452437
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,-0.00551264910314919,0.00193055075677491,-0.00929652858642802,-0.00172876961987036,0.00430276253334504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,40015,0.0128672094647511,0.00451583317870262,0.00401617643449394,0.0217182424950082,0.00438655373033758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40522,0.00899757470984344,0.0031586149429528,0.00280668942165595,0.0151884599980309,0.00439702510869737
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,-0.0165010627009879,0.0057942682292106,-0.0278578284302407,-0.00514429697173511,0.00440876669932925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,-0.00947317193938037,0.00333706063863357,-0.0160138107911022,-0.00293253308765858,0.00453541295972859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,0.0148445671869759,0.00523386093537874,0.00458619975363357,0.0251029346203182,0.00457154988049472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,-0.00966660294302895,0.00341015817773759,-0.0163505129713946,-0.00298269291466328,0.00459332460781947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB1,Calbindin,40305,0.0112251864335841,0.00396747921737706,0.00344892716752506,0.0190014456996431,0.00467086280215704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,0.01391385970896,0.00491872562823053,0.00427315747762813,0.0235545619402918,0.00467896294609312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,0.00724777817994494,0.00256445617004995,0.00222144408664704,0.0122741122732428,0.00471664109376824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,0.0130551074286466,0.00462474491575937,0.00399060739375828,0.022119607463535,0.0047653203126509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,-0.00719290391688279,0.00255290537149126,-0.0121965984450057,-0.00218920938875991,0.00484528717293174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,0.00947842107047902,0.00336574817361107,0.00288155465020132,0.0160752874907567,0.00486656255977422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,0.00816133392330598,0.00289807420383357,0.00248110848379218,0.0138415593628198,0.00486774812081988
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.00766650632741599,0.00272290824268531,-0.0130034064830792,-0.00232960617175278,0.0048764423618898
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.0229136256551854,0.00817238853272736,0.00689574413103973,0.038931507179331,0.00505800970997753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,40379,-0.00777552300757602,0.00277397714609276,-0.0132125182139178,-0.00233852780123422,0.00506871756440896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.022992219427925,0.00821715465946793,0.00688659629536786,0.0390978425604821,0.00514711624729415
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,40309,0.00708505245535163,0.00253772363572417,0.00211111412933226,0.012058990781371,0.00524634126353937
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,0.0133695921002433,0.00479417523378943,0.00397300864201605,0.0227661755584706,0.00529937674422537
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0109649599830334,0.00393325907945285,0.00325577218730578,0.0186741477787609,0.00531390253157517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,37482,-0.00936680769723752,0.00336277236480533,-0.015957841532256,-0.00277577386221906,0.00535319906671089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,0.0241788706738025,0.00868824746188551,0.00714990564850694,0.0412078356990981,0.00539323370999684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.026645640491239,0.00958431617172803,0.00786038079465203,0.0454309001878259,0.00544142947101884
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37562,-0.0132777369030249,0.00477816589930151,-0.0226429420656559,-0.00391253174039399,0.00546317918679084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.010542925662843,0.00380070467229489,0.00309354450514506,0.017992306820541,0.00554480610870167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,0.0136559715608447,0.00492502662134375,0.00400291938301092,0.0233090237386784,0.00556471948457842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37882,0.00931108725849323,0.00335818906578803,0.00272903668954868,0.0158931378274378,0.00556782964473039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,40332,0.0171682697408753,0.00620019679624381,0.00501588402023742,0.0293206554615131,0.0056295954087646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37714,-0.00895907544804686,0.00323553517967921,-0.0153007244002181,-0.0026174264958756,0.00563132240982102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39990,0.0232643716122649,0.00840395590897396,0.00679261803067591,0.0397361251938538,0.00564224699715186
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.00860202336573368,0.00311232491082795,-0.0147021801909565,-0.0025018665405109,0.00571879597811407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,-0.0114583973947963,0.00414637921971336,-0.0195853006654345,-0.00333149412415813,0.00572697970368975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,0.0240483729875447,0.00870253261907296,0.00699140905416171,0.0411053369209277,0.00572738604306514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37998,-0.00795202590903486,0.00288068258532186,-0.0135981637762657,-0.00230588804180401,0.00577966171011824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39961,0.0173481868873826,0.00629894815241117,0.00500224850865672,0.0296941252661085,0.0058915091363028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,0.0157038111956817,0.00570367635123146,0.00452460554726801,0.0268830168440953,0.00590678279945146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0161407711890926,0.0058687157066824,0.00463808840399507,0.0276434539741901,0.00596080689271044
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,0.0155334597141444,0.00566109583240425,0.00443771188263205,0.0266292075456567,0.00607952073485368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,40359,0.0176097956552068,0.00642068958795627,0.00502524406281256,0.0301943472476011,0.00610111538349753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,0.0169287511708402,0.00618387746077158,0.00480835134772788,0.0290491509939525,0.0061967075366119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0189039785679894,0.00691560646386698,-0.0324585672371687,-0.00534938989881013,0.00627435851843651
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.00974868520811276,0.00356707023281513,0.0027572275517951,0.0167401428644304,0.00628485278612164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37562,-0.00938582091102904,0.00344457158482511,-0.0161371812172863,-0.00263446060477182,0.00644228142858608
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0227701359347281,0.00835983670244326,0.00638485599793929,0.0391554158715169,0.00646307936534819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,0.00865123696620783,0.00317772730110722,0.00242289145603769,0.014879582476378,0.00648701075626356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,40359,-0.00675670700164056,0.00248463735971025,-0.0116265962266727,-0.00188681777660847,0.0065472696467045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,-0.00657530445648906,0.00241969295298618,-0.011317902644342,-0.00183270626863615,0.00658781261638729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0165695399674262,0.00609971215565017,0.00461410414235191,0.0285249757925006,0.00660610492576743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37671,0.0144530022868849,0.00533341787160494,0.00399950325853926,0.0249065013152306,0.00673913089041849
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.0224056283493703,0.0082695580325006,0.00619729460566914,0.0386139620930715,0.00674876797391278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,0.00790015553956811,0.00291833434093639,0.00218022023133279,0.0136200908478034,0.00679517637698461
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37990,0.0132276721533246,0.00488638166460641,0.00365036409069607,0.0228049802159532,0.00679694946162002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37942,0.00946348889209894,0.00349734155775937,0.00260869943889056,0.0163182783453073,0.00682032794796474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.0146457985541586,0.00541868926360648,-0.0252664295108273,-0.00402516759748993,0.00688405036157021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0149745503650896,0.00556104242433422,0.00407490721339451,0.0258741935167846,0.00709533795824415
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,0.00881949355075331,0.00328772136198146,0.00237555968126965,0.015263427420237,0.00731394662248931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37648,0.0143526613144075,0.00535966331459895,0.00384772121779359,0.0248576014110215,0.00741762665179733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,0.012289957930538,0.00459137529223466,0.00329086235775808,0.021289053503318,0.00744184618768969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37562,0.0200723759071809,0.00749939084889194,0.0053735698433527,0.0347711819710091,0.00744805031232221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40489,0.0113585196501489,0.00424491084618357,0.00303849439162915,0.0196785449086687,0.0074627514159194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,40341,-0.00972052122688972,0.00363455030156362,-0.0168442398179544,-0.00259680263582503,0.00749225045654657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0125610662006138,0.00470105733854239,0.00334699381707069,0.0217751385841569,0.00755010036001511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,0.0109120470311158,0.00408977167278935,0.0028960945524487,0.018927999509783,0.00763533699407281
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37748,0.00705026805785,0.00264766167839129,0.00186085116820306,0.0122396849474969,0.00775802755262229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0149222665592059,0.00560742375124772,-0.0259128171116514,-0.00393171600676033,0.00779662154369273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,0.00673559360433323,0.00253162459758767,0.00177360939306138,0.0116975778156051,0.00780840473425324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37622,0.0164652144117871,0.00619161721573451,0.00432964466894744,0.0286007841546267,0.00784036970743065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.011702474994867,0.00440664222549592,0.00306545623289504,0.020339493756839,0.0079238133804892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.00974216285611199,0.003682022479654,0.00252539879599014,0.0169589269162338,0.00815752699726658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0151317783954348,0.00571917044584602,0.00392220432157655,0.026341352469293,0.00815945666446825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOST,Sclerostin,40330,0.00955569126668234,0.00361313997764615,0.00247393691049588,0.0166374456228688,0.00818424841749309
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37900,0.0126090315359166,0.0047739337078999,0.00325212146843278,0.0219659416034004,0.00827024358596158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,0.0088626515729783,0.00335846230491806,0.00228006545533891,0.0154452376906177,0.00832740685383386
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,0.0111788979871532,0.00423801638272846,0.0028723858770054,0.0194854100973009,0.00835345370942404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37562,-0.00911159648338202,0.00345651616583731,-0.0158863681684231,-0.00233682479834089,0.00839727998190479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37562,-0.0101406145898081,0.00384912593605634,-0.0176849014244786,-0.0025963277551377,0.0084354386959277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.00999589590789384,0.00379495066083667,0.00255779261265397,0.0174339992031337,0.00844846053403101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,0.0129678574134012,0.00492628981034518,0.00331232938512465,0.0226233854416778,0.00848706310271367
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,0.0587063968048687,0.0223029736076847,0.0149925685338067,0.102420225075931,0.0084924798607919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39961,0.0174017829796169,0.00662224465807795,0.00442218344978407,0.0303813825094496,0.00860294208053948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,40042,0.0183324887642178,0.00698532974935671,0.00464124245547868,0.032023735072957,0.00868794889171214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0151682130131571,0.00578043870668093,0.00383855314806253,0.0264978728782518,0.0086989310935549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0089353427044971,0.00341066109340988,0.00225044696141374,0.0156202384475805,0.0088074859781343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,0.0210086852861095,0.0080369809429844,0.00525620263786007,0.0367611679343589,0.00895727823389013
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,-0.0256397604050015,0.00981851496229583,-0.0448840497311013,-0.00639547107890167,0.00902801370465466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,0.014687622418481,0.00562555166850848,0.00366154114820442,0.0257137036887577,0.00903972017407321
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.0147193782504438,0.00563829363938988,-0.025770433783648,-0.00366832271723966,0.00904664474244556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0080612147602558,0.00309215411929539,-0.0141218368340748,-0.00200059268643684,0.00914263287346269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,40411,0.0140605754654821,0.00540052962785917,0.00347553739487809,0.024645613536086,0.00923478913384619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,0.0211631585222514,0.00812957495084723,0.00522919161859086,0.037097125425912,0.00924351966873806
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0128328416289446,0.00493222859510884,0.0031656735825313,0.022500009675358,0.00928147562106124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,0.0103199252372967,0.00397238734107469,0.00253404604879033,0.0181058044258031,0.00938939046827296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,40359,0.00815512827177748,0.00314534259462857,0.00199025678630549,0.0143199997572495,0.00952954458230434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,40291,0.0171024703413573,0.0066019058776669,0.00416273482113022,0.0300422058615845,0.00959145851568784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,40341,0.0155770957295747,0.00601373178370453,0.00379018143351384,0.0273640100256356,0.00959925627409309
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,0.0117324319292252,0.00453009753369335,0.00285344076318623,0.0206114230952641,0.00960962844909036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00657376669755837,0.00253905132539202,0.00159722609979001,0.0115503072953267,0.00963245048121533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,-0.0221104191077451,0.00854652918745352,-0.038861616315154,-0.00535922190033618,0.00969043875447801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0287927725013314,0.0111362312255763,0.00696575929920191,0.0506197857034608,0.00973249372868697
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,0.0184857484128277,0.00715202523276054,0.00446777895661705,0.0325037178690384,0.00975565068592454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00713177003912924,0.00275935617395333,-0.0125401081400778,-0.00172343193818072,0.00976019749465399
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37628,0.012722379584771,0.00493049077146747,0.00305861767269476,0.0223861414968472,0.00988081350245182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,37482,-0.00768046231053242,0.00297865783443691,-0.0135186316660288,-0.00184229295503607,0.00993396712988932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,38013,0.00624261463108651,0.00243390487444279,0.00147216107717863,0.0110130681849944,0.0103325357729007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37628,0.00708136553862609,0.00276299296237392,0.0016658993323732,0.012496831744879,0.0103902157149303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37598,0.0149523020882632,0.00583650516728351,0.00351275196038753,0.0263918522161389,0.0104224116123031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,-0.00615064544891837,0.00240194869024289,-0.0108584648817944,-0.00144282601604231,0.0104555648662456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,-0.0228588649474954,0.00892946505050452,-0.0403606164464842,-0.00535711344850649,0.0104802518973041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLC,Galectin-10,40333,-0.0157549621657709,0.0061548686766059,-0.0278185047719184,-0.00369141955962329,0.0104837405125557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0104782787114177,0.00409507208708405,0.00245193742073297,0.0185046200021024,0.0105142257776398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0047478828449325,0.00185698347839688,0.00110819522727461,0.00838757046259038,0.0105756937407085
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0141568538983614,0.00554317361717467,0.00329223360869907,0.0250214741880238,0.0106626775716401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,0.0115295060929883,0.00451507985801161,0.00267994957128557,0.0203790626146911,0.0106738052894906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-0.012001744378434,0.00472030088744303,-0.0212535341178224,-0.00274995463904568,0.0110132013488724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,-0.00960173663990832,0.0037863085276061,-0.0170229013540163,-0.00218057192580035,0.0112270904554753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39831,0.0140441572346134,0.0055401468956644,0.00318546931911117,0.0249028451501156,0.0112552251528778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0142409916323994,0.00563671219332157,0.0031930357334891,0.0252889475313097,0.0115312914410575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,-0.00533419174514478,0.00211291070673354,-0.00947549673034253,-0.00119288675994703,0.0115935188663226
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0111680340580102,0.00443082668765757,0.00248361375020135,0.019852454365819,0.0117295172537299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,0.00739680937341962,0.00294014942457814,0.00163411650124647,0.0131595022455928,0.0118862508049623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0107221947393473,0.00426700507807177,0.00235886478632659,0.0190855246923679,0.0119891101766209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,37457,-0.00955786475618812,0.00380878703700537,-0.0170230873487186,-0.0020926421636576,0.012104849954699
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39961,-0.0123502681542429,0.00492633301986972,-0.0220058808731875,-0.00269465543529824,0.0121865551566796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,-0.00802242394823214,0.00320119801303058,-0.0142967720537721,-0.00174807584269219,0.0122201254436489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,-0.00999821713496264,0.0039964814835221,-0.017831320842666,-0.00216511342725932,0.0123700004958152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,0.0107002328269914,0.00427785626897602,0.00231563453979844,0.0190848311141845,0.0123835201316282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40453,0.0120827593163484,0.00484396032358733,0.00258859708211729,0.0215769215505796,0.0126271472046407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,0.0176924368581905,0.00709597593055473,0.0037843240343032,0.0316005496820777,0.0126663512455618
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,0.0222816208423217,0.00894657285731553,0.00474633804198324,0.0398169036426601,0.0127678425430589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00738123562336062,0.00297009252268425,-0.0132026169678217,-0.0015598542788995,0.0129607288337691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.0076109322423203,0.00307011119141536,-0.0136283501774944,-0.0015935143071462,0.0131860862217925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,-0.00600918452741275,0.00242498696642648,-0.0107621589816086,-0.00125621007321685,0.0132236670624208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.0093720218277001,0.00378457241682438,-0.0167897837646759,-0.00195425989072431,0.0132848177062086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MB,Myoglobin,40536,0.011384806690388,0.00459785467840267,0.00237301152071877,0.0203966018600572,0.013292373946317
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00875827659396209,0.0035414746258364,-0.0156995668606014,-0.00181698632732274,0.0134087749386273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0175520421832368,0.00709817935938978,0.00363961063883278,0.0314644737276407,0.0134201315539116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.00888283141773769,0.00360380111803433,0.00181938122639041,0.015946281609085,0.0137197274822969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37934,0.00595627935216775,0.00241788083717484,0.00121723291130506,0.0106953257930304,0.0137738865151193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,-0.0104908287420361,0.00426538885919655,-0.0188509909060613,-0.00213066657801085,0.0139226915346617
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0109970177755032,0.00447170946877525,0.0022324672167037,0.0197615683343027,0.0139355543588416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,40341,0.00706639889850395,0.00287568650968835,0.00143005333951479,0.0127027444574931,0.0140095261210678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,0.0147157674637678,0.00598869213759012,0.00297793087409115,0.0264536040534444,0.0140109813455323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37551,0.0158385571527157,0.00645697557607955,0.00318288502359979,0.0284942292818316,0.0141824395688199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,0.0102508562029898,0.00419010981379179,0.00203824096795789,0.0184634714380217,0.0144403376634768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,0.00574879889287183,0.00235736068461574,0.00112837195102498,0.0103692258347187,0.0147526978010019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,-0.0105051834461746,0.00430895388369942,-0.0189507330582255,-0.00205963383412378,0.0147824240893546
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,0.00499588291723785,0.00205023768189844,0.000977417060716906,0.0090143487737588,0.0148334372651358
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,0.0266195477348024,0.0109334293824093,0.00519002614528022,0.0480490693243247,0.0149176641978154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37628,0.0266459335094544,0.0109597366990551,0.00516484957930649,0.0481270174396024,0.015059791878069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,40278,0.0135308234004963,0.00557249678418657,0.00260872970349057,0.0244529170975019,0.0151873956679447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,40359,-0.00859805492141695,0.00354781141533205,-0.0155517652954678,-0.00164434454736612,0.0153836223082943
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,0.01682697319804,0.00694628136369011,0.00321226172520738,0.0304416846708726,0.0154298382343063
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37562,-0.0082295892678606,0.00340420387052914,-0.0149018288540977,-0.00155734968162348,0.0156420134266934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.012565591142671,0.00520255796574404,0.00236857752981263,0.0227626047555293,0.015736876803679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,0.00716516918913031,0.00296771191956471,0.00134845382678348,0.0129818845514771,0.0157734474769999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.00928300219687328,0.00385392016109125,0.00172931868113442,0.0168366857126121,0.0160224207053405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.00934822334538798,0.00388681875167247,0.00173005859210993,0.016966388098666,0.0161813359355694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,40305,0.0167746899627498,0.00698687047581414,0.00308042383015409,0.0304689560953455,0.0163668117786225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,-0.00566861030250794,0.00236222691130947,-0.0102985750486745,-0.00103864555634138,0.016420300002983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0161350128227268,0.00673203871646563,0.00294021693845418,0.0293298087069994,0.0165529125085024
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,0.0107622685026959,0.00449116092848502,0.00195959308286525,0.0195649439225265,0.0165741465899145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,-0.00581960032562407,0.0024287911491227,-0.0105800309779046,-0.00105916967334357,0.0165849136813022
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.0246390597932876,0.0103193962853325,0.00441304307403593,0.0448650765125393,0.0169682463881031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.022371771240053,0.00938912441008812,0.00396908739628028,0.0407744550838257,0.0171963661263787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37562,-0.01190927342424,0.004999625663944,-0.0217085397255703,-0.00211000712290979,0.0172315298842682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,-0.00785113485115625,0.00330243966999214,-0.0143239166043408,-0.00137835309797165,0.0174484426702729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37714,-0.00783242137644083,0.00329477392001542,-0.0142901782596711,-0.00137466449321061,0.0174575072421871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39961,0.0136738506011765,0.00575536613864327,0.00239333296943569,0.0249543682329173,0.0175209517200325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37598,0.0261937689189589,0.0110324835046007,0.00457010124994161,0.0478174365879763,0.0175993684300383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,40355,0.0087795790651779,0.00370386376842231,0.00152000607907017,0.0160391520512856,0.0177814799080169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37562,-0.00890817352208714,0.00375864026797298,-0.0162751084473142,-0.0015412385968601,0.0177999640022703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,40316,0.0282808139015967,0.0119498688116821,0.00485907103069979,0.0517025567724937,0.0179632319426331
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00943418615016754,0.00399336600684048,-0.0172611835235749,-0.00160718877676021,0.018168417486626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,0.00829403761224866,0.00351417317404495,0.00140625819112056,0.0151818170333768,0.0182812447974526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.026175656653579,0.0110909939927127,0.00443730842786207,0.047914004879296,0.0182828463963509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40489,0.00446409879626992,0.00190446890689449,0.000731339738756713,0.00819685785378312,0.0190896751151264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,37541,0.00997600097224578,0.00425858936274203,0.00162916582127139,0.0183228361232202,0.0191668558338332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,0.0274402527169584,0.0117182812221734,0.00447242152149848,0.0504080839124184,0.0192128665256398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.00826048634152207,0.00352921463194808,-0.0151777470201403,-0.00134322566290383,0.0192675852524486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39801,0.00772116608769768,0.00330786986038459,0.00123774116134389,0.0142045910140515,0.0195990934046087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,-0.00719392367794007,0.00308326211738273,-0.0132371174280102,-0.00115072992786992,0.0196493383755083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37598,-0.0122394285207383,0.0052456844990655,-0.0225209701389067,-0.00195788690256993,0.0196506767882785
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,-0.0122533651179943,0.00525426671642941,-0.022551727882196,-0.00195500235379271,0.019711597308826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,0.0116543624663161,0.00500971512810316,0.00183532081523389,0.0214734041173983,0.020014752469481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,40042,0.0103048139160679,0.00443615435712909,0.00160995137609486,0.0189996764560409,0.0201964683496488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0104107486699327,0.00448290305648071,0.00162425867923047,0.0191972386606348,0.0202304037693433
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,37482,-0.00815103724648117,0.00351582122468439,-0.0150420468468626,-0.00126002764609976,0.0204436504159909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0148938355234738,0.00642603549390727,0.00229880595541553,0.027488865091532,0.0204789691772198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37981,-0.00319289554304495,0.00137880915162903,-0.00589536148023784,-0.000490429605852061,0.0205900395440666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,0.00613151071526257,0.00264830718967881,0.000940828623492107,0.011322192807033,0.0206137714409079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,40403,-0.0100734709006552,0.0043536361765574,-0.0186065978067077,-0.00154034399460269,0.0206909943260529
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,0.00722986798769782,0.00313045160267026,0.00109418284646411,0.0133655531289315,0.0209273283708907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,40257,0.0143905464278248,0.0062362378113478,0.00216752031758313,0.0266135725380665,0.0210359981687951
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,40312,0.0144898356371438,0.00628490584316571,0.00217142018453902,0.0268082510897486,0.0211515585016472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.00807525202823043,0.00351301022900551,0.00118975197937964,0.0149607520770812,0.0215388861094222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0106043093132018,0.00463652941594539,0.00151671165794888,0.0196919069684548,0.0222045392194182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37598,-0.00584554900565487,0.00255631466351143,-0.0108559257461373,-0.000835172265172458,0.0222286084449818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,37482,-0.00992654699509081,0.00434627716424242,-0.0184452502370059,-0.00140784375317567,0.022392278398781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.0152169974678608,0.0066657085886194,-0.0282817863015548,-0.0021522086341668,0.0224535335456166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39903,0.00912490199782334,0.00399916961503516,0.00128652955235442,0.0169632744432923,0.0225206446178435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,0.0126519585252135,0.00555450366777484,0.00176513133637477,0.0235387857140522,0.0227550343620004
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.013220769841524,0.00580577592221693,0.00184144903397886,0.0246000906490692,0.0227917110697572
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37562,0.00813517201276385,0.00357403635729201,0.0011300607524715,0.0151402832730562,0.0228509238362932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0163281376528729,0.00718368051420414,0.00224812384503281,0.030408151460713,0.0230449721161951
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37671,0.0242151375050535,0.010655271917629,0.00333080454650059,0.0450994704636063,0.0230664680833023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.00440101463811649,0.00193739185934026,0.000603726593809582,0.00819830268242341,0.023123088259091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0164575795437482,0.00724793230443195,0.00225163222706158,0.0306635268604348,0.0231839046860874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,40341,0.00852103211596744,0.0037602773271989,0.00115088855465759,0.0158911756772773,0.0234608076797647
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,0.0112629045470124,0.00497388391083069,0.0015140920817842,0.0210117170122405,0.0235651862096121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,-0.00837154304630133,0.0037041983194502,-0.0156317717524237,-0.00111131434017893,0.0238337966685368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37901,0.0127122264830628,0.00563241558055043,0.00167269194518394,0.0237517610209416,0.0240255558009971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37942,0.0202192083505704,0.00896189695427549,0.00265389032019046,0.0377845263809504,0.024078408286952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSND,Barttin,37482,-0.00724281326294924,0.00321693593919468,-0.0135480077037708,-0.000937618822127681,0.0243727969711685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,0.0134212758315175,0.00596554457700062,0.0017288084605963,0.0251137432024387,0.0244752343170806
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,38013,-0.00581039441939093,0.00258269595925932,-0.0108724784995392,-0.000748310339242672,0.0244814233498903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00924835026409101,0.00413101046969522,-0.0173451307846936,-0.00115156974348838,0.0251881008851876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,0.00913128823655237,0.00408076939466056,0.00113298022301768,0.0171295962500871,0.0252608528506576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,0.0154774958293829,0.00692040383077342,0.00191350432106695,0.0290414873376988,0.0253330592832783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,0.0141387576887946,0.00634487711722563,0.00170279853903232,0.0265747168385568,0.025872006601732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,-0.00741625173057483,0.00333329090632773,-0.0139495019069772,-0.000883001554172484,0.0261041693548191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.0130063316454311,0.00586099999148432,-0.0244938916287403,-0.0015187716621218,0.0264948100646138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,-0.0118715244682281,0.00535872891370309,-0.0223746331390862,-0.00136841579737005,0.0267519147757983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.0155865765360353,0.00704967003924659,0.001769223259112,0.0294039298129586,0.0270527679522621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,0.0252314177113997,0.0114202184734939,0.00284778950335154,0.0476150459194478,0.0271665666699216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,-0.00930226400652306,0.00421167459520781,-0.0175571462131304,-0.00104738179991574,0.0272107372578609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,37541,-0.0103757509557261,0.00469962325193173,-0.0195870125295123,-0.00116448938193995,0.0272766420760049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2,Prothrombin,38013,-0.00302683057056069,0.00137743488958621,-0.00572660295414967,-0.000327058186971713,0.0280058834298975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,37541,-0.0188289557436125,0.00859942860968689,-0.0356838358185988,-0.00197407566862617,0.0285738319855599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,-0.0092386088849802,0.00422549306845991,-0.0175205752991616,-0.000956642470798779,0.0288041166471033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,-0.0110655095853096,0.00506835960211629,-0.0209994944054575,-0.00113152476516167,0.0290321284710672
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00575163466631407,0.00264276677553388,0.000571811786267661,0.0109314575463605,0.0295449968595017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,-0.0102820202624609,0.00472813510303275,-0.0195491650644051,-0.00101487546051669,0.0296744215356183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,0.00550074718332323,0.00253174024445524,0.00053853630419096,0.0104629580624555,0.0298191452058095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRELP,Prolargin,40357,-0.00471294927814214,0.00217013552918697,-0.0089664149153486,-0.000459483640935681,0.0298907329979139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40490,0.00546280133177867,0.00251592429175238,0.000531589719944007,0.0103940129436133,0.0299238675146122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37900,-0.0118589317317686,0.00547675310063986,-0.0225933678090228,-0.0011244956545145,0.0303805912475971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,0.0197317478173565,0.00913098752760329,0.00183501226325405,0.037628483371459,0.030715610423549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.0353490904089241,0.0163633185967692,-0.0674211948585917,-0.00327698595925639,0.0307673328834704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,0.015486991507126,0.00718672483388111,0.00140101083271905,0.029572972181533,0.0311815208563422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,-0.00909697057572525,0.00423213984631464,-0.0173919646745019,-0.000801976476948565,0.0316127559192542
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.0064760148837964,0.00301284902044814,-0.0123811989638748,-0.000570830803718047,0.0316157521298706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37598,-0.00676267183481886,0.00315255137534191,-0.012941672530489,-0.000583671139148709,0.0319597243583402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,-0.00959202146250693,0.00447998606039679,-0.0183727941408846,-0.000811248784129212,0.0322825667609678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,0.0123140133548394,0.00575243673145177,0.00103923736119396,0.0235887893484849,0.0323169000279138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0134195518719653,0.00627084199446567,0.00112870156281256,0.025710402181118,0.0323738136393262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,40207,0.00897636243224231,0.00420538152488039,0.000733814643476749,0.0172189102210079,0.0328177377244948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.00643242277257085,0.00301392318318224,0.000525133333533666,0.012339712211608,0.0328389148535805
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALLD,Palladin,37598,-0.00829104317685601,0.00388846076120849,-0.0159124262688246,-0.000669660084887371,0.0330074706237643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0108636318122342,0.00510873444196883,0.000850512305975312,0.0208767513184931,0.0334813051989031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0201101301504841,0.00946785373828168,0.00155313682345202,0.0386671234775162,0.0336851999350288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0110006554210442,0.00517940375121533,0.000849024068662109,0.0211522867734262,0.0336923528588059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,37482,-0.00906854324761402,0.00428602914369351,-0.0174691603692533,-0.000667926125974733,0.0343775065714294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,-0.0103303924271766,0.00488941163613936,-0.0199136392340098,-0.000747145620343479,0.0346359784835353
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0151555758055298,0.00717941370987014,0.00108392493418428,0.0292272266768752,0.0347902463295316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00558035631574915,0.00264916617362989,-0.0107727220160637,-0.000387990615434565,0.0351803704249815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00903915676327607,0.00429774563768421,-0.0174627382131371,-0.000615575313415022,0.0354644365422775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00787424931950262,0.00374863827983659,0.000526918291022901,0.0152215803479823,0.0356984310998816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0133234224767534,0.00634444531299168,0.000888309663289703,0.0257585352902171,0.0357437212301633
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.024586655531886,0.0117310505486531,0.001593796456526,0.047579514607246,0.0361130549608177
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37959,0.0093154446214431,0.00444494972931855,0.000603343151978736,0.0180275460909075,0.0361241129079594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,0.00559250373874653,0.00266936470087624,0.000360548925029104,0.010824458552464,0.036180683184612
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0084318126327167,0.00402964425944148,0.00053370988421139,0.016329915381222,0.0364176066243464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,-0.00446253402808849,0.00214162725796877,-0.00866012345370727,-0.000264944602469705,0.0372021360921788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,0.0185148080543133,0.00889162482678825,0.00108722339380835,0.0359423927148183,0.0373362137148236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,-0.00903574529615538,0.00434133427425882,-0.0175447604737027,-0.000526730118608085,0.0374231525602341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0074420209494761,0.00358569522124252,0.000414058315840751,0.0144699835831114,0.0379589711196833
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,37231,-0.0135417392665882,0.00653164312105898,-0.0263437597838638,-0.00073971874931263,0.038168864901726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.00761132335936702,0.00367191062056162,0.000414378543066253,0.0148082681756678,0.038205073542031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,0.00495819513129874,0.00239334863663048,0.000267231803502994,0.00964915845909448,0.0383168806268523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,0.0184463109015435,0.00891300465415112,0.000976821779407298,0.0359158000236797,0.0385062697939949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPL,Periplakin,37598,0.00637949400706304,0.00308477039006894,0.000333344042527921,0.0124256439715982,0.0386537805541264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.00793135762884146,0.00383744013943765,0.000409974955543668,0.0154527403021393,0.0387662106896467
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.00937785625122495,0.00453781073873617,-0.0182719652991478,-0.000483747203302054,0.0387911062259285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,40359,0.0147467933628717,0.00713781005766621,0.000756685649845927,0.0287369010758975,0.038843603484766
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00494981966756176,0.00239585736707986,-0.00964570010703828,-0.000253939228085242,0.0388490528193983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37714,-0.00763836481377889,0.00370280805793458,-0.0148958686073307,-0.000380861020227124,0.0391456066334972
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0101541971384447,0.0049472217888843,0.000457642432231469,0.0198507518446579,0.0401399267971824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37598,0.00502091022870338,0.00245099245794215,0.000216965011136766,0.00982485544627,0.0405287639035451
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37671,0.00613135972070572,0.00299378243691011,0.000263546144361903,0.0119991732970495,0.0405766597894198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,40355,-0.00864367891260209,0.00422596867931563,-0.0169265775240607,-0.000360780301143468,0.0408345961042384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,0.0049488805125099,0.00242166217839685,0.000202422642852072,0.00969533838216774,0.0410135544791373
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,0.00701204414904869,0.00343147007051078,0.00028636281084755,0.0137377254872498,0.0410277909896116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39961,0.0100240557084622,0.00491069137504429,0.000399100613375421,0.019649010803549,0.0412407106485254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRTN,Neurturin,40044,0.00942346419227857,0.00463506064667683,0.000338745324791988,0.0185081830597652,0.0420610164973998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0556307409753595,0.0273696471739465,0.0019862325144244,0.109275249436295,0.0421124992224165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00702876517824666,0.00346531077358777,0.000236756062014639,0.0138207742944787,0.042544078164658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0110508265089773,0.00545256282528939,0.000363803371410136,0.0217378496465446,0.0427076881513146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37959,0.00570998364343863,0.00281846321930027,0.000185795733610104,0.0112341715532672,0.0427925053240223
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,-0.0148886121358644,0.007357749075204,-0.0293098003232642,-0.000467423948464543,0.0430389598836209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.00574624749658407,0.00284000073578343,0.000179846054448547,0.0113126489387196,0.0430565710511933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,0.0122411569754981,0.00605020638181343,0.000382752467143794,0.0240995614838524,0.0430657501550027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,37482,-0.00870536257566243,0.0043084363967863,-0.0171498979133636,-0.000260827237961276,0.0433479543469995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.007819451541435,0.00387439623744837,-0.0154132681668338,-0.000225634916036198,0.0435868973878757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40536,0.0134907721445735,0.00669103994963706,0.000376333843284848,0.0266052104458621,0.0437910123337868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00985741096831966,0.00489686452133036,-0.0194552654301272,-0.000259556506512165,0.0441345295524943
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,-0.0109066006169351,0.00543638709393093,-0.0215619193210397,-0.000251281912830454,0.0448530786498737
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,0.0123791748069372,0.00617415374583981,0.000277833465091162,0.0244805161487832,0.0449834483567204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40536,-0.0060511494539754,0.00302130716974379,-0.0119729115066732,-0.000129387401277559,0.0452128295690855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,-0.0154203246509762,0.00770260773676733,-0.0305174358150402,-0.000323213486912253,0.0453095952260119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,0.00975511541667143,0.00489424989566027,0.0001623856211773,0.0193478452121656,0.0462624987769654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,37541,-0.0183172350890013,0.00921334182862497,-0.0363753850731062,-0.00025908510489632,0.0468191440296896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,0.00702552269143745,0.00353379906389028,9.92765262124917e-05,0.0139517688566624,0.0468220637050355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00875692440277381,0.00440729442667587,-0.0173952214790585,-0.000118627326489092,0.0469525980242351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37628,0.00531480594270885,0.00268240679921313,5.72886162511152e-05,0.0105723232691666,0.0475719861683398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37812,0.0184881078655176,0.00934880681668831,0.000164446504808471,0.0368117692262266,0.0479954849413773
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,40458,-0.00552906448546824,0.00280097322690832,-0.0110189720102085,-3.91569607279376e-05,0.0484012109481371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,0.0135161444085111,0.0068485948472457,9.28985079095019e-05,0.0269393903091127,0.0484483816703389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,0.00994476683874569,0.00505119323238509,4.44281032709118e-05,0.0198451055742205,0.0489970731438488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,40044,-0.0268207857328115,0.013659367820022,-0.0535931466600545,-4.84248055683846e-05,0.0496006050779142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,40456,-0.00792054840953499,0.0040341465205438,-0.0158274755898008,-1.36212292691385e-05,0.049619733351529
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,0.00777431534905819,0.00396007757654719,1.25632990256941e-05,0.0155360673990907,0.0496439060428774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37959,0.00469592035565746,0.00239634562507578,-9.17069491068734e-07,0.00939275778080599,0.0500610720595287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,0.00649513297510903,0.00331657489431321,-5.35381774487316e-06,0.0129956197679629,0.050202246839959
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37942,-0.00483259979238777,0.00247172197765384,-0.0096771748685893,1.19752838137564e-05,0.0505853873637206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,40332,0.00879209278051449,0.004516723757132,-6.0685783464234e-05,0.0176448713444932,0.0516046140868119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0120044940953069,0.00617637803965343,-0.000101206862413834,0.0241101950530276,0.0519595396271475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.006280444060352,0.00323868762329135,-0.012628271802003,6.73836812990465e-05,0.0524992625641252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39871,-0.01268102250967,0.00654568444129603,-0.0255105640146102,0.000148518995270186,0.0527256523768421
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,0.00833706637861338,0.00430833905752223,-0.000107278174130185,0.0167814109313569,0.0529961990673454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,0.0201703593904059,0.0104474617735941,-0.00030666568583862,0.0406473844666503,0.0535480982970197
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,0.00634188390798953,0.00328671117956892,-0.000100070003965558,0.0127838378199446,0.0536799914872319
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37598,0.00906935009766158,0.00470345760491855,-0.000149426807978784,0.018288127003302,0.053847980853256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37714,-0.00756803042894856,0.00392702085652987,-0.0152649913077471,0.000128930449849982,0.0539799847546007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,-0.011504744549202,0.00597528163999826,-0.0232162965635986,0.000206807465194581,0.054202288238245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,37541,-0.00871981879408665,0.00453401383534853,-0.0176064859113698,0.000166848323196475,0.0544765117509949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37990,0.0174610721544544,0.00908374532446326,-0.000343068681493565,0.0352652129904024,0.0545974473884928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.00684341286352601,0.00356259196027153,-0.000139267378606197,0.0138260931056582,0.0547647389401464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPS,Colipase,40311,-0.012279302553865,0.00640769335125949,-0.0248383815223335,0.000279776414603642,0.0553401153144677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.0056877986009782,0.00297721619764698,-0.0115231423483663,0.000147545146409887,0.0560981317396639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,40341,0.0112322478240763,0.00587959497672325,-0.000291758330301286,0.0227562539784539,0.0561025665217686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,0.00868721543069347,0.00454955711303844,-0.000229916510861867,0.0176043473722488,0.0562201415400384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.011058611845885,0.00579316311672283,-0.000295987862891737,0.0224132115546618,0.05629514998607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39980,-0.0301108838371932,0.0158056140286536,-0.0610898873333543,0.000868119658967926,0.0567887468968985
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.00846879211975515,0.00445509885172187,-0.000263201629619713,0.01720078586913,0.0573308241797918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37598,-0.00765438401010449,0.00402918313714095,-0.0155515829589008,0.000242814938691782,0.0574896445554199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0122418410318104,0.0064487008101132,-0.000397612556011458,0.0248812946196323,0.0576729384017925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,-0.00693687553137383,0.00365523832336019,-0.0141011426451598,0.000227391582412135,0.0577456688966213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00519416362833457,0.00274759258940399,-0.000191117846897248,0.0105794451035664,0.0587168692759465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37959,0.011280850652895,0.00597168107704002,-0.00042364425810347,0.0229853455638934,0.0589054875989074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0141595145904721,0.00750367063894787,-0.000547679861865684,0.02886670904281,0.0591773832088835
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.015404856977113,0.00816405732807723,-0.00059669538591837,0.0314064093401444,0.0591939975669138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,-0.00947140242324838,0.00502271800198853,-0.0193159297071459,0.000373124860649134,0.0593524042262889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,0.00520358455821535,0.00276083357147067,-0.000207649241867157,0.0106148183582979,0.059479936800915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,37482,-0.00844103688530627,0.0044809952225914,-0.0172237875215854,0.000341713750972876,0.0596221910987742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRN,Progranulin,40262,0.00427085632428163,0.00226902433801795,-0.000176431378233546,0.0087181440267968,0.0598213112993365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,0.0168151011167395,0.00894715543805528,-0.000721323541848805,0.0343515257753279,0.060214909360513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00864027250364816,0.00459840075628319,-0.0176531379859632,0.000372592978666896,0.0602702814768187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0108374194639917,0.00578209762835377,-0.000495491887581689,0.0221703308155651,0.06091038935925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,-0.0051976422340788,0.00278222314094971,-0.0106507995903402,0.000255515122182639,0.0617617878052486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.00909356164070269,0.0048689564285538,-0.000449592959262756,0.0186367162406681,0.0618276193339299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37572,0.00909991090581102,0.00487550116817036,-0.000456071383802888,0.0186558931954249,0.0619998142663002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39953,-0.0155199222747669,0.00833198573298941,-0.0318506143114262,0.000810769761892307,0.0625245296636531
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,-0.00704698097055615,0.00378652171283948,-0.0144685635277215,0.00037460158660923,0.0627526418071566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37628,0.00391193172771949,0.00210733218755465,-0.000218439359887625,0.0080423028153266,0.0634269654321252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,0.0047871422548765,0.0025909149454806,-0.000291051038265464,0.00986533554801847,0.0646727044465552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,0.0081567884536006,0.00441795541159927,-0.000502404153133976,0.0168159810603352,0.0648738983247698
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37562,0.00744648408870801,0.00403725833138474,-0.000466542240806077,0.0153595104182221,0.0651414680981646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,0.014795029413074,0.00802354799063596,-0.000931124648572517,0.0305211834747205,0.0652089292705302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,40044,0.00860527561442227,0.00467276444406697,-0.000553342695948986,0.0177638939247935,0.0655554005499124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,-0.0103966286121353,0.00566378211508157,-0.0214976415576952,0.000704384333424622,0.0664345412193474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,-0.00462995551082193,0.00252632105935936,-0.00958154478716627,0.000321633765522405,0.06687105948549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,0.0119571657062791,0.00654160939422604,-0.000864388706403941,0.0247787201189621,0.0675925716167229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00509538069717023,0.00279124958985259,-0.000375468498940833,0.0105662298932813,0.0679466977946747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,0.0141353162902584,0.00774330626058497,-0.00104156398048809,0.029312196561005,0.0679499745794332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.00582863760997292,0.00320138434922702,-0.0121033509344579,0.000446075714512036,0.0686774284250656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0122569596778817,0.00673500996179016,-0.0254575792029904,0.000943659847227024,0.0687989498259262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37901,0.00993343428509713,0.00545988163036316,-0.000767933710414665,0.0206348022806089,0.0688803118697204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,40332,-0.00330189016124669,0.0018155361245633,-0.00686034096539076,0.000256560642897368,0.068978173660857
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.00502009090874522,0.00276086015864778,-0.0104313768196949,0.000391195002204431,0.0690358395322623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,-0.00805173632022987,0.00443983622093381,-0.0167538153132601,0.000650342672800392,0.0697736365246885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37819,0.00753904481095899,0.00417153295861715,-0.00063715978793063,0.0157152494098486,0.0707442171064238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.00510840276792769,0.00282994774396836,-0.0106551003461057,0.000438294810250289,0.071078566078651
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.00675251881643523,0.00375688275136528,-0.000610971376240724,0.0141160090091112,0.072298722077906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,40341,-0.00585365005336985,0.00326539394883678,-0.0122538221930899,0.000546522086350231,0.073050783877311
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39951,0.018563436209065,0.0103638629832041,-0.00174973523801505,0.0388766076561451,0.0732855897742471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.00581294323191896,0.00324959069310546,-0.000556254526567737,0.0121821409904057,0.0736624726707088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0111525838542762,0.00623653617400107,-0.00107102704676586,0.0233761947553183,0.0737563743319752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,0.0034237909081645,0.00191541010332955,-0.000330412894361417,0.00717799471069042,0.0738801326894663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,0.0175912173007555,0.0098507851721012,-0.00171632163656289,0.0368987562380738,0.0741592796975942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.00614906379954663,0.00344995891820178,-0.000612855680128856,0.0129109832792221,0.0747133335116983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00523762626405464,0.0029388473722231,-0.000522514585502632,0.0109977671136119,0.0747390044771614
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37598,-0.00971067883134896,0.00545172900103878,-0.020396067673385,0.000974710010687038,0.0749010944849545
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,0.00623533703597735,0.00350492235011822,-0.000634310770254352,0.0131049848422091,0.0752585935529489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.00500186253320549,0.00281479943957789,-0.0105188694347781,0.000515144368367162,0.0755935665032224
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.00608541524389178,0.00342621299544259,-0.000629962227175706,0.0128007927149593,0.0757339148129222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.00703071229123095,0.00396388371183298,-0.00073849978396168,0.0147999243664236,0.0761370579122303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37901,0.011779352058032,0.00664350037771673,-0.00124190868229274,0.0248006127983568,0.0762407132165013
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0136199173405717,0.00770208265122595,-0.00147616465583114,0.0287159993369746,0.0770271171492117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.00800847777293521,0.00454185781006567,-0.00089356353479351,0.0169105190806639,0.0778758193181845
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,0.00653096371986232,0.0037085681211423,-0.000737829797576584,0.0137997572373012,0.0782498059295113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37562,0.0102349376726629,0.00583354006386024,-0.00119880085250318,0.021668676197829,0.0793684753734371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,0.00977921235858997,0.00559966352775824,-0.00119612815581618,0.0207545528729961,0.080765442873626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,40384,-0.00924284669482406,0.00530508621871622,-0.0196408156835079,0.00115512229385973,0.0814820188587378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.00816941757479226,0.00470786326217713,-0.0173968295686594,0.00105799441907491,0.0827163907213043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,0.00428989000333168,0.00248870704881322,-0.000587975812342227,0.00916775581900559,0.0847772588085093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,-0.0156472281391022,0.00909783914431858,-0.0334789928619666,0.00218453658376224,0.085477127252113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.00723679918273029,0.00423101440888277,-0.00105598905867993,0.0155295874241405,0.0872118453183767
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37901,-0.0180956964241172,0.010592800338541,-0.0388575850876575,0.00266619223942306,0.0876034935997499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,-0.01142511581063,0.00670595263925281,-0.0245687829835656,0.00171855136230546,0.0884557102086069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,-0.00550942993692547,0.00324264867897052,-0.0118650213477077,0.000846161473856739,0.0893330794267078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.00798538735272352,0.00470548742364353,-0.0012373679976178,0.0172081427030648,0.0897127618923555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00574649323302344,0.00338751073569913,-0.0123860142749937,0.000893027808946849,0.0898383624706209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,-0.00428552116644586,0.00253544977714701,-0.009255002729654,0.000683960396762283,0.0910050766376036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.00656351021776069,0.00388668345781091,-0.0010543893595487,0.0141814097950701,0.0912936662622362
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00338671333523402,0.0020072037291724,-0.000547405973943882,0.00732083264441192,0.0915728456432018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00575576211097704,0.00341560316211922,-0.0124503443087307,0.000938820086776623,0.0919859279239864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,40042,0.00790334359951076,0.00469963097371597,-0.00130793310897254,0.0171146203079941,0.0926481220197561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,0.00519807815948901,0.00309183536895569,-0.000861919163664134,0.0112580754826422,0.0927425189281597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.00952800524098718,0.00567429839288529,-0.00159361960906799,0.0206496300910423,0.0931423728707089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,0.00280854961192339,0.00167402449466557,-0.000472538397621119,0.0060896376214679,0.0934242061540816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.0089457603430071,0.00533287464177887,-0.00150667395487948,0.0193981946408937,0.0934693919554098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,-0.00532282442746208,0.00317653533981318,-0.0115488336934959,0.000903184838571748,0.0938259754427897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,-0.00212803835581482,0.00127126253001999,-0.00461971291465401,0.000363636203024369,0.0941626293917844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,0.00822798433689991,0.00492912435692884,-0.00143309940268062,0.0178890680764804,0.0950899542845038
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,-0.00893551321865454,0.00536444094668189,-0.019449817474151,0.00157879103684196,0.0957984520109552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.00647689170769001,0.00389017830605394,-0.00114785777217572,0.0141016411875557,0.0959491740739838
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2,Complement C2,40372,0.00371678782765796,0.00224438498079556,-0.000682206734701341,0.00811578239001725,0.0977337403316601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,0.00595778585794912,0.0036082807442261,-0.00111444440073403,0.0130300161166323,0.0987327843291971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,0.00435873652874695,0.00264209865554387,-0.00081977683611904,0.00953724989361294,0.0990229286694305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,40434,0.00952139313385671,0.00577262098515398,-0.00179294399704508,0.0208357302647585,0.099084229657914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.012273217523003,0.00744455877470237,-0.0268645527214196,0.00231811767541363,0.0992503040640467
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37642,-0.00491590725502473,0.0029891458147566,-0.0107746330519477,0.000942818541898203,0.100079053259078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,-0.00541877727869341,0.00329959861233416,-0.0118859905588684,0.00104843600148155,0.100561403284926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,40044,0.0072621341037058,0.00442432774868812,-0.00140954828372292,0.0159338164911345,0.100732583898447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.00643378252371132,0.00394053362037178,-0.01415722841964,0.00128966337221737,0.102552143746434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,40305,0.0284931166451747,0.0175329217043869,-0.00587140989542367,0.062857643185773,0.104156689323499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37628,0.0128294377720304,0.00790412380511408,-0.00266264488599316,0.028321520430054,0.104585072699447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,40173,0.015706497562559,0.00969632378698209,-0.00329829705992584,0.0347112921850439,0.105286610306879
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,-0.00525809887398876,0.00324734269492773,-0.0116228905560471,0.00110669280806959,0.105427479874032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37562,-0.00485551976928514,0.0029997048965959,-0.0107349413666131,0.00102390182804283,0.105543241082634
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.00752424127668693,0.00465098402338839,-0.0166401699625282,0.00159168740915431,0.105731611168337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.00377958152407805,0.00234425274829588,-0.00837431691073798,0.000815153862581876,0.106925850962703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,0.00807331036734061,0.00501523050695108,-0.00175654142628351,0.0179031621609647,0.107474447384711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,-0.00944147860873902,0.00586597993340091,-0.0209387992782048,0.00205584206072677,0.107524430015001
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,0.00794056508057031,0.00494043135004292,-0.00174268036551382,0.0176238105266544,0.10802034259385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37562,-0.0094238370478258,0.00588100157425831,-0.0209506001333721,0.00210292603772049,0.109086762469363
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37562,-0.00633352107207316,0.003956194705261,-0.0140876626943847,0.00142062055023839,0.109420422078193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,0.00398134795141795,0.00248704126722993,-0.000893252932352724,0.00885594883518862,0.109432665962778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,40044,-0.00512826614628675,0.00320571718758731,-0.0114114718339579,0.00115493954138437,0.109679848964904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,40044,0.0134345558806452,0.00841310963607703,-0.00305513900606576,0.0299242507673562,0.110317245781875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.00986159994970331,0.00617568463229548,-0.00224274192959584,0.0219659418290025,0.110324767426655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,40042,-0.00763924523488281,0.00478711270046222,-0.0170219861277888,0.00174349565802314,0.110555085353869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,37541,-0.0136437932998654,0.00855780042663709,-0.0304170821360741,0.00312949553634331,0.110890593456264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,40013,0.0107875858302429,0.00677905040114542,-0.00249935295600217,0.0240745246164879,0.111559638072718
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,0.0109446061319809,0.00690037743418062,-0.00258013363901312,0.0244693459029749,0.112742748021918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.00723090334686549,0.00456633047424604,-0.00171910438265675,0.0161809110763877,0.113321489290974
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00778793078614181,0.004941229150044,-0.017472739920228,0.00189687834794443,0.115024111961936
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIT,Vitrin,37990,-0.00542653272365264,0.00344627886234589,-0.0121812392938506,0.0013281738465453,0.115370693658058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00367224345114969,0.00233462877678758,-0.00824811585365335,0.000903628951353972,0.115754844027047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.0119311148632307,0.00759537998245775,-0.0268180596288479,0.00295582990238647,0.116244351525028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,40171,0.00857415726317998,0.0054698265895411,-0.00214670285232059,0.0192950173786805,0.117009281136285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37562,-0.0069753546615185,0.004454094734404,-0.0157053803409503,0.00175467101791334,0.117360017452447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37959,-0.00530956994280892,0.00339076088418967,-0.0119554612758207,0.00133632139020284,0.117397011575696
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39961,0.0064421862239761,0.00411986907215523,-0.00163275715744814,0.0145171296054003,0.117911465910035
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37572,-0.0051225454507157,0.00328093999513628,-0.0115531878411828,0.00130809693975141,0.118476108045782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.00954618299209273,0.00612092050888369,-0.0215431871895048,0.00245082120531931,0.11887879209562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.00596150142003965,0.00382790987563579,-0.00154120193620651,0.0134642047762858,0.119404372631725
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.00354174471092085,0.00227560478022915,-0.000918440658328283,0.00800193008016999,0.119633629149553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37714,-0.00838606546375568,0.005391824688162,-0.0189540418525532,0.00218191092504184,0.119891412055577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37900,-0.00492263129854612,0.00316783369195888,-0.0111315853347855,0.00128632273769328,0.120221672851697
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,0.005079557603508,0.00327766255970208,-0.00134466101350806,0.0115037762205241,0.12122490860633
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.00824004415165148,0.00532923088644181,-0.00220524838577446,0.0186853366890774,0.122077225154594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39980,0.011742329824608,0.00760910471405639,-0.00317151541494252,0.0266561750641585,0.122803928417215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0115696037267077,0.00750708219900963,-0.00314427738335117,0.0262834848367666,0.123298504976619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39980,-0.00811920603345205,0.0052736823598678,-0.0184556234587929,0.00221721139188884,0.123685445801776
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.00387030625760737,0.00252808244238783,-0.00108473532947277,0.00882534784468751,0.125807762587756
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.00786302242923365,0.00513811576445933,-0.00220768446910664,0.0179337293275739,0.125954550355642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00549005580001793,0.00358793172204132,-0.00154229037518306,0.0125224019752189,0.12600496795449
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,0.0112774452838857,0.00737295505075548,-0.00317354661559507,0.0257284371833664,0.126147447847302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.00838228109985202,0.00549136284451785,-0.019145352275107,0.00238079007540297,0.126918640913816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,37541,0.0124677762695056,0.00817281033237886,-0.003550931981957,0.0284864845209681,0.127153895234335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00544521842669566,0.00358166466047098,-0.0124652811612188,0.00157484430782746,0.128458753132975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37959,0.005210817231125,0.00342909160187991,-0.00151020230855962,0.0119318367708096,0.128637171250968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37766,-0.00467532441078763,0.00309786757735483,-0.0107471448624031,0.00139649604082783,0.131269540645787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,-0.0043792741039181,0.00290603562077337,-0.0100751039206339,0.0013165557127977,0.131845199394164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,40341,0.00968867418598756,0.00643581255968159,-0.00292551843098835,0.0223028668029635,0.132233084328405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,-0.0047696912352563,0.00317953503575539,-0.0110015799053369,0.00146219743482427,0.133606859057539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,0.00773470119455259,0.00515777392174354,-0.00237453569206474,0.0178439380811699,0.133737078036375
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37562,-0.00485007585902699,0.00323489799909291,-0.0111904759372491,0.00149032421919512,0.133820439232157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,0.00412813639104964,0.00275631713695596,-0.00127424519738405,0.00953051797948332,0.134234559306208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.00929383680789267,0.00623607070047989,-0.00292886176504792,0.0215165353808333,0.136159855664835
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00805339922258894,0.00540829725105209,-0.018653661834651,0.00254686338947315,0.136489814826093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40471,0.00913911561680792,0.00613908657722187,-0.00289349407454695,0.0211717253081628,0.136592188658265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,0.00823448443960955,0.0055574737650353,-0.00265816413985964,0.0191271330190787,0.138441624124323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00528738609075728,0.00357506249143145,-0.0122945085739629,0.00171973639244837,0.139174159423998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERVV_1,,37562,-0.00668732468680453,0.00452535875179466,-0.0155570278403221,0.00218237846671299,0.139500160636058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00721804868976066,0.00488663670778347,-0.0167958566370163,0.00235975925749495,0.139672985068722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37671,-0.0071265127308886,0.00482956500129059,-0.0165924601334181,0.00233943467164095,0.140074754890148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,0.00522111732341047,0.00353962044114104,-0.00171653874122596,0.0121587733880469,0.140222395021511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,-0.00572735995617925,0.0038870499942015,-0.0133459779448142,0.00189125803245569,0.140650266786035
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,0.00916723461440538,0.00622525706888956,-0.00303426924061817,0.0213687384694289,0.140882531025605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,-0.00779808538755921,0.00529612830609641,-0.0181784968675082,0.00258232609238976,0.140933679245928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00496486783991242,0.00337241206853569,-0.00164505981441753,0.0115747954942424,0.140990383515515
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,0.0068655456717426,0.00466605590249395,-0.00227992389714553,0.0160110152406307,0.141208311762777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37598,-0.00814737958733833,0.00553787004261716,-0.019001604870868,0.0027068456961913,0.141257790876643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,0.0052746482923264,0.00361050790824337,-0.00180194720783061,0.0123512437924834,0.144061894382822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,0.00620833764902211,0.00424985106569098,-0.00212137043973222,0.0145380457377764,0.14408427530396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,0.00549801167928093,0.00377329545017846,-0.00189764740306887,0.0128936707616307,0.145116907153167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37628,-0.00928916595639277,0.00638649689646631,-0.0218066998734667,0.00322836796068119,0.145831284102137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,-0.00491657725137246,0.0033828049493767,-0.0115468749521508,0.00171372044940587,0.146135943862799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,0.00110160999711928,0.000761348935367496,-0.000390633916201015,0.00259385391043957,0.147943220125503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,37482,-0.00816587895390586,0.00564832864250161,-0.019236603093209,0.00290484518539729,0.148280932148293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.00645138127735529,0.00446430634818333,-0.00229865916508404,0.0152014217197946,0.148449284198554
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0128741712514784,0.00895142697638615,-0.0304189681251952,0.00467062562223848,0.150394076278721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37562,0.00808933879759986,0.00564826583907919,-0.00298126224699535,0.0191599398421951,0.152115880312081
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,-0.00873311348894027,0.00612648221908064,-0.0207410186383383,0.00327479166045779,0.1540416581971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,0.00959257456242715,0.00675495076125011,-0.00364712892962307,0.0228322780544774,0.155607248704128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,-0.00714006502646855,0.00503166488582456,-0.0170021282026847,0.0027219981497476,0.155914410747288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,0.00792271889649053,0.00559557872771647,-0.00304461540983374,0.0188900532028148,0.156831615940263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,37482,0.00972557802835021,0.00688308053330314,-0.00376525981692394,0.0232164158736244,0.157688784472763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,40172,0.00928725692286916,0.00657371817659511,-0.00359723070325725,0.0221717445489956,0.157738457438028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,-0.00654930161168727,0.00463734529215053,-0.0156384983843023,0.00253989516092777,0.157886724732665
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,0.0042956421412011,0.00305375112764683,-0.00168971006898668,0.0102809943513889,0.159543161425852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,0.00793137693302047,0.00564774451913642,-0.00313820232448691,0.0190009561905278,0.160240067422238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,40355,-0.0241889301166604,0.0172333048935797,-0.0579662077080766,0.00958834747475573,0.160452967617304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,37482,-0.0123171764784568,0.00883786785286779,-0.0296393974700777,0.00500504451316406,0.16343745269413
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,40044,0.00774216611240764,0.00556891341514244,-0.00317290418127153,0.0186572364060868,0.164473679075723
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,37541,-0.0102986377634483,0.00742626698076285,-0.0248541210457435,0.00425684551884689,0.165530862376551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,-0.00723953665556413,0.00522159686376675,-0.017473866508547,0.00299479319741871,0.165625853559297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,-0.00246742685231683,0.00178065163505347,-0.00595750405702163,0.00102265035238796,0.165865110267454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,-0.0052089567940277,0.00376161417225187,-0.0125817205716414,0.00216380698358597,0.166143838077762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,0.012481898188983,0.00904685607121761,-0.00524993971060348,0.0302137360885695,0.167704236231488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCIN,Adseverin,37541,0.00947877300414405,0.00689314133673932,-0.00403178401586502,0.0229893300241531,0.169123334795527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37598,0.00538289451099267,0.00392026761548363,-0.00230083001535525,0.0130666190373406,0.169746658897642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7,Complement component C7,37678,-0.00403780734701933,0.0029564991468233,-0.00983254567479301,0.00175693098075434,0.172043999750783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.00499552327298054,0.00366119885971171,-0.00218042649205442,0.0121714730380155,0.172449294352604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,0.0335690322474597,0.0246283645219815,-0.014702562215624,0.0818406267105433,0.172898490597893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.00337215741184117,0.00247468674950335,-0.00822254344086774,0.0014782286171854,0.173013142274576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00719155826229288,0.00527991089727465,-0.00315706709636542,0.0175401836209512,0.173201524291621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40471,-0.00393527213074053,0.0028899184144788,-0.00959951222311897,0.00172896796163791,0.173304059462379
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.00705885497125103,0.00519569866878216,-0.00312471441956199,0.0172424243620641,0.174298046467989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,37457,0.00447367714149503,0.00329495425598706,-0.0019844332002396,0.0109317874832297,0.174571110199462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,40359,-0.0150145676498644,0.0110736627638179,-0.0367189466669474,0.00668981136721856,0.175156318407725
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.00641537056713515,0.00474193911718614,-0.01570957123682,0.00287883010254968,0.176110565804637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39961,-0.0041765297763632,0.00308985521654258,-0.0102326460007867,0.00187958644806025,0.176493868790462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37697,-0.0124791005619893,0.00923500343519522,-0.030579707294972,0.00562150617099331,0.176627964866587
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAT,Catalase,37786,0.00687120696816372,0.00510337298511515,-0.00313140408266197,0.0168738180189894,0.178194821848124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00341287557776287,0.00253814434647168,-0.00156188734132162,0.00838763849684736,0.17876297039372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGN,Cingulin,37572,0.0052949980228213,0.00393834044674419,-0.00242414925279732,0.0130141452984399,0.178818263865818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,-0.00906572846330312,0.00674399102351694,-0.0222839508693963,0.00415249394279007,0.178880912708145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,40359,-0.00567669696270168,0.00422970663662262,-0.013966921970482,0.00261352804507866,0.179582140003089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37934,-0.00586376107035259,0.0043708334021447,-0.0144305945385562,0.00270307239785102,0.179759383391434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,-0.0037305887910119,0.00278245092240238,-0.00918419259892057,0.00172301501689676,0.180022779664118
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,40359,0.00987854865821669,0.00737351273471605,-0.00457353630182677,0.0243306336182602,0.180350848320752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,37482,-0.00530599643106164,0.00396657841396825,-0.0130804901224394,0.00246849726031614,0.181025450538609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37900,0.00503383545011071,0.00376552843382728,-0.00234660028019075,0.0124142711804122,0.181303863208739
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37901,0.0324714886137105,0.0243111201974182,-0.015178306973229,0.0801212842006501,0.181681716100327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAG,S-arrestin,37541,-0.00668170134694092,0.00501188497718147,-0.0165049959022166,0.00314159320833477,0.182498788983284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00357608562680705,0.00268500883171456,-0.0016865316833535,0.00883870293696759,0.182922685907348
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00879621068327793,0.00660673401501237,-0.0217454093527022,0.00415298798614631,0.183080329595665
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37572,-0.00743171525030266,0.00559829968022801,-0.0184043826235496,0.00354095212294423,0.184368065805621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,-0.00517431129456978,0.00390159368590848,-0.0128214349189504,0.00247281232981083,0.184795198387923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,37541,-0.00789323542681302,0.00595368729254893,-0.0195624625202089,0.00377599166658289,0.184938171236466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,0.00434326172890174,0.00327897757058324,-0.0020835343094414,0.0107700577672449,0.185330552464332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,0.00738025000117866,0.00557933433664742,-0.00355524529865028,0.0183157453010076,0.185930277555444
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00973677880946564,0.00737648439385895,-0.0241946882214292,0.00472113060249789,0.18686627583711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0035268188673451,0.00267649763215431,-0.00171911649167735,0.00877275422636754,0.187627263073317
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,-0.00690413207819025,0.0052440249938494,-0.0171824210661351,0.00337415690975457,0.188001865817743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,-0.00490622941937621,0.00373065790868809,-0.0122183189204049,0.00240586008165244,0.188494938879275
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37942,-0.00285386192363574,0.00217167641704213,-0.00711034770103833,0.00140262385376684,0.188825301397621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.00703855417264718,0.00535886855238278,-0.00346482819002307,0.0175419365353174,0.189054120195889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,0.00757396878758382,0.00577231290473579,-0.00373976450569833,0.018887702080866,0.189502142173077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,-0.0173778683051237,0.0132773662499177,-0.0434015061549624,0.00864576954471495,0.190613671660011
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,-0.0148301265540047,0.0113443784288317,-0.0370651082745148,0.00740485516650534,0.191141553940819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.00716272085590927,0.00550002050269837,-0.00361731932937953,0.0179427610411981,0.192830347153347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,-0.00406198116584514,0.00312163168420022,-0.0101803792668776,0.0020564169351873,0.193199651119502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00598993842601088,0.00460591305478066,-0.015017528013381,0.00303765116135921,0.193456346262768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,-0.00439185029660715,0.00337971039791568,-0.0110160826765219,0.00223238208330759,0.193803685783688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.00588712583119885,0.0045429674965868,-0.00301709046211128,0.014791342124509,0.195040103221518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,38013,-0.00910001090030426,0.00702241777836491,-0.0228639497458995,0.00466392794529096,0.195048691959016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,-0.00546761714792546,0.0042265961485219,-0.0137517455990284,0.00281651130317747,0.195818599552945
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.00951559118673695,0.00741098091238661,-0.00500993140154081,0.0240411137750147,0.199169188012034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,0.00263001359737587,0.00205461539221067,-0.00139703257135705,0.00665705976610879,0.200545740534539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,37541,-0.00608465863899875,0.00475506965914836,-0.0154045951709295,0.00323527789293204,0.200703239704521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,37541,0.00777289486749196,0.00607924621659206,-0.00414242771702847,0.0196882174520124,0.201062320764771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,40387,-0.00363271405481827,0.0028436814867582,-0.00920632976886435,0.0019409016592278,0.201455439856844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,0.00724301958487676,0.00567121799000538,-0.00387256767553378,0.0183586068452873,0.201566321077976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37900,-0.00548038644666103,0.0042937424388531,-0.0138961216268131,0.00293534873349105,0.201848244929788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,-0.00395373864314693,0.00309878855919333,-0.0100273642191658,0.002119886932872,0.20201060384339
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-0.00604206919534361,0.00474032639582415,-0.015333108931159,0.00324897054047173,0.20246981111984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,0.0101173446956243,0.00796994757377044,-0.00550375254896574,0.0257384419402144,0.20430728789271
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,37482,-0.00850386133988256,0.00672159944772568,-0.0216781962574249,0.00467047357765977,0.205838597636149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00400869285076467,0.00318056383677193,-0.0102425979708377,0.00222521226930832,0.207557751306618
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37562,-0.00620958353449443,0.00493194006802764,-0.0158761860678286,0.00345701899883974,0.208032903709255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,0.00555027323671108,0.00443598347625284,-0.00314425437674449,0.0142448008501666,0.210886253082138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.00482931428050427,0.00386261762742563,-0.0124000448302585,0.00274141626924996,0.211223055901433
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFD,Complement factor D,38013,0.0022296609193625,0.00178397859856462,-0.00126693713382415,0.00572625897254915,0.211385077220349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.00867010444560139,0.00694188950412315,-0.00493599898247999,0.0222762078736828,0.211703744504816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00497382824682299,0.00399091340938346,-0.0127960185292146,0.0028483620355686,0.212680321415476
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37598,0.00196560442720988,0.0015793630445348,-0.00112994714007832,0.00506115599449808,0.213317498663216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,38013,-0.00231890052895132,0.00186447035880129,-0.00597326243220185,0.00133546137429921,0.213619894876785
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,40305,0.00479415980089182,0.00386242943953334,-0.00277620190059352,0.0123645215023772,0.214539495055734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,0.00741977043794877,0.00597957267407003,-0.00430019200322849,0.019139732879126,0.214678373378818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00826042661268927,0.00666189006498903,-0.0213177311400678,0.00479687791468924,0.215015227215152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,0.0126707724180746,0.0102270365657382,-0.00737421925077224,0.0327157640869215,0.215382874322367
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.00832339821891478,0.00672289812897324,-0.00485348211387278,0.0215002785517023,0.215713140346659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39961,0.00452393269862498,0.00366391567037478,-0.00265734201530959,0.0117052074125596,0.216951125421653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.00847185209667364,0.00686453491586678,-0.00498263633842524,0.0219263405317725,0.217165903846538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37671,0.00413885810514153,0.00336178176176406,-0.00245023414791603,0.0107279503581991,0.218288616879771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00739651104964802,0.00602020118344123,-0.0191961053691928,0.00440308326989679,0.219238280256628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40497,0.00343147560239423,0.00279453056650972,-0.00204580430796482,0.00890875551275328,0.219492914052688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,-0.0059884573464515,0.00488898706535607,-0.0155708719945494,0.00359395730164641,0.220639891808239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.011791286673119,0.00963774253882294,-0.00709868870297399,0.0306812620492119,0.221178303756227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0101738752323208,0.00832803830882093,-0.00614907985296826,0.0264968303176098,0.22186510285982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESPL1,Separin,37482,-0.00656879064587728,0.00537799889309436,-0.0171096684763422,0.00397208718458767,0.22194947204642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00445162920108128,0.00364520942481444,-0.0115962396737176,0.00269298127155503,0.222021938184607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37900,0.00889116655298602,0.00728195887018846,-0.00538147283258337,0.0231638059385554,0.222112897328859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.0135896384080764,0.0111373881000062,-0.00823964226793568,0.0354189190840885,0.222414068810401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37900,0.00600704225117098,0.00492968901850102,-0.00365514822509103,0.015669232727433,0.223038746553899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,-0.00766027317324165,0.0062904024084209,-0.0199894618937466,0.00466891554726331,0.223332710615139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,-0.00753254342953264,0.0061970737285933,-0.0196788079375755,0.00461372107851022,0.224193669563889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,0.00601718569534657,0.00495104662427111,-0.0036868656882248,0.0157212370789179,0.224259797787685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,0.00502024684922621,0.0041331347496722,-0.00308069726013131,0.0131211909585837,0.2245241064026
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-0.00861225097783,0.00709425668062901,-0.0225169940718628,0.00529249211620285,0.224779135272385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,0.00526970252952494,0.0043476115319664,-0.00325161607312921,0.0137910211321791,0.225498990519089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,37541,-0.00662990362717763,0.00547041649131423,-0.0173519199501535,0.00409211269579826,0.225551133375181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,-0.00731877250551935,0.00604738214015453,-0.0191716415002222,0.00453409648918354,0.226209097006107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37998,-0.00589146959952256,0.00487433452308959,-0.0154451652647782,0.00366222606573305,0.226810142738152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,40044,0.00437734770227877,0.00362190127971626,-0.0027215788059651,0.0114762742105226,0.226843606416422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,37541,-0.00530732902279498,0.00439292927248787,-0.0139174703968712,0.00330281235128126,0.227010388845163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,0.00881576680601106,0.00730487447372904,-0.00550178716249785,0.02313332077452,0.227514678511781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.00713391933951305,0.0059173534877607,-0.00446409349649792,0.018731932175524,0.227996078255841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,-0.00299557097520681,0.0024919959733506,-0.00787988308297399,0.00188874113256037,0.229351579178014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,40341,-0.00997364762201245,0.00829714113554064,-0.0262360442476721,0.00628874900364722,0.229358843770434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0160143099779246,0.0133381001831811,-0.0101283663811104,0.0421569863369595,0.229907662313733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,-0.00788305120231946,0.00656739022999861,-0.0207551360531167,0.0049890336484778,0.230027954241802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00727635849868845,0.00607443838531074,-0.0046295407365206,0.0191822577338975,0.230990601518568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.00546839350077178,0.00456947996154245,-0.00348778722385143,0.014424574225395,0.231436885011815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,-0.00422009463177135,0.00353401867136653,-0.0111467712276497,0.00270658196410704,0.232446605425601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,40044,0.00360865668710671,0.00304223611016157,-0.00235412608880997,0.00957143946302339,0.235567083661463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.00971844732467173,0.00821648409899079,-0.00638586150935022,0.0258227561586937,0.236910297222008
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37562,-0.00821325503498728,0.00695077142110282,-0.0218367670203488,0.00541025695037425,0.237373121190732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.00802047347944405,0.00679434742083527,-0.00529644746539308,0.0213373944242812,0.237837037760229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37572,0.00851197354929456,0.00721393026620589,-0.00562732977246898,0.0226512768710581,0.238047200083608
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,-0.00407173085549782,0.00345619884614522,-0.0108458805939425,0.00270241888294682,0.238779980085014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37900,0.00491686317073405,0.00417374696794299,-0.00326368088643422,0.0130974072279023,0.23879937649942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.00244442356438125,0.00207537820882549,-0.00651216485367921,0.0016233177249167,0.238888840360719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37934,0.00347694129509194,0.00295356141977011,-0.00231203908765747,0.00926592167784135,0.239135282493788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,37541,-0.00546452345929886,0.00464953379420114,-0.0145776096959331,0.00364856277733538,0.23990242458924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37572,0.00344276666996306,0.00293062665067732,-0.0023012615653645,0.00918679490529061,0.240114292774255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,40044,-0.00331371902696498,0.00282329155199837,-0.00884737046888178,0.00221993241495181,0.240530053817677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.00447119270443388,0.00381037280800059,-0.00299713799924727,0.011939523408115,0.240646104265941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,-0.00308045349351741,0.00263023895620711,-0.00823572184768334,0.00207481486064853,0.241552208234481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00963012280255406,0.00823029809906473,-0.00650126147161282,0.0257615070767209,0.241985603304602
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,40042,0.00417396497326637,0.00357116424038783,-0.00282551693789378,0.0111734468844265,0.242503422171382
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.00231067353129373,0.00197829708440334,-0.00156678875413681,0.00618813581672428,0.242819735172192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39980,-0.00338995429290559,0.00290516418451405,-0.00908407609455313,0.00230416750874195,0.243280046661926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,-0.00620166659699516,0.00532294786808474,-0.0166346444184413,0.00423131122445092,0.244007350192818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39946,0.00614692207691939,0.00527675511031089,-0.00419551793928996,0.0164893620931287,0.244075102721908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39602,0.00304871140750969,0.00261886964958332,-0.00208427310567361,0.00818169592069299,0.244388630828902
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,0.00662846678939962,0.00569546221579511,-0.00453463915355879,0.017791572732358,0.244516419838273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,40372,0.00274509233618364,0.00236162886687228,-0.00188370024288603,0.00737388491525331,0.245101632731923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,40419,-0.00362503984123148,0.00312842899789627,-0.00975676067710818,0.00250668099464522,0.246578986103438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.00668620639846123,0.00578832875741606,-0.00465891796607426,0.0180313307629967,0.248062844362557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00687903780064207,0.0059571844352063,-0.0185551192936464,0.00479704369236229,0.248215433279957
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.00281811250309796,0.00244299980969982,-0.0076063921301096,0.00197016712391368,0.248707298594911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,-0.00566244324492751,0.00491325830357364,-0.0152924295199318,0.00396754303007681,0.24914395173177
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,0.00912855001852,0.00793550668436861,-0.00642504308284248,0.0246821431198825,0.250020507237912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,-0.00366138583719261,0.00318644700645741,-0.00990682196984914,0.00258405029546392,0.25055646861288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCLN,Nicalin,40044,0.00574633888925605,0.00500187739356615,-0.0040573408021336,0.0155500185806457,0.250641064303783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37598,-0.0112315243960417,0.00982652849234212,-0.0304915202410322,0.00802847144894889,0.25306775782719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,-0.0052190152075345,0.00456889106872566,-0.0141740417022368,0.0037360112871678,0.253353009234529
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37990,-0.00276257745669245,0.00241884676201638,-0.00750351711024455,0.00197836219685965,0.253430494852846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00440896214357283,0.0038770399055679,-0.0120079603584859,0.00319003607134025,0.25547627851058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37643,0.00884285659881183,0.00777770597333302,-0.00640144710892089,0.0240871603065445,0.255580174675909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37900,-0.00292519091297883,0.00258830107521183,-0.00799826102039402,0.00214787919443635,0.258429525897405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,-0.00466358792619081,0.00412843198892178,-0.0127553146244775,0.00342813877209589,0.258650495064682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,-0.00583299156688751,0.00517009840866001,-0.0159663844478611,0.00430040131408611,0.259245239501388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37942,0.00724353309615937,0.00642959015125224,-0.00535846360029502,0.0198455297926138,0.259934519018929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39802,-0.00277161311763545,0.00246034984071996,-0.00759389880544658,0.00205067257017568,0.259966561082928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.00938177177662554,0.0083431758304899,-0.00697085285113467,0.0257343964043858,0.260828263144439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,-0.00236871649317249,0.00210940575119131,-0.00650315176550746,0.00176571877916248,0.261483930120681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37562,-0.00452593011321927,0.00403084626846338,-0.0124263887994075,0.00337452857296895,0.261532898368491
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.00318614212914029,0.00283857776286549,-0.00237747028607608,0.00874975454435665,0.26169144831351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,-0.00786928210393781,0.00702006439056542,-0.021628608309446,0.00589004410157041,0.262321166538742
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,40017,-0.00585758265559754,0.00523120364434617,-0.016110741798516,0.00439557648732095,0.262842285217351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00309544166548274,0.00276665208323153,-0.00232719641765106,0.00851807974861654,0.263228787391984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.00859942159184604,0.0076906731428809,-0.00647429776820052,0.0236731409518926,0.263514542111047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.00465865906873783,0.00418004342203604,-0.0035342260384528,0.0128515441759285,0.265085050060402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37562,-0.00469641596782604,0.00422462381377177,-0.0129766786428187,0.00358384670716664,0.266297556239812
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37981,-0.0023221876635212,0.00209197415081417,-0.00642245699911697,0.00177808167207457,0.266998908304497
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,0.00371566133259274,0.00335681860757533,-0.00286370313825492,0.0102950258034404,0.268354113785004
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,0.00391593831373257,0.00353868693597526,-0.00301988808077893,0.0108517647082441,0.26848016303711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,-0.00347988974465533,0.00315046923692283,-0.00965480944902408,0.00269502995971342,0.269366065268852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.00555454263098077,0.0050376005827011,-0.00431915451111338,0.0154282397730749,0.270213871059573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37714,0.00302899567035292,0.00276921323944376,-0.00239866227895685,0.00845665361966269,0.274057781975797
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,-0.00364790664410287,0.00333837328508799,-0.0101911182828753,0.0028953049946696,0.274533788564259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.0026639269119886,0.00243836500087211,-0.00744312231369793,0.00211526848972073,0.274630531477288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,-0.00531994488769963,0.00487220507060751,-0.0148694668260904,0.00422957705069109,0.274898551218033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,0.00466654658161973,0.00429002892310322,-0.00374191010766258,0.013075003270902,0.276715411055913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37824,0.00296347575631309,0.00273585883156153,-0.00239880755354751,0.00832575906617369,0.278740249900677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,40044,-0.00476234616016649,0.00440290162634406,-0.0133920333478009,0.00386734102746787,0.27943009520743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.00854598738592894,0.00790237299019769,-0.00694266367485853,0.0240346384467164,0.279518789027952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37572,0.00587576763535864,0.00543334021069989,-0.00477357917761314,0.0165251144483304,0.279526534274466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.00545824219972899,0.00504844149939768,-0.00443670313909046,0.0153531875385484,0.279639724745984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37901,0.0107909261434114,0.00998331779400135,-0.00877637673283122,0.0303582290196541,0.279762854591165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37721,0.00254638414939714,0.00236114200047683,-0.00208145417153745,0.00717422247033173,0.280850593220631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.00370733604929659,0.00345519309192863,-0.00306484241088352,0.0104795145094767,0.283301470923505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37572,-0.00376230585156051,0.00352791913779391,-0.0106770273616366,0.00315241565851555,0.286245465980786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37572,0.00608312899700336,0.00571696454920627,-0.00512212151944092,0.0172883795134476,0.287326197401621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.00460840136004442,0.00433103629647974,-0.00388042978105587,0.0130972325011447,0.287326482296453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,0.00323011133615392,0.00303706785401167,-0.00272254165770896,0.0091827643300168,0.287543498232374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37987,-0.00647236009637534,0.00609554150828144,-0.018419621452607,0.00547490125985628,0.288336933873342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,-0.00803206381214617,0.00758894470669563,-0.0229063954372696,0.00684226781297726,0.289897259220642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.00298641515273714,0.00282740408250803,-0.0025552968489786,0.00852812715445287,0.290875357724464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.0024612095904613,0.00233406422443791,-0.0070359754703596,0.002113556289437,0.291684853306447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37714,0.00226768367479132,0.00215552775662861,-0.00195715072820076,0.00649251807778341,0.292804143162204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37598,-0.00472233652131805,0.0045156401810478,-0.0135729912761717,0.00412831823353563,0.295684879227515
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,0.00599070872438575,0.0057292042400738,-0.0052385315861589,0.0172199490349304,0.295744165452295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00277492813720003,0.00265689205617574,-0.00243258029290441,0.00798243656730447,0.296306939775452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00478397206596007,0.00458796066374151,-0.0137763749668934,0.00420843083497328,0.297095833843169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.00846419689319718,0.00815011998690819,-0.00751003828114287,0.0244384320675372,0.299039033118676
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,0.00755760918486765,0.00728738167256743,-0.00672565889336453,0.0218408772630998,0.299716754681926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,-0.00322727206552378,0.00312273236149274,-0.00934782749404955,0.002893283363002,0.301399778785273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-0.00633918784704305,0.00615018541974873,-0.0183935512697505,0.00571517557566446,0.302685915650826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.00667098371975745,0.0064762968347463,-0.00602255807634531,0.0193645255158602,0.302996667740496
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37598,-0.00525103455622662,0.00510008669347748,-0.0152472044754425,0.00474513536298923,0.303218111617734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,0.00227402371902214,0.00221206594295331,-0.00206162552916634,0.00660967296721062,0.303963998277252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37572,-0.00378873854860957,0.00368601918075766,-0.0110133361428946,0.00343585904567544,0.304031206761043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.00372710522459267,0.00363340891896655,-0.00339437625658178,0.0108485867057671,0.305007440310266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,40341,0.00537924410982161,0.00525146338871097,-0.00491362413205188,0.0156721123516951,0.305693892715434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00493830233630766,0.00482174700182544,-0.0143889264598855,0.0045123217872702,0.305772692993122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37714,0.00423675719819361,0.00414748259125125,-0.00389230868065883,0.0123658230770461,0.307024399193623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37572,-0.00223597955102832,0.00219090871086836,-0.0065301606243303,0.00205820152227367,0.307476194342344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.0040674046259251,0.00398992823179068,-0.0118876639602348,0.00375285470838464,0.308022826629667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,-0.00278425709546683,0.00273669238128951,-0.00814817416279427,0.00257965997186061,0.308988304661999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.00411855125792046,0.00406527893158873,-0.0120864979638344,0.00384939544799344,0.311028606415749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37959,0.00361151318894799,0.00357654167112485,-0.00339850848645672,0.0106215348643527,0.312619738576635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,-0.00717978788132167,0.00711669397799571,-0.0211285080781933,0.00676893231554991,0.313057491511044
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.00520938928256103,0.00516671862418595,-0.00491737922084343,0.0153361577859655,0.31334839772992
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,0.00460833437295139,0.00457283505979364,-0.00435442234424414,0.0135710910901469,0.313583933322316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,-0.00460087971472902,0.0045812424178884,-0.0135801148537903,0.00437835542433225,0.315258628070393
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37562,-0.0103964161597971,0.0103574478583417,-0.0306970139621468,0.00990418164255267,0.315511703799246
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,0.00741128130377405,0.00740222486608743,-0.00709707943375732,0.0219196420413054,0.316737372389377
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37598,-0.00249164266426968,0.00249268602826999,-0.00737730727967885,0.00239402195113949,0.317531512066915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,-0.00344977943639133,0.00345293900513217,-0.0102175398864504,0.00331798101366772,0.317771432783765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37598,0.00442762112296094,0.00443906449389223,-0.00427294528506783,0.0131281875309897,0.318578016899468
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,-0.00250818625094274,0.00251567042212035,-0.00743890027829862,0.00242252777641313,0.318770245996078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40471,0.00277510627732592,0.00278485749681469,-0.00268321441643086,0.00823342697108271,0.319023054681789
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00879938090314249,0.00886912548793963,-0.0261828668595042,0.00858410505321917,0.321148916049202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,0.00619804834747429,0.00625420213239251,-0.00606018783201504,0.0184562845269636,0.321693391872897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00651692542228076,0.00657754199336608,-0.0194089077292783,0.00637505688471677,0.321809182814837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,0.00199425300214434,0.00201707399915238,-0.00195921203619434,0.00594771804048301,0.322834948023721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.00418104233339994,0.00423624813111263,-0.00412200400358082,0.0124840886703807,0.323676335260609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,-0.00773326218466629,0.00784551075920735,-0.0231104632727127,0.00764393890338011,0.324302140800556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39961,0.00446210904230812,0.00453093453276515,-0.00441852264191157,0.0133427407265278,0.324732835158378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,-0.00640586976623365,0.0065136520704254,-0.0191726278242674,0.00636088829180013,0.32540254530721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.00424928920359164,0.00432230418243274,-0.00422242699397653,0.0127210054011598,0.325572636664076
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.00268854943540106,0.00273689454207707,-0.00267576386706999,0.00805286273787211,0.325952691941194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,40279,0.00659085849708593,0.00671387758074801,-0.00656834156118016,0.019750058555352,0.32627405720287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.00236823839053022,0.00243218423026092,-0.00239884270078118,0.00713531948184162,0.330218821934552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,40044,-0.00293492217043446,0.00301952762955582,-0.00885319632436387,0.00298335198349495,0.331075295465703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,40042,0.00444230495939037,0.00457343944795151,-0.00452163635859459,0.0134062462773753,0.331400565365366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,-0.00398526049322272,0.00411582842491824,-0.0120522842060625,0.00408176321961704,0.332923644323263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.00940574953885561,0.00973144378006451,-0.00966788027007083,0.028479379347782,0.333795975115297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,-0.00662486413667283,0.00685599437879759,-0.0200626131191161,0.00681288484577045,0.333918012035418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.00421651396216709,0.00438575706295209,-0.004379569881219,0.0128125978055532,0.336360460283293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,-0.00201071129242517,0.00209229919204871,-0.00611161770884063,0.0020901951239903,0.336563978164347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.00611950812775685,0.00639264026947783,-0.00641006680041971,0.0186490830559334,0.338446198711918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.00559534406814472,0.00585394912815256,-0.0170690843593237,0.00587839622303429,0.339178823535546
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.00483910355612984,0.00506731694473568,-0.0050928376555521,0.0147710447678118,0.339613184369949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,0.00706288212396967,0.0074173815617975,-0.00747518573715343,0.0216009499850928,0.341006468201292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,40228,-0.00315223907357878,0.00331274238275093,-0.0096452141437706,0.00334073599661305,0.341339971228262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00593476113102628,0.00625505731774177,-0.00632515121174759,0.0181946734738001,0.342742888503734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00399844090158911,0.00421683571354849,-0.00426655709696593,0.0122634389001441,0.343040424979221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,-0.00222631379810656,0.00234874852956422,-0.00682986091605243,0.00237723331983932,0.343211330666422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,0.00230904715426124,0.00244506113461424,-0.00248327266958267,0.00710136697810515,0.344993812844575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37937,-0.00205924977933005,0.00218290644822005,-0.00633774641784134,0.00221924685918124,0.345517642399871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,40455,0.00385568760201968,0.00408879618787529,-0.00415835292621589,0.0118697281302553,0.345701043317648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,40305,0.00247865677455746,0.00263268232215273,-0.0026814005768619,0.00763871412597681,0.346465687612952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37572,0.00538072315241398,0.00571581171136149,-0.00582226780185454,0.0165837141066825,0.346529971704169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00233432964223805,0.00248508178716927,-0.00253643066061373,0.00720508994508982,0.347575082893684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37998,-0.00793892334532025,0.00847189524497241,-0.0245438380254662,0.00866599133482568,0.348729273070414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,37541,-0.0048026187484462,0.0051452375361336,-0.0148872843192681,0.00528204682237565,0.350625278325349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_DRA,,40288,0.00312996007542829,0.00336920028835174,-0.00347367248974112,0.0097335926405977,0.352907398001732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37959,-0.00185321731776729,0.00199615853478673,-0.00576568804594929,0.0020592534104147,0.353220933704253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,-0.00741434493110284,0.00803347190509705,-0.0231599498650931,0.00833126000288738,0.356059873546869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,0.00554420601494854,0.00601483297604879,-0.00624486661810709,0.0173332786480042,0.356673134668912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,0.00467778730886534,0.00509398543388288,-0.00530642414154511,0.0146619987592758,0.358480532590995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0035048200283138,0.00382226427584919,-0.0109964580089782,0.00398681795235061,0.359186421527956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.00338378577069886,0.0036923881406675,-0.00385329498500943,0.0106208665264072,0.359461921788269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.00972500805247204,0.0106605293831607,-0.0306196456434669,0.0111696295385229,0.361656365857719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37562,-0.00426059899026971,0.00469465714575866,-0.0134621269959567,0.00494092901541725,0.364136879599084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37562,-0.00554252257859619,0.00612643543240784,-0.0175503360261156,0.00646529086892317,0.365646463069479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.00411354563359769,0.00455309067479474,-0.0130376033561954,0.004810512089,0.366297204484981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.00240462160117502,0.0026644898758333,-0.00762702175780829,0.00281777855545824,0.366821030770725
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37562,-0.00400444648883587,0.00444416736561894,-0.012715014525449,0.00470612154777725,0.367574760610853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40471,0.00217466832782418,0.00242438207378401,-0.00257712053679248,0.00692645719244084,0.369732923737304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,-0.00232916311253826,0.00261439024047647,-0.00745336798387214,0.00279504175879561,0.372995649012654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.00260575090076696,0.00293169275068317,-0.00314036689057206,0.00835186869210597,0.37411507709982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00615757915930001,0.00693095762564066,-0.00742709778695569,0.0197422561055557,0.37433292019032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37562,0.00389718366873724,0.00439534392603158,-0.00471769042628466,0.0125120577637591,0.375277261242741
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,0.00308964727063261,0.00349221990459029,-0.00375510374236436,0.00993439828362957,0.376319497028261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,0.00648578348767687,0.00733453530018833,-0.00788990570069226,0.020861472676046,0.37656127936282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_A,,37959,-0.002692024859429,0.00306064185467686,-0.00869088289459564,0.00330683317573765,0.379112175672085
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.00928962831712932,0.0105792399473755,-0.0114456819797266,0.0300249386139852,0.379905256476717
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,0.00436715275653721,0.0049975686140331,-0.00542808172696767,0.0141623872400421,0.382212781352733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,0.0050947747837964,0.00584361901510296,-0.0063587184858054,0.0165482680533982,0.383304826180963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,37482,0.00582462913349482,0.00669302016965273,-0.00729369039902453,0.0189429486660142,0.384177515690238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37562,0.00443917159965479,0.00511412969027769,-0.00558452259328949,0.0144628657925991,0.385398764484668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37959,-0.00303290896471126,0.00350581477899439,-0.00990430593154027,0.00383848800211774,0.3869947919414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00314060383309998,0.00364033305183903,-0.0102756566147045,0.00399444894850451,0.388304830358531
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00543334858315364,0.00630365312271487,-0.0177885087036748,0.00692181153736749,0.388738057675108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.00736516537348183,0.00857769651097112,-0.0241774505349852,0.00944711978802156,0.390551340461989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,0.00438967265155693,0.00512769658171529,-0.00566061264860504,0.0144399579517189,0.391973727544443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.00977255065372693,0.0114405707421432,-0.0126509680008737,0.0321960693083275,0.39300632895498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.00810900937773885,0.00952683184664343,-0.02678159979716,0.0105635810416823,0.394687199800187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.00564829596152872,0.0066622298527098,-0.00740967454978249,0.0187062664728399,0.396559598088091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37572,-0.00476742409216405,0.00562888787030277,-0.0158000443179575,0.00626519613362938,0.397034725410204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00442103590725869,0.00522554354460435,-0.00582102944016584,0.0146631012546832,0.397543900590436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37598,-0.00820537426795578,0.009699643700517,-0.0272166759209691,0.0108059273850575,0.397598296781618
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,-0.00219980812675117,0.00261805765011915,-0.0073312011209847,0.00293158486748236,0.400784030096468
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,0.00153964544300511,0.00183378239630885,-0.00205456805376024,0.00513385893977045,0.401146966985834
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,-0.00501596747803073,0.00597556543501877,-0.0167280757306675,0.00669614077460606,0.401252975533781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.00685720358170541,0.00817219639294933,-0.0228747085118861,0.00916030134847527,0.401434066489185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,37541,-0.00286525390918752,0.00342056591269255,-0.00956956309806491,0.00383905527968987,0.402239826139397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.00397047759688302,0.00474537115480633,-0.0132714050603034,0.00533044986653737,0.402773298471416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,40044,0.00347013241577622,0.00415458119032157,-0.00467284671725406,0.0116131115488065,0.403587257626337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37671,0.00264650180951195,0.0031708495097717,-0.00356836322964058,0.00886136684866447,0.403938362785566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00473952958361213,0.00569201827194809,-0.0158958853966304,0.00641682622940612,0.405050324880367
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,-0.00381042640040274,0.00459016358992458,-0.0128071470366549,0.00518629423584943,0.406478510589414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.00422653676643155,0.00509370844388331,-0.0142102053164428,0.00575713178357974,0.406691704907032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,40359,0.00310593190700585,0.00374431837520611,-0.00423293210839812,0.0104447959224098,0.406830991079199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,-0.00677268080122333,0.00821930442470042,-0.0228825174736361,0.00933715587118949,0.409956383990064
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00625795809696764,0.0075971110983252,-0.00863237965574974,0.021148295849685,0.41010642122136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,-0.00448268696285122,0.00545261276082451,-0.0151698079740673,0.00620443404836482,0.411022461952623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37714,-0.00656292626285458,0.00799330577850912,-0.0222298055887325,0.0091039530630233,0.411630939828708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.00212171424485626,0.00258618776602365,-0.00294721377655009,0.0071906422662626,0.411999445907019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,37482,-0.00346265664351411,0.00422885062245578,-0.0117512038635274,0.00482589057649921,0.412905553683472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,40299,-0.00604757556266838,0.00740774618952456,-0.0205667580941365,0.00847160696879977,0.414292036915041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00248716858363389,0.00305311094414377,-0.00847126603415567,0.00349692886688789,0.415296617697097
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37714,0.0130423362738457,0.0160217751926656,-0.0183603431037788,0.0444450156514702,0.415637710485688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,0.00297919575228922,0.00367782355203464,-0.00422933840969868,0.0101877299142771,0.417930082553291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,0.00215043796905222,0.00266808981896858,-0.00307901807612621,0.00737989401423064,0.420266596541638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.00290243811235385,0.00360401894439911,-0.0099663152433761,0.0041614390186684,0.420641736550154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,-0.00458170727090179,0.00569399814320114,-0.015741943631576,0.00657852908977245,0.421033085240783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39961,0.00420636384767067,0.00526131259149744,-0.00610580883166432,0.0145185365270057,0.424018912782409
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.00501772634034553,0.00631262060069428,-0.00735501003701526,0.0173904627177063,0.426702143865094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,-0.00269898775926805,0.00339909738932862,-0.00936121864235215,0.00396324312381605,0.427191878187212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,40341,-0.00436553935069825,0.00552582157790233,-0.0151961496433868,0.00646507094199033,0.429524730101734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,0.00474905555216796,0.00605056565835552,-0.00711005313820885,0.0166081642425448,0.432529586061211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,40042,0.00203417892709734,0.00259273476901343,-0.00304758122016898,0.00711593907436366,0.432718322710155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0053806966741659,0.00685883057041008,-0.00806261124383785,0.0188240045921697,0.432765289413835
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.00328261866482912,0.00420836402757017,-0.0049657748292084,0.0115310121588666,0.435389272026646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,37410,0.00319837198429793,0.00411763375708588,-0.00487219017959038,0.0112689341481863,0.437320464922107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0024814196211002,0.00322600856503055,-0.00384155716635967,0.00880439640856007,0.441790874706303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,0.00343802227846455,0.00448044276355445,-0.00534364553810218,0.0122196900950313,0.442893299898278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,-0.0036578871289308,0.00481238442835096,-0.0130901606084987,0.00577438635063709,0.447207146285623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.00279558306657476,0.00367892245025295,-0.0100062710690705,0.00441510493592101,0.447332906984769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,0.0043993254390422,0.00580438515227831,-0.00697726945942328,0.0157759203375077,0.448505366095553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.00231385484341786,0.00305448361290606,-0.00830064272471374,0.00367293303787802,0.448747630251732
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.00408724248473577,0.00541213571445074,-0.0146950284850592,0.00652054351558768,0.450140483365225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,-0.00412457750809806,0.00548648822227065,-0.0148780944237485,0.00662893940755242,0.452202816481468
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,-0.00401370681884237,0.00534219955599411,-0.0144844179485908,0.00645700431090609,0.452470634709282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-0.00232432257754195,0.00309472680135582,-0.00838998710819935,0.00374134195311545,0.452630218811231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40489,-0.00418269667231213,0.00558350006838211,-0.0151263568063411,0.00676096346171681,0.453797477080367
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.00263120070092221,0.00352461434334925,-0.00953944481388674,0.00427704341204232,0.455365714468287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37874,-0.00397000357385809,0.00532506429513856,-0.0144071295923297,0.00646712244461349,0.455963485413487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,40228,0.0030131866808738,0.0040521851137604,-0.0049290961420966,0.0109554695038442,0.457132290609042
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,0.00297231412000817,0.00400321711229921,-0.00487399142009829,0.0108186196601146,0.457808972129455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.00569164817015928,0.00770257038061263,-0.02078868611616,0.00940538977584147,0.459963358529639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,-0.00327034222036358,0.00443055849533855,-0.0119542368712271,0.00541355243049998,0.460444337338532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,37482,-0.00291686682856453,0.00395345458871211,-0.0106656378224403,0.0048319041653112,0.460648044895001
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37900,-0.00244048572012391,0.00331125733245427,-0.00893055009173428,0.00404957865148646,0.461118850047322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,-0.00273042656354612,0.00371758838967232,-0.0100168998073039,0.00455604668021163,0.462678177137589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,-0.00432770100605995,0.00591772201898934,-0.0159264361632791,0.00727103415115915,0.464601535534906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00641440707292851,0.00878558294787496,-0.0108053355049064,0.0236341496507634,0.465338386609663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00285254076164148,0.00393516173799011,-0.00486037624481913,0.0105654577681021,0.468535048835666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00199595371666782,0.00275597051921127,-0.00340574850098627,0.00739765593432192,0.468938058177402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.00416023646670133,0.00578258991076925,-0.0154941126918091,0.00717363975840641,0.471879578048153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,40227,-0.00354386807115043,0.00493361361553815,-0.0132137507576052,0.00612601461530435,0.472576294649233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,-0.00333432184039217,0.00464351099787613,-0.0124356033962294,0.00576695971544505,0.472732798491398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00341671584580795,0.0047766262092946,-0.0127789032160254,0.00594547152440947,0.474437058097523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNLY,Granulysin,40332,-0.00338957036427232,0.00474592296237031,-0.0126915793705181,0.00591243864197348,0.47510982161786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37714,-0.00286055457288932,0.00401974759735696,-0.010739259863709,0.00501815071793031,0.476709278359645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,0.00488151983563122,0.00686026417921006,-0.0085645979556205,0.0183276376268829,0.476745022160269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40536,0.00266511313422024,0.00375985308179466,-0.00470419890609729,0.0100344251745378,0.478437532663434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37598,-0.00324459371349413,0.00459953611106852,-0.0122596844911884,0.00577049706420017,0.480562894742698
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.00229969327362038,0.00326028383884372,-0.00868984959775407,0.00409046305051331,0.48059274318403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,0.00192751873864934,0.00273635921363364,-0.0034357453200726,0.00729078279737128,0.481187732866663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.00414176230013679,0.00588283555418246,-0.0156721199863344,0.00738859538606083,0.481419040884489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,0.00707475073340494,0.0100809030436448,-0.0126838192321389,0.0268333206989488,0.482817994752754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,-0.00595566519146263,0.00850010830350917,-0.0226158774663406,0.0107045470834153,0.483529254942347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,40203,-0.00204757057987846,0.00292498006127027,-0.00778053149996819,0.00368539034021126,0.483919594062155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00268040794108039,0.00383336718047937,-0.01019380761482,0.00483299173265917,0.484420142842929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,-0.0058492095683707,0.00836813407412279,-0.0222507523536514,0.01055233321691,0.484571174121491
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,-0.00827582496512838,0.0118512355437444,-0.0315042466308674,0.0149525967006107,0.48499440155957
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,-0.00241068316164018,0.00345704301992195,-0.00918648748068721,0.00436512115740684,0.485611666671523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00359633478658948,0.005169399157171,-0.0137283571346446,0.00653568756146568,0.486631040930898
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,-0.0032967075046158,0.00474595387627515,-0.0125987771021151,0.00600536209288348,0.487296215448736
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.00220906027164391,0.00319750287789296,-0.00405804536902629,0.00847616591231411,0.489657239940245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,-0.00304781767086209,0.00443787250731391,-0.0117460477851974,0.00565041244347318,0.492236955367815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00286072429867352,0.00418819541780746,-0.0110695873175761,0.00534813872022911,0.494590799407949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37900,0.00236797696731957,0.00347124783448447,-0.00443566878826999,0.00917162272290913,0.495143970145506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,-0.00162663812949132,0.0023938885326534,-0.00631865965349197,0.00306538339450934,0.496833460807707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,0.00193199970627047,0.00287971268882222,-0.00371223716382108,0.00757623657636202,0.502294124870627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37857,-0.00445847090019987,0.00669024649859727,-0.0175713540374505,0.00865441223705078,0.505158274502228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37671,0.00236908115922812,0.00357720568151067,-0.00464224197653279,0.00938040429498903,0.507808822119681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,40406,0.0024813872049516,0.00376620795494161,-0.00490038038673395,0.00986315479663715,0.509998007620726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40475,0.00133550757719904,0.00203340267345213,-0.00264996166276713,0.00532097681716522,0.511328855449692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37562,-0.00518560083672344,0.00795470221435275,-0.0207768171768548,0.0104056155034079,0.514482752559807
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,37541,-0.00702773463119077,0.0107964268188846,-0.0281887311962045,0.014133261933823,0.515102113344083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,0.0032579007333979,0.00502684737022923,-0.00659472011225139,0.0131105215790472,0.516931136296838
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37959,0.00414760105709859,0.00642056324742244,-0.00843670290784939,0.0167319050220466,0.518298681802668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.00374328563338565,0.00580479702375819,-0.0076341165331804,0.0151206877999517,0.519028745494831
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.00251264412881942,0.00393353297625984,-0.00519708050464987,0.0102223687622887,0.522979926866566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,-0.00259706512729711,0.00409042574599054,-0.0106142995894386,0.00542016933484435,0.525496203155583
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,40288,0.00644874254165822,0.0101572307435324,-0.0134594297156652,0.0263569147989816,0.525508155866459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.00539082184385719,0.00855141446348259,-0.0113699505045687,0.0221515941922831,0.528443066103942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,40379,0.00141031287067624,0.00225155777636234,-0.00300274037099394,0.00582336611234642,0.531079911616638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,40411,0.00213407036744026,0.00346175828828729,-0.00465097587760283,0.00891911661248334,0.537593114266483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,-0.00158954095313182,0.00258125567279275,-0.00664880207180561,0.00346972016554196,0.53803593127071
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.00345124370520826,0.00561486744255412,-0.0144563838926143,0.00755389648219781,0.538788856470205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,0.00408072561707833,0.00664457896720999,-0.00894264915865325,0.0171041003928099,0.539130976816979
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37942,0.00307444501457411,0.00502109313061531,-0.0067668975214319,0.0129157875505801,0.540345698486238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,0.00265247187715563,0.00436044282814534,-0.00589399606600924,0.0111989398203205,0.542995212539037
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.00204780119886371,0.0033738380580121,-0.00456492139484001,0.00866052379256742,0.543882956918822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,37482,-0.00663544331475139,0.0109578713344442,-0.028112871130262,0.0148419845007592,0.54482995898703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37598,-0.00171345045896666,0.00285441343294259,-0.00730810078753413,0.0038811998696008,0.54832925443238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,-0.00261708083647193,0.00436222962849802,-0.011167050908328,0.00593288923538419,0.548555599302375
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,-0.00519397453510388,0.00867631413944648,-0.022199550248419,0.0118116011782112,0.549424379099901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPGN,Epigen,37900,0.00274918758519594,0.00462613627531786,-0.00631803951442707,0.0118164146848189,0.552339574155481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.00661354508991382,0.0111864529190067,-0.0153119026313393,0.0285389928111669,0.55438978080239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,37429,0.00193493183039194,0.00327504670137872,-0.00448415970431035,0.00835402336509423,0.554657718515554
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.00299857991770227,0.00509914894571093,-0.0129929118512957,0.00699575201589116,0.556505583260945
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,-0.00383914882015908,0.00653008783503845,-0.0166381209768344,0.00895982333651629,0.556598189278534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,40044,-0.00280050958941057,0.00477758987224307,-0.012164585739007,0.00656356656018586,0.557765582937054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,40044,-0.00162176579807412,0.00277958611220947,-0.00706975457800469,0.00382622298185644,0.559594904135678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39961,0.00194707799185165,0.00333791785727636,-0.00459524100841001,0.00848939699211332,0.559685627743912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,-0.00316165584820083,0.00543439422921202,-0.0138130685374564,0.00748975684105473,0.560720730590051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.001719820822272,0.00297669370922798,-0.00411449884781485,0.00755414049235884,0.563432890469051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,-0.00269563228437313,0.00466694228700216,-0.0118428391668974,0.00645157459815111,0.563542883931079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.00293319927462266,0.00510875245400183,-0.0129463540844663,0.00707995553522093,0.565874944674127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,-0.00193431018521538,0.00338156263351443,-0.00856217294690366,0.0046935525764729,0.567318930048524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37562,-0.00387409730111634,0.0067868795581013,-0.0171763812349949,0.0094281866327622,0.568130378060961
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39980,-0.00452308891321391,0.00794523930621218,-0.0200957579533898,0.011049580126962,0.569172400513186
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.00206023129958286,0.00361905666358147,-0.00915358236020255,0.00503311976103683,0.569180315535901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00416830090313943,0.00732638716926941,-0.0101914179486286,0.0185280197549075,0.569404171851708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00179120022587504,0.00316147354947997,-0.00798768838285579,0.00440528793110571,0.571013624513915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.00156668720331,0.0027876925488264,-0.00389719019238974,0.00703056459900973,0.574123051353765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37598,0.00154656746439499,0.00277281129320563,-0.00388814267028804,0.00698127759907802,0.577016734073581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,40236,0.00359950483265953,0.00647793437722068,-0.00909724654669299,0.016296256212012,0.578453734125052
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,-0.00377825929685493,0.00679968541345815,-0.0171056427072329,0.00954912411352305,0.578458200521054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40489,0.00130105250210148,0.00235136804382116,-0.003307628863788,0.00590973386799095,0.580053903702064
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.00151701422404489,0.00274676640213544,-0.00386664792414058,0.00690067637223036,0.5807567362664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00255129175184422,0.00464606857293109,-0.0116575861547892,0.00655500265110071,0.582926222078657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,0.00168021430349363,0.00306487860596253,-0.00432694776419292,0.00768737637118019,0.583551525608357
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00327053284629607,0.00598414097111624,-0.0149994491496839,0.00845838345709175,0.584708537237316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00498166464456095,0.00912596996726789,-0.022868565780406,0.0129052364912841,0.585159224713525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00171274407948389,0.00313814311637437,-0.00786350458757765,0.00443801642860988,0.585224634270964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NENF,Neudesin,37900,-0.00550088608136195,0.0101207818569479,-0.0253376185209798,0.0143358463582559,0.586778199958365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39961,-0.00191451424699759,0.00353275342809918,-0.00883871096607198,0.0050096824720768,0.587872724228729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,-0.0043665873440964,0.00813015927053257,-0.0203016995143402,0.0115685248261474,0.591217945513669
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00245886123947594,0.00458330246918982,-0.0065244116001361,0.011442134079088,0.591634254755253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00230278525749922,0.00430968444711508,-0.00614419625884633,0.0107497667738448,0.593122008696589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.00107278108742699,0.00201085657905552,-0.00501405998237581,0.00286849780752184,0.593698691146728
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,-0.00441300441201945,0.00829094699190916,-0.0206632605161614,0.0118372516921225,0.594547922646641
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,-0.00120208963421874,0.00226335068094805,-0.00563825696887691,0.00323407770043943,0.595349501015213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,-0.00247978816397113,0.00467737942642542,-0.0116474518397649,0.0066878755118227,0.596005743158321
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.00455569028139647,0.00859331893723113,-0.0122872148355766,0.0213985953983695,0.596021469518072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,0.00316832340815189,0.00597678324291379,-0.00854617174795913,0.0148828185642629,0.596048019125333
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39961,0.00338631593075011,0.00644601083397119,-0.00924786530383342,0.0160204971653336,0.599357751275604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.00462896600116463,0.00881175760353924,-0.0126420789017723,0.0219000109041015,0.599370235592753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.00120054255990581,0.00228819299897326,-0.00328431571808179,0.00568540083789341,0.599821047841302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,40398,0.0072864423126831,0.0139628330624608,-0.0200807104897401,0.0346535951151063,0.601785119647045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,0.00223840245433066,0.00430969620425769,-0.00620860210601443,0.0106854070146757,0.6034993096725
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,-0.00162582910301564,0.00315159352899241,-0.00780295241984076,0.00455129421380948,0.605950293643804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,40042,-0.00159857946577612,0.00310337311918186,-0.00768119077937257,0.00448403184782034,0.606483247212287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37959,0.00775411709205607,0.0150579418590297,-0.0217594489516422,0.0372676831357544,0.606594997506315
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.00488492178266387,0.00952102406957879,-0.0235461289590383,0.0137762853937106,0.607912989812155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,0.00156596333167979,0.00305395237646032,-0.00441978332618244,0.00755170998954202,0.608123542594164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00248922003088811,0.0049239553853008,-0.0121401725860777,0.00716173252430147,0.613193216471844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37577,-0.00324614716841261,0.00645822346260535,-0.0159042651551191,0.00941197081829387,0.615227388410539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,-0.00264801143293052,0.00526851792142319,-0.01297430655892,0.00767828369305894,0.61524662386308
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.0032222786531282,0.00642340036937409,-0.0158121433771014,0.00936758607084501,0.615924329277899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,-0.00191878882270826,0.00389152498468681,-0.0095461777926944,0.00570860014727789,0.621971050239804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37671,0.0041594785779024,0.00844625810391813,-0.0123951873057771,0.0207141444615819,0.622399500125141
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00319344011895461,0.00649660066269628,-0.0095398971799301,0.0159267774178393,0.623040528681631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.000819932172680981,0.00167552205438659,-0.00246409105391674,0.0041039553992787,0.624595545002126
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37998,0.00200003132824117,0.00408915171270884,-0.00601470602866816,0.0100147686851505,0.624774107042001
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40489,-0.00276177226102695,0.00568239294694191,-0.0138992624370331,0.0083757179149792,0.626957674966854
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,-0.00401217261979031,0.00829287046067338,-0.0202661987227101,0.0122418534831295,0.62852748602064
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,0.00402223206034027,0.0083349047576531,-0.0123141812646598,0.0203586453853403,0.62940427902622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37598,-0.00174491183124265,0.00363662819360089,-0.00887270309070039,0.00538287942821508,0.631366327355419
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,-0.002505939476761,0.00523685845010327,-0.0127701820389634,0.0077583030854414,0.63228844733241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,0.00212474909437262,0.00444714998109245,-0.00659166486856858,0.0108411630573138,0.632815159238735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00222712989799777,0.00466450430842675,-0.0113695583425142,0.00691529854651867,0.633038926226608
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,-0.00221948422609791,0.00465695674719646,-0.011347119450603,0.00690815099840715,0.633658187217892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,-0.00201221211117395,0.00422948021157453,-0.01030199332586,0.00627756910351214,0.634254006616894
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,40341,0.00264611481332501,0.00560549178755141,-0.00834064909027575,0.0136328787169258,0.636892181995435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,-0.00143420872430456,0.00304107847591518,-0.00739472253709832,0.00452630508848921,0.637211696866846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37598,0.00279721898020891,0.00594062682654576,-0.00884640959982077,0.0144408475602386,0.637746671664871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,0.00222715425844953,0.00473116066318328,-0.0070459206413897,0.0115002291582888,0.637833135450018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F3,Tissue factor,40393,-0.00123225741973626,0.00262298219376714,-0.00637330251951986,0.00390878768004734,0.638509683810867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,0.00178966013143336,0.00381462605938179,-0.00568700694495495,0.00926632720782167,0.63896491822247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,0.00191519547449769,0.00410192262423769,-0.00612457286900819,0.00995496381800357,0.640576470143573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40489,-0.00127363625815624,0.00274201561532302,-0.00664798686418935,0.00410071434787688,0.642303700647659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,-0.0024752100558334,0.00537141667087188,-0.0130031867307423,0.0080527666190755,0.644941575550821
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,40258,-0.00180485285036506,0.00392408505001019,-0.00949605954838503,0.0058863538476549,0.645563936548368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00255716786830928,0.0055735923620418,-0.0134814088979112,0.00836707316129264,0.646384971573244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,0.00433121064988454,0.00944935445950077,-0.014189524090737,0.022851945390506,0.646700999334526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,-0.0028838765961628,0.00630105764902441,-0.0152339495882506,0.00946619639592504,0.647188965010073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.00114069869307027,0.00250021947782455,-0.00375973148346585,0.0060411288696064,0.64822533879172
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37598,-0.00248548760698926,0.00545335375934673,-0.0131740609753089,0.00820308576133034,0.648561250427076
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,0.00121309273805116,0.00268338934421831,-0.00404635037661672,0.00647253585271905,0.651221320833984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,0.00204240978169156,0.00452577160637347,-0.00682810256680045,0.0109129221301836,0.651792105771974
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00192784075607068,0.00427618228661608,-0.00645347652569683,0.0103091580378382,0.652117933084474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.00182665999546302,0.00409214331895071,-0.00619394090968037,0.00984726090060642,0.655328530574209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0032200829519908,0.00722728228226356,-0.0173855562252274,0.0109453903212458,0.65593274136392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.00239722024421076,0.00543529760279912,-0.013050403545697,0.00825596305727552,0.65918640233228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,-0.0049357776554592,0.0112475486033849,-0.0269809729180936,0.0171094176071752,0.660789776919423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,0.00107923991398511,0.00246180665265949,-0.0037459011252275,0.00590438095319772,0.661107066747205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,0.00287846406685706,0.00657476699900957,-0.0100080792512017,0.0157650073849158,0.661535051560675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-0.00222641745033528,0.00513848448403384,-0.0122978470390416,0.00784501213837104,0.664816209491417
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,0.0031673817148094,0.00732978815848346,-0.0111990030758182,0.017533766505437,0.665657910734736
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00160004390868934,0.00371234191927369,-0.00887623407046578,0.00567614625308709,0.666469553835386
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37714,0.00211653027959651,0.00492220920293609,-0.00753099975815824,0.0117640603173512,0.667205535778513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,0.00178629988375799,0.00415644264703463,-0.00636032770442988,0.00993292747194586,0.667372376612708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39925,0.00136929304920658,0.00319835227594802,-0.00489947741165154,0.00763806351006471,0.668566420957478
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00228283642510703,0.00537741205880932,-0.0128225640603733,0.00825689121015924,0.671191046691378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,-0.00249417331608485,0.00589315313155984,-0.0140447534539421,0.00905640682177243,0.672132620942597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C5,Complement C5,38013,0.000606005056348477,0.00143242441626808,-0.00220154679953697,0.00341355691223392,0.672256369207956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37900,0.00318272066814879,0.00755318206331164,-0.011621516175942,0.0179869575122396,0.673488143878888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,0.00309342946155043,0.00734247128351019,-0.0112978142541295,0.0174846731772304,0.673538129212254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,0.00348140962042208,0.00833578537577355,-0.0128567297160941,0.0198195489569382,0.676212647631359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.00150160323851436,0.00360611945259808,-0.00856959736560659,0.00556639088857787,0.677119902514762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,-0.00133407429337131,0.0032314516738454,-0.00766771957410829,0.00499957098736567,0.679730221821892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,0.00256296776828938,0.00622050943545352,-0.00962923072519952,0.0147551662617783,0.680331080052512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,40042,-0.00278506768215749,0.00679470391650331,-0.016102687358504,0.010532551994189,0.681893731484095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,40042,-0.00410741064888306,0.0100715348065509,-0.0238476188697229,0.0156327975719567,0.683408708482896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37572,0.00266005942860737,0.006540600483077,-0.0101595175182236,0.0154796363754383,0.684235287585428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.00162131017489281,0.00398790514132115,-0.00619498390209665,0.00943760425188226,0.684338945052501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,-0.00178720582309197,0.00441662852413129,-0.0104437977303893,0.00686938608420537,0.685737633104279
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARTN,Artemin,40044,0.00168053247458718,0.00416942233507107,-0.00649153530215212,0.00985260025132647,0.68690871097182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.00084118947685532,0.00208976516062593,-0.00493712919168214,0.0032547502379715,0.687301666565342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,-0.00101560350739836,0.00256157742688862,-0.00603629526410005,0.00400508824930333,0.691759344329679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40536,0.000711591217287802,0.00181508034408452,-0.00284596625711786,0.00426914869169347,0.695030955312369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,-0.000841844964226778,0.00216682715451019,-0.00508882618706675,0.00340513625861319,0.697640145673863
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,0.00220857848370836,0.0057088167313938,-0.00898070230982349,0.0133978592772402,0.698856622663313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,-0.00162297259302163,0.00420546386829538,-0.00986568177488058,0.00661973658883732,0.699562090619524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37959,0.00110032818295606,0.00285131990993652,-0.00448825884051952,0.00668891520643165,0.699575813635619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.000852366864352311,0.00223876473010307,-0.00524034573535432,0.0035356120066497,0.703408054585024
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,0.00299343261562533,0.00793707466507791,-0.0125632337279274,0.018550098959178,0.706071475295624
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,0.00451439477604009,0.012011869240539,-0.0190288689354163,0.0280576584874965,0.707049871777826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,37482,-0.00108973435091925,0.00290755594190129,-0.00678854399704579,0.00460907529520728,0.707819820202277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,-0.00175565387893916,0.00468702435672421,-0.0109422216181186,0.0074309138602403,0.707980760974956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37598,0.00180614522334634,0.00482945396250587,-0.00765958454316516,0.0112718749898578,0.708421217340714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRL,Prolactin,40471,0.00266003848542225,0.00716517710631479,-0.0113837086429547,0.0167037856137992,0.710459728415832
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37572,-0.00148858263394387,0.00403062118298383,-0.00938860015259218,0.00641143488470444,0.711896359876114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,0.0011677485186153,0.00316702095262406,-0.00503961254852785,0.00737510958575845,0.712341147061138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,0.00145440578188889,0.00396566655348495,-0.0063183006629416,0.00922711222671939,0.713811877621303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,40044,-0.000979237019260692,0.00268452289694865,-0.00624090189728005,0.00428242785875866,0.715287046296073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,40042,-0.00185442844334978,0.0051061998510222,-0.0118625801513533,0.00815372326465373,0.716481380364287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.00294197006341222,0.0081085295852772,-0.0188346880505555,0.0129507479237311,0.716741265931838
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,-0.00138075193352518,0.00384326175539398,-0.00891354497409739,0.00615204110704703,0.719402190028822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.00138938313552649,0.00391708429337068,-0.00906686835053302,0.00628810207948003,0.722820422572873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-0.00164843220644152,0.00466316012551833,-0.0107882260524574,0.00749136163957441,0.723717613575378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,37541,-0.0021383909897085,0.00610379738787304,-0.0141018338699397,0.00982505189052265,0.726090832637366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00149606316650205,0.00427082353660645,-0.00986687729825069,0.00687475096524658,0.726120238647273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,0.00279716079492148,0.00808769428747624,-0.013054720008532,0.0186490415983749,0.729458056897908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,0.00140361603955146,0.0040785289955425,-0.00659030079171185,0.00939753287081476,0.730740801910483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIM,Vimentin,40042,0.0037960799497234,0.0110930338804433,-0.0179462664559454,0.0255384263553922,0.732202029960317
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37987,-0.00151843352409231,0.00445630785225012,-0.0102527969145026,0.00721592986631794,0.733306100578656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,-0.00112423328476619,0.00331775589065649,-0.00762703483045291,0.00537856826092052,0.734725498357057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00102765516913987,0.00307041689378142,-0.00499036194267171,0.00704567228095144,0.737860012953285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.00152887347156639,0.00462765597773339,-0.0105990791879238,0.00754133224479107,0.741120042442345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,37482,-0.00129724279769559,0.00392795846023962,-0.00899604137976524,0.00640155578437407,0.741209740008424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37990,-0.000898369380237162,0.00273093771559556,-0.00625100730280446,0.00445426854233014,0.742190980490802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37880,0.00156882118993171,0.00478892768742899,-0.00781747707742912,0.0109551194572925,0.74322420622181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00113953847793978,0.00347861833638903,-0.00795763041726228,0.00567855346138271,0.743231719504234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37598,0.000912745822036984,0.0027920026238295,-0.00455957932066885,0.00638507096474281,0.74373784517905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,-0.00206515650596507,0.00637481637697401,-0.0145597966048341,0.010429483592904,0.745976871503889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTTG1,Securin,37714,-0.00124856271041541,0.00387627059425198,-0.00884605307514929,0.00634892765431847,0.747378897710817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,-0.00123717146148177,0.00391869104280766,-0.00891780590538477,0.00644346298242124,0.75222736446897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00119662406061225,0.00381458138376906,-0.0086732035727996,0.0062799554515751,0.753755881696327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.000667664453499257,0.00215169876674223,-0.0035496651293155,0.00488499403631402,0.756339579744184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.00164795752653537,0.00535279807857195,-0.00884352670746566,0.0121394417605364,0.758187338096129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,0.000939685667063499,0.00305963542702333,-0.00505719976990222,0.00693657110402922,0.758754155156407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37942,-0.00169285658263405,0.00558188601553282,-0.0126333531730784,0.00924764000781029,0.761683594430067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00077937043133168,0.00260169528889796,-0.00431995233490833,0.00587869319757169,0.764514765005253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,0.00335026205181522,0.0112169173705141,-0.0186348959943925,0.0253354200980229,0.765189424561825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37714,-0.001709710469072,0.00578311127622046,-0.0130446085704641,0.0096251876323201,0.767510780271982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39878,-0.00194483486720134,0.00657912464981948,-0.0148399191808475,0.0109502494464448,0.767534256231259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37562,-0.00111544499549159,0.00379964627728828,-0.00856275169897662,0.00633186170799344,0.769094601454739
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,0.00256832647362595,0.00877391186289167,-0.0146285407776417,0.0197651937248936,0.769738449568889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.00474087931976145,0.0162178547214262,-0.0365278745737568,0.0270461159342339,0.770042893838569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00104754887517283,0.00360249652368561,-0.00810844206159664,0.00601334431125097,0.771220973137018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,-0.00173293814056944,0.00598041735358072,-0.0134545561535877,0.00998867987244876,0.771996913422237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00181341041178899,0.00634616440374883,-0.0106250718195587,0.0142518926431367,0.775074154588852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,-0.00181068693127329,0.00640055591172195,-0.0143557765182483,0.0107344026557017,0.777261621714611
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37998,-0.0015072229607347,0.00534570018419213,-0.0119847953217513,0.00897034940028187,0.777985756115629
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.00280399016306729,0.0101341717730219,-0.0170589865120556,0.0226669668381902,0.782025191106506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,37541,0.00116316001060431,0.00421473447270197,-0.00709771955589156,0.00942403957710017,0.782571868230439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37942,-0.00240530064041981,0.00887434313625689,-0.0197990131874833,0.0149884119066437,0.786364529393855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00161243100086969,0.00595157790094054,-0.0100526616849738,0.0132775236867132,0.786452334665701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,38013,0.00052537388988502,0.00194184921517604,-0.00328065057186001,0.00433139835163005,0.786738665150668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00142875619596091,0.00529674189973077,-0.00895285792751139,0.0118103703194332,0.787362663203225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.00107942253715307,0.00402755998288398,-0.00897344010360567,0.00681459502929952,0.788696563516341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEB,Nebulin,37562,0.000913193432206139,0.00340922752539743,-0.00576889251757282,0.0075952793819851,0.788811806890376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.000512119802653066,0.00191475008304361,-0.00324079036011241,0.00426502996541854,0.78911816216805
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.000680714303855374,0.00254537280991157,-0.00566964501128206,0.00430821640357131,0.789139972340896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,-0.000939665597982665,0.00351404199555533,-0.00782718790927112,0.00594785671330579,0.789162377063313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.000840051283665229,0.00315268439784588,-0.00701931270344316,0.0053392101361127,0.789892324379818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00106591289178474,0.00402462865398471,-0.00682235927002529,0.00895418505359478,0.791131093448078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39980,-0.00230436944536176,0.00877373385969798,-0.0195008878103698,0.0148921489196463,0.792828389352158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37572,-0.00105847276480606,0.00403826312866473,-0.00897346849698893,0.00685652296737681,0.793240061948944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,40044,0.001945722237795,0.0074498552673606,-0.0126559940862318,0.0165474385618218,0.793960354892406
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FN1,Fibronectin,38013,0.000640073211247756,0.00245297432594127,-0.00416775646759713,0.00544790289009264,0.794144597640342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,40417,-0.00267346262711791,0.0105419744384829,-0.0233357325265444,0.0179888072723086,0.79980654962564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37572,-0.000637885812842033,0.00254632940608612,-0.00562869144877083,0.00435291982308677,0.80219542721415
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00175247753524097,0.00700537427555643,-0.0119780560448496,0.0154830111153316,0.802466045424028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.000803187772151751,0.00323802090803543,-0.00554333320759769,0.00714970875190119,0.804099696262992
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.000821798877711073,0.00333028945778507,-0.00734916621496981,0.00570556845954766,0.805093865586488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40471,0.000668655899785905,0.00275122092358313,-0.00472373711043702,0.00606104891000883,0.807977757244677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.000933515968921533,0.00384382611551322,-0.00660038321748438,0.00846741515532744,0.808116763883081
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,-0.00408462374181024,0.0168308001062805,-0.03707299195012,0.0289037444664995,0.808250683700167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,-0.00110101337084151,0.00454592957199011,-0.0100110353319421,0.00780900859025911,0.808630809051589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,-0.00146697955373735,0.00606221323905833,-0.0133489175022917,0.010414958394817,0.808793674877494
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.000834062450169133,0.00345444945014909,-0.00760478337246135,0.00593665847212308,0.809212689997954
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,39311,-0.00108458701705751,0.00451300974971264,-0.00993008612649429,0.00776091209237927,0.810081983275084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,0.00188679656397663,0.00792972556366913,-0.0136554655408149,0.0174290586687681,0.81193153515816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.00107307017029794,0.00451897647104164,-0.00993026405353955,0.00778412371294368,0.812304674520982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.00127611030110158,0.00544727912454562,-0.00940055678300783,0.011952777385211,0.814781778215184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.000919647426459379,0.00404839952931754,-0.00885451050392175,0.00701521565100299,0.820300297775149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,-0.000605463378588306,0.00267502218353933,-0.0058485068583254,0.00463758010114878,0.820940198314405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,40044,-0.00101031150157636,0.00449242506472673,-0.00981546462844075,0.00779484162528803,0.822066059291745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.000816736205248155,0.00363611056313272,-0.00794351290898828,0.00631004049849197,0.822279334983963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00121313012168105,0.00542935760784697,-0.0118546710330611,0.009428410789699,0.823197351391248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,40354,0.000815356226458836,0.00366751030067378,-0.00637296396286178,0.00800367641577945,0.824068628818334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0010224816550135,0.0046395732130813,-0.00807108184262584,0.0101160451526528,0.825576021213215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,0.00176884302183415,0.00807580420116615,-0.0140597332124515,0.0175974192561198,0.826630144987752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,-0.000844362032804744,0.00392709421423165,-0.00854146669269877,0.00685274262708928,0.829763382133617
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00186660766772952,0.0086819713590503,-0.0188832715314681,0.0151500561960091,0.829772112725925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39934,-0.000713922444702097,0.00336425430032767,-0.00730786087334434,0.00588001598394014,0.831947381243964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTN,Titin,37562,0.0012879409691152,0.00614490640647763,-0.010756075587581,0.0133319575258114,0.833987126689289
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,-0.000423482035521851,0.00205619254296031,-0.00445361941972406,0.00360665534868036,0.836829669446998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00105262834707234,0.00514951785272065,-0.00904042664426013,0.0111456833384048,0.838033957280445
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37671,-0.000824693046150084,0.00405295258009709,-0.00876848010314038,0.00711909401084021,0.838763344875046
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,0.00147853846948704,0.0072728979007763,-0.0127763414160345,0.0157334183550086,0.838908109692266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.000753334693845725,0.00377240544519972,-0.00664057997874574,0.00814724936643718,0.84172135818659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,0.000861565719742455,0.00431615984724079,-0.00759810758084949,0.0093212390203344,0.841785512355442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.000751275126557563,0.00379169608738983,-0.00818299945784162,0.0066804492047265,0.842940449674747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,0.00152918423805295,0.00773342120126506,-0.0136283213164266,0.0166866897925325,0.843253796119658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.000487742567162817,0.00246797606800402,-0.00532497566045071,0.00434949052612507,0.84333867116265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.00155846579334324,0.00794647201764561,-0.0171335509479286,0.0140166193612421,0.844518447477747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,0.00102854926346084,0.00527945004676451,-0.0093191728281976,0.0113762713551193,0.845535866003936
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.000997781504297338,0.00512211790931489,-0.0110371326065545,0.00904156959795984,0.845553140074049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00114459953063981,0.00589217878365467,-0.0104040708853233,0.012693269946603,0.845977323361764
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.000978329117124776,0.00505998864095021,-0.0108959068533872,0.00893924861913763,0.846690931107933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.000667926896100185,0.00345778441592539,-0.00610933055911358,0.00744518435131395,0.846831833576134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,40357,-0.000643219241028301,0.00336555137177775,-0.00723969992971268,0.00595326144765608,0.848435167463479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.000509142371937795,0.00271813729064454,-0.0058366914616011,0.00481840671772551,0.851418144193594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.000930850975821893,0.00498096252796359,-0.0106935375306305,0.00883183557898675,0.851755795813952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.00188398909386004,0.0101555702622407,-0.0217889068078518,0.0180209286201317,0.852829652843862
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.000748939224272259,0.00404043845515753,-0.00717032014783651,0.00866819859638102,0.852948414498254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.000834027828959838,0.00451418995563312,-0.00968184014200075,0.00801378448408108,0.853422074423017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.000666474175163159,0.00363932521549005,-0.00779955159752366,0.00646660324719734,0.854697866331821
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.000681560894244147,0.00373028217508079,-0.00799291395740249,0.00662979216891419,0.855028096239338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00103785584504674,0.00572512524021213,-0.0122591013158625,0.010183389625769,0.856149455376143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,40228,0.000203572978007432,0.00114103707332929,-0.00203285968571797,0.00244000564173283,0.858402906172853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37572,-0.00109159669985248,0.00612773955688502,-0.0131019662313471,0.0109187728316422,0.858615628633882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00094232732420737,0.00537016903459226,-0.0114678586320082,0.00958320398359347,0.860709143398309
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.000899566612315993,0.00514381469336567,-0.00918231018668072,0.0109814434113127,0.861174129182188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37987,0.000413782055975707,0.0023951484228555,-0.00428070885282107,0.00510827296477248,0.862843905106733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,37482,-0.000988479663258735,0.00584345562869661,-0.0124416526955041,0.0104646933689866,0.865673322080019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.000746251568063573,0.00444276362712666,-0.00796156514110468,0.00945406827723183,0.866609371774721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37714,-0.00086660021604739,0.00518090378511766,-0.011021171634878,0.00928797120278323,0.867161610217251
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37562,-0.000742254161640715,0.00446624218686024,-0.00949608884788679,0.00801158052460536,0.868008340249359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,37482,0.00120340296236506,0.00760347825025276,-0.0136994144081303,0.0161062203328605,0.874246451706225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FST,Follistatin,40396,-0.000767980964773053,0.00485688315676444,-0.0102874719520314,0.00875151002248525,0.874362523889466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00126557546559073,0.00815183908875259,-0.0172431800795458,0.0147120291483644,0.876626383428481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39992,-0.000688668633941882,0.00447598325769568,-0.00946159581902541,0.00808425855114164,0.877723205133968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39980,0.00205765023929237,0.0134094438891607,-0.0242248597834627,0.0283401602620474,0.87804711237659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39980,0.000586091078910815,0.00382208071796795,-0.00690518712830637,0.008077369286128,0.87812942294685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.000338758297221048,0.00222196297418215,-0.00469380572661807,0.00401628913217597,0.878826864091979
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,0.000393100726448574,0.00260566331612035,-0.00471399937314731,0.00550020082604446,0.880085333352724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,37482,0.00100858219578583,0.00692162255076406,-0.0125577980037117,0.0145749623952834,0.884148865464662
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.000678597077666849,0.00477305522906157,-0.0100337853266275,0.00867659117129383,0.886945955304863
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,0.000656291814810122,0.00470395336753917,-0.00856345678556665,0.00987604041518689,0.889042128184973
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,-0.000768952285526231,0.0055375559305032,-0.0116225619093125,0.01008465733826,0.889561522941833
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,37482,0.00077282943572365,0.00572367224309284,-0.0104455681607383,0.0119912270321856,0.892595493484329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,0.000441895997761698,0.00332578022101714,-0.0060766332354319,0.00696042523095529,0.894298332186532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,0.000810088660913609,0.00628474731399501,-0.0115080160745166,0.0131281933963438,0.897440670833306
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37572,-0.000570233157669861,0.00454097449832183,-0.00947054317438065,0.00833007685904093,0.900070227742234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39961,-0.000707802294790871,0.00566297267232516,-0.0118072287325482,0.0103916241429664,0.900534856828077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,0.000657942446818527,0.0052677995824678,-0.00966694473481837,0.0109828296284554,0.900605504921805
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,40003,0.000721065027075592,0.00585667277251343,-0.0107580136070507,0.0122001436612019,0.902014817702153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.000485573079242675,0.00397175331121675,-0.00729906341074215,0.0082702095692275,0.902697671499452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,0.000969764927659342,0.00796230620725576,-0.0146363552385619,0.0165758850938806,0.90306363266904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,0.000615377487809305,0.00510172507285593,-0.00938400365498832,0.0106147586306069,0.903992703665479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37998,-0.000499769682082646,0.0041666931721847,-0.00866648829956466,0.00766694893539937,0.904529319008142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.000534076242444678,0.00453041243318483,-0.00941368461148694,0.00834553212659758,0.906159085264842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.00151698562120149,0.0128711553856723,-0.0267444501771191,0.0237104789347161,0.906180873918864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,40044,-0.000449835664070279,0.00385454445710474,-0.00800474279999558,0.00710507147185502,0.907097170380841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37572,-0.000379247901204452,0.00326928062516635,-0.0067870379265305,0.0060285421241216,0.907651566064255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.000643698319640224,0.005713321293199,-0.0118418080543103,0.0105544114150298,0.910296591596204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.000704152423404574,0.00646569045918145,-0.0119686008765911,0.0133769057234002,0.913278672976909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.000526448983056148,0.00497426996223072,-0.00922312014291606,0.0102760181090284,0.91571532652556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,0.000404160765490055,0.00385335017403414,-0.00714840557561686,0.00795672710659697,0.916468226986418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.000565440827553677,0.00540386875972376,-0.0111570235966122,0.0100261419415049,0.916666020838593
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.000632707991815044,0.00615040281103798,-0.0126874975014495,0.0114220815178194,0.918065406171549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37598,-0.000597948360654562,0.00585953903157152,-0.0120826448625347,0.0108867481412256,0.918720928128724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.000700454016451322,0.00690300341120814,-0.0142303407024193,0.0128294326695166,0.919177919817344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,0.000627458822729269,0.00622885452018278,-0.011581096036829,0.0128360136822875,0.919762738391668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.000323796119458182,0.00329296592161102,-0.00677800932581578,0.00613041708689941,0.921672010223302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.000534388591950219,0.00567043010216463,-0.0105796544082925,0.0116484315921929,0.924918930105214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,-0.000225372185539215,0.00247646757630306,-0.00507924863509321,0.00462850426401478,0.927489562241027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00048816730478768,0.00568840748799674,-0.0116374459812613,0.0106611113716859,0.931612478636475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.00033349100003933,0.0038961986475073,-0.00730305834907498,0.00797004034915364,0.931790529662847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37598,-0.000705383691070141,0.00832700631966367,-0.0170263160776109,0.0156155486954707,0.932492950560312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37572,-0.00035709714722043,0.00457782076584524,-0.00932962584827711,0.00861543155383625,0.93782452876185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37572,0.000339700194761025,0.00437408739029323,-0.00823351109021371,0.00891291147973576,0.938098139414983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.000496489965405318,0.00639470865532413,-0.01203713899903,0.0130301189298406,0.938115009315086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39961,0.000313092683276438,0.00413755955634147,-0.00779652404715284,0.00842270941370571,0.93968193715129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37598,-0.000507657773696995,0.00714085098702641,-0.0145037257082688,0.0134884101608748,0.943325572498985
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.000473225432530429,0.00685404557579829,-0.0139071547610951,0.0129607038960342,0.944956265156719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.000361068464964313,0.00538643236853962,-0.010918475907302,0.0101963389773733,0.946556492100534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.000289908446728823,0.00447792564216437,-0.00906664270537099,0.00848682581191334,0.948380506815257
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.000471746893788054,0.00729754360077444,-0.0138314385637298,0.014774932351306,0.948457942323102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37598,0.00024748425738455,0.00407044071208919,-0.00773057953831026,0.00822554805307936,0.951519128501976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.000352912442056266,0.00694986209807841,-0.0132688172701774,0.0139746421542899,0.95950164495457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.000323786553371187,0.00646518347662318,-0.0129955461675526,0.0123479730608102,0.960058146891213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.000225088697684869,0.00457977953224223,-0.0087512791855099,0.00920145658087963,0.960801827419027
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37714,0.000324675866798252,0.00687315659337419,-0.0131467110562152,0.0137960627898117,0.962324056355782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-9.59752575531827e-05,0.00209544921191977,-0.00420305571291592,0.00401110519780956,0.963468953354906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37942,0.000159839785845534,0.00361852204665031,-0.00693246342558907,0.00725214299728014,0.964767419524767
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.000362605137890077,0.00848770178633664,-0.0169985006391099,0.0162732903633297,0.965924380102658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,40044,0.000205794990868637,0.00504473515373605,-0.00968188591045402,0.0100934758921913,0.967460634726572
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37572,0.000235285439907874,0.0062058128628201,-0.0119281077712195,0.0123986786510353,0.969757052227233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37714,-0.00020583559745234,0.00570091008158668,-0.0113796193573622,0.0109679481624576,0.971198586026606
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,40305,-6.41915908029124e-05,0.00178887675143681,-0.00357039002361906,0.00344200684201324,0.971375511771625
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37959,-0.000136753120176695,0.00410087637817698,-0.00817447082140357,0.00790096458105018,0.973398134252895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.000272768014069449,0.00830248585545282,-0.016545640290757,0.0160001042626181,0.97379169408809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,9.89871004134156e-05,0.00301561032538972,-0.00581160913735044,0.00600958333817727,0.973814637234473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37598,-8.80840921504356e-05,0.00298871076920192,-0.0059459571997862,0.00576978901548533,0.976488381677517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,-0.00023186680679419,0.00821088678521988,-0.0163252049058251,0.0158614712922368,0.977471926506299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.000169367551988435,0.00682381773525056,-0.0132053152091027,0.0135440503130795,0.980198869480215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-7.55987632681306e-05,0.00357719651001923,-0.00708690392290583,0.00693570639636957,0.983139465268501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,40044,7.90925527189881e-05,0.00461967373788364,-0.00897546797353295,0.00913365307897092,0.986340457048704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,40044,0.000100824616652862,0.00597995944978776,-0.0116198959049312,0.0118215451382369,0.986548185768092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-5.27916779064597e-05,0.00338479035913144,-0.00668698078180408,0.00658139742599116,0.987556345157049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,3.07639641375228e-05,0.00263912820588438,-0.00514192731939586,0.0052034552476709,0.990699554023743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,3.60136208409872e-05,0.00428473601586773,-0.00836206897025977,0.00843409621194175,0.993293906303266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,3.22643372643519e-05,0.00424920012663748,-0.0082961679109451,0.0083606965854738,0.993941786729243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,40044,2.19208254828794e-05,0.00293406748750434,-0.00572885145002563,0.00577269310099139,0.994039044727391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-7.50897248021603e-05,0.0120408665706903,-0.0236751882033552,0.0235250087537509,0.995024325725621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39980,5.25671375959917e-05,0.010061340658674,-0.019667660553405,0.019772794828597,0.995831406288411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,8.340424522611e-06,0.00236978082864844,-0.00463642999962834,0.00465311084867356,0.997191911487127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37998,6.32052916354801e-06,0.00439740751713761,-0.00861259820442616,0.00862523926275326,0.998853197524301
